Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,A1BG,Alpha-1B-glycoprotein,43287,129,2.73 [0.99-7.55],0.0534345664973041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AAMDC,Mth938 domain-containing protein,42083,123,1.10 [0.80-1.53],0.5538747301885893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AARSD1,Alanyl-tRNA editing protein Aarsd1,49371,166,1.20 [0.95-1.53],0.1337104618858337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABCA2,ATP-binding cassette sub-family A member 2,41815,123,1.16 [0.72-1.88],0.5399872753084297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABHD14B,Protein ABHD14B,49070,166,1.22 [0.96-1.56],0.0995859803566826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABL1,Tyrosine-protein kinase ABL1,49371,166,1.13 [0.92-1.38],0.2349231034165859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABO,Histo-blood group ABO system transferase,43258,128,0.97 [0.86-1.09],0.5670135160825647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ABRAXAS2,BRISC complex subunit Abraxas 2,41815,123,1.01 [0.78-1.32],0.9411204715888192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",48422,162,1.17 [1.00-1.38],0.0532097201188265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",42437,128,1.01 [0.79-1.29],0.9117098775664542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",43226,128,0.94 [0.78-1.14],0.5295451627128817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACAN,Aggrecan core protein,49148,165,1.00 [0.61-1.65],0.984472118059141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE,Angiotensin-converting enzyme,43258,128,1.36 [0.73-2.52],0.3376216614979632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,48693,163,1.46 [1.17-1.83],0.000747350050109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACHE,Acetylcholinesterase,42273,122,1.19 [0.71-1.97],0.5130706183093227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOT13,Acyl-coenzyme A thioesterase 13,43035,128,0.98 [0.84-1.13],0.7694192572204637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,49610,166,1.35 [1.07-1.70],0.0109173793222314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP1,Low molecular weight phosphotyrosine protein phosphatase,41967,124,0.73 [0.49-1.10],0.1383629461360331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP5,Tartrate-resistant acid phosphatase type 5,49833,167,1.27 [0.84-1.90],0.2578126748972479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP6,Lysophosphatidic acid phosphatase type 6,49949,168,0.89 [0.74-1.07],0.217061227285517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRBP,Acrosin-binding protein,43021,127,1.07 [0.70-1.63],0.7572692967653459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACRV1,Acrosomal protein SP-10,41967,124,0.94 [0.77-1.14],0.5132385890081421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACSL1,Long-chain-fatty-acid--CoA ligase 1,41815,123,1.29 [0.87-1.93],0.2061926665856956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",48693,163,1.40 [1.08-1.81],0.0102192550562158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN2,Alpha-actinin-2,41815,123,1.31 [1.01-1.69],0.0393360181182006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTN4,Alpha-actinin-4,48668,162,0.71 [0.43-1.18],0.1909613991498112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,49142,166,2.19 [1.34-3.57],0.0016716764691252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY1,Aminoacylase-1,49610,166,1.05 [0.84-1.31],0.6878875661330095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,41815,123,1.10 [0.81-1.48],0.553121623215215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACYP1,Acylphosphatase-1,42120,122,0.89 [0.68-1.17],0.4119866327184819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA,Adenosine deaminase,50157,167,1.34 [0.94-1.90],0.1054246869335121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADA2,Adenosine deaminase 2,49318,166,1.56 [1.16-2.11],0.0031694025616301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,41967,124,1.97 [1.37-2.84],0.0002549082655781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,48693,163,1.45 [0.93-2.27],0.100513150677144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,49224,166,1.02 [0.70-1.49],0.9010292989930458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,50157,167,0.90 [0.62-1.31],0.5701865011983323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,49969,168,1.32 [0.83-2.10],0.2337579341443852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,43035,128,1.73 [1.03-2.91],0.0378245674552383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,41967,124,1.67 [1.10-2.55],0.0168615610375977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,50221,168,0.90 [0.51-1.58],0.709772348731781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,49371,166,1.14 [0.82-1.58],0.4503654705518299
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,48693,163,1.27 [0.89-1.80],0.1916339952363957
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,41967,124,1.34 [0.84-2.12],0.2145161808066854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,49753,165,0.98 [0.72-1.33],0.9029051127823672
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,43224,130,2.11 [1.38-3.22],0.0005632184044269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL4,ADAMTS-like protein 4,42083,123,2.11 [1.06-4.19],0.0333277325730711
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL5,ADAMTS-like protein 5,43226,128,0.94 [0.61-1.45],0.7741442687763744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,48422,162,0.94 [0.61-1.44],0.770452450149818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADD1,Alpha-adducin,42273,122,0.85 [0.66-1.09],0.1948301353613935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRB3,Adhesion G protein-coupled receptor B3,49142,166,1.31 [0.88-1.96],0.1862177983660403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRD1,Adhesion G-protein coupled receptor D1,42273,122,1.03 [0.66-1.61],0.8793154455276222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE1,Adhesion G protein-coupled receptor E1,43035,128,0.98 [0.72-1.34],0.922589041382858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE2,Adhesion G protein-coupled receptor E2,49821,165,1.22 [0.75-1.97],0.4175272032216549
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRE5,Adhesion G protein-coupled receptor E5,49979,168,1.14 [0.74-1.76],0.5557147333273552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRF5,Adhesion G protein-coupled receptor F5,43226,128,1.36 [0.74-2.50],0.3256853017863146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG1,Adhesion G-protein coupled receptor G1,49371,166,1.16 [1.00-1.34],0.0479192260121796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG2,Adhesion G-protein coupled receptor G2,49610,166,0.66 [0.41-1.06],0.0844995464595086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRV1,Adhesion G-protein coupled receptor V1,41816,123,1.09 [0.87-1.38],0.4450983857236997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH1B,All-trans-retinol dehydrogenase,42273,122,1.03 [0.83-1.30],0.7705848498890173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,48693,163,1.07 [0.90-1.26],0.4503278027772899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,43287,129,1.48 [1.16-1.89],0.001407312628577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,50024,168,2.35 [1.39-3.98],0.0014379560425086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADRA2A,Alpha-2A adrenergic receptor,41815,123,1.07 [0.84-1.34],0.5958940457316176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFAP1,Actin filament-associated protein 1,42273,122,0.96 [0.77-1.19],0.6888939987122187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFM,Afamin,43287,129,0.57 [0.25-1.32],0.1906567612611412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AFP,Alpha-fetoprotein,49063,166,1.14 [0.93-1.41],0.2044306626768179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGBL2,Cytosolic carboxypeptidase 2,41816,123,0.93 [0.77-1.11],0.4035493347069137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGER,Advanced glycosylation end product-specific receptor,49500,165,1.12 [0.81-1.56],0.4857074386892909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR2,Anterior gradient protein 2 homolog,48048,165,1.10 [0.96-1.26],0.187923783965289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGR3,Anterior gradient protein 3,48341,161,0.95 [0.75-1.20],0.6568801975738496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,49821,165,1.83 [1.31-2.54],0.0003657109815856
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRP,Agouti-related protein,50157,167,1.27 [0.98-1.65],0.0737005180236482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGT,Angiotensinogen,43258,128,0.92 [0.41-2.03],0.8300646351076351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGXT,Serine--pyruvate aminotransferase,49610,166,1.15 [0.97-1.37],0.1128525167732279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHCY,Adenosylhomocysteinase,49610,166,1.06 [0.87-1.30],0.5764709402777515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK,Neuroblast differentiation-associated protein AHNAK,42083,123,1.15 [0.67-1.95],0.616472459413854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHNAK2,Protein AHNAK2,42083,123,0.97 [0.54-1.74],0.921714992776198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,43021,127,0.97 [0.75-1.27],0.842397049505915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSG,Alpha-2-HS-glycoprotein,43258,128,1.02 [0.55-1.92],0.9464554463338136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AHSP,Alpha-hemoglobin-stabilizing protein,49538,165,1.03 [0.87-1.21],0.7413454750961395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIDA,"Axin interactor, dorsalization-associated protein",42038,121,0.80 [0.62-1.04],0.0970683125412004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1,Allograft inflammatory factor 1,48422,162,1.23 [0.94-1.59],0.1264928171132761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIF1L,Allograft inflammatory factor 1-like,42083,123,0.91 [0.65-1.29],0.6069746798679718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",49290,166,1.06 [0.93-1.21],0.3796846042598826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK1,Adenylate kinase isoenzyme 1,49610,166,1.10 [0.89-1.36],0.3577271807841571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AK2,"Adenylate kinase 2, mitochondrial",43118,128,0.93 [0.79-1.09],0.3433696651154597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKAP12,A-kinase anchor protein 12,42273,122,0.61 [0.25-1.47],0.2695791622448443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B1,Aldo-keto reductase family 1 member B1,48422,162,1.08 [0.90-1.30],0.410631699567006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1B10,Aldo-keto reductase family 1 member B10,42038,121,1.22 [0.96-1.56],0.1085131556848747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR1C4,Aldo-keto reductase family 1 member C4,48693,163,0.97 [0.74-1.27],0.8333083853806038
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKR7L,Aflatoxin B1 aldehyde reductase member 4,41967,124,1.27 [1.02-1.57],0.0315999436227589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT1S1,Proline-rich AKT1 substrate 1,48439,166,0.99 [0.81-1.22],0.9438867276430406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT2,RAC-beta serine/threonine-protein kinase,43149,126,0.97 [0.85-1.11],0.6774710859658616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AKT3,RAC-gamma serine/threonine-protein kinase,48192,162,1.03 [0.80-1.31],0.8399840473001925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALCAM,CD166 antigen,50221,168,2.26 [1.16-4.41],0.0169482201027539
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH1A1,Retinal dehydrogenase 1,49619,166,1.15 [0.91-1.47],0.239132330291839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH2,"Aldehyde dehydrogenase, mitochondrial",43021,127,0.99 [0.71-1.38],0.9573961352350604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",49458,166,1.11 [0.93-1.33],0.2624067742307125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",43149,126,1.11 [0.78-1.59],0.5594686026173707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALMS1,Alstrom syndrome protein 1,42437,128,1.11 [0.78-1.58],0.5595306644546441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPI,Intestinal-type alkaline phosphatase,41967,124,1.06 [0.92-1.21],0.439702812505051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALPP,"Alkaline phosphatase, placental type",49371,166,1.08 [0.95-1.23],0.249305387918041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBN,Ameloblastin,48668,162,1.25 [0.84-1.87],0.2723715797338134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMBP,Protein AMBP,49953,168,2.75 [1.44-5.25],0.0021254765524624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,43224,130,1.17 [0.61-2.24],0.62959625382817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMFR,E3 ubiquitin-protein ligase AMFR,48439,166,0.89 [0.70-1.12],0.311823995510062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO1,Amphoterin-induced protein 1,42038,121,0.88 [0.60-1.29],0.5128417265408873
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMIGO2,Amphoterin-induced protein 2,49371,166,1.69 [0.94-3.02],0.0785849478738946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMN,Protein amnionless,48668,162,1.18 [0.89-1.58],0.2565879855294917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOT,Angiomotin,42273,122,0.67 [0.42-1.06],0.0897025920071792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOTL2,Angiomotin-like protein 2,42856,127,0.94 [0.65-1.37],0.7536676200889136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMPD3,AMP deaminase 3,43118,128,0.94 [0.74-1.19],0.6205040124671233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,40537,122,0.83 [0.58-1.19],0.3179209848571177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2A,Pancreatic alpha-amylase,47701,157,0.92 [0.69-1.23],0.5830186985635492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMY2B,Alpha-amylase 2B,46244,155,0.91 [0.68-1.22],0.5229740443884754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANG,Angiogenin,49482,167,1.18 [0.79-1.75],0.412555919272173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT1,Angiopoietin-1,49428,164,0.97 [0.82-1.14],0.6906567123629381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,50024,168,2.26 [1.64-3.12],6.431951268557611e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,48888,162,2.26 [1.41-3.62],0.0007231885917464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL2,Angiopoietin-related protein 2,49658,165,1.29 [0.92-1.81],0.1449876014692019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL3,Angiopoietin-related protein 3,49644,167,1.24 [0.85-1.81],0.270700346434831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,49744,165,1.77 [1.31-2.39],0.0002299237718556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL7,Angiopoietin-related protein 7,50024,168,1.12 [0.78-1.63],0.5356596796188491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANK2,Ankyrin-2,41815,123,1.15 [0.93-1.42],0.189034412191668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,41967,124,1.05 [0.85-1.30],0.6593820845861745
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRA2,Ankyrin repeat family A protein 2,41687,124,0.77 [0.55-1.08],0.132120657972932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANKRD54,Ankyrin repeat domain-containing protein 54,48422,162,1.29 [1.05-1.57],0.0141412975880029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,42083,123,1.30 [0.92-1.83],0.1412494503101233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANPEP,Aminopeptidase N,49725,167,1.78 [1.13-2.81],0.0130668771734179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA1,Annexin A1,42045,121,1.12 [0.77-1.63],0.5541991343836693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA10,Annexin A10,48439,166,1.09 [0.93-1.27],0.27555681483451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA11,Annexin A11,49460,166,1.13 [0.92-1.40],0.2492272458071073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA2,Annexin A2,41458,123,1.38 [1.14-1.68],0.0012162787249562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA3,Annexin A3,49969,168,1.23 [1.01-1.48],0.0357673526035142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA4,Annexin A4,49372,165,1.11 [0.92-1.34],0.2804221052792122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANXA5,Annexin A5,48285,166,1.19 [0.75-1.86],0.4595650292656859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC1,Amiloride-sensitive amine oxidase [copper-containing],48668,162,0.88 [0.67-1.15],0.3489344599663199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AOC3,Membrane primary amine oxidase,49806,167,1.61 [1.02-2.55],0.0396249437209639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP1G2,AP-1 complex subunit gamma-like 2,43021,127,1.00 [0.81-1.24],0.9993216056387152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP2B1,AP-2 complex subunit beta,42038,121,0.74 [0.50-1.11],0.1419060909863044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3B1,AP-3 complex subunit beta-1,43035,128,0.99 [0.79-1.23],0.9119190297262828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP3S2,AP-3 complex subunit sigma-2,43118,128,1.10 [0.78-1.56],0.5922926443100801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,49371,166,1.27 [0.97-1.67],0.0812571036858322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APCS,Serum amyloid P-component,42898,127,0.78 [0.47-1.30],0.3441992369564706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,49866,168,1.31 [1.06-1.61],0.0128748749983804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APLP1,Amyloid-like protein 1,49610,166,0.85 [0.65-1.11],0.226993550093321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA1,Apolipoprotein A-I,43287,129,1.34 [0.76-2.38],0.3108640304497122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA2,Apolipoprotein A-II,43258,128,1.20 [0.85-1.68],0.2939504643956571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA4,Apolipoprotein A-IV,43287,129,1.34 [0.87-2.06],0.1803751352109927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOB,Apolipoprotein B-100,43258,128,0.87 [0.42-1.82],0.7196552342655096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOBR,Apolipoprotein B receptor,42083,123,0.93 [0.62-1.38],0.70986922382441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOC1,Apolipoprotein C-I,43204,129,1.10 [0.71-1.71],0.678213881307286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOD,Apolipoprotein D,41345,125,1.03 [0.68-1.56],0.8781530958722665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOE,Apolipoprotein E,43287,129,1.10 [0.89-1.36],0.3736704954173707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOF,Apolipoprotein F,43258,128,0.98 [0.55-1.74],0.9458786239570128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOH,Beta-2-glycoprotein 1,49619,166,1.07 [0.74-1.54],0.7223829484021875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOL1,Apolipoprotein L1,43258,128,0.88 [0.65-1.19],0.4043027467890498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOM,Apolipoprotein M,49726,167,0.71 [0.45-1.14],0.1616182607342047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APP,Amyloid-beta precursor protein,49548,166,1.03 [0.84-1.26],0.7806197271221141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APPL2,DCC-interacting protein 13-beta,42273,122,0.94 [0.80-1.09],0.3970763798747743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APRT,Adenine phosphoribosyltransferase,49145,165,1.17 [0.87-1.57],0.2875778986455919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARAF,Serine/threonine-protein kinase A-Raf,42437,128,1.07 [0.84-1.36],0.5810107252653431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,49371,166,1.87 [1.44-2.44],3.544623822731373e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARF6,ADP-ribosylation factor 6,43035,128,0.96 [0.83-1.13],0.6448000386117314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARFIP1,Arfaptin-1,43149,126,0.96 [0.75-1.23],0.7356824238880283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG1,Arginase-1,49302,165,0.97 [0.75-1.25],0.7970108902030096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARG2,"Arginase-2, mitochondrial",43021,127,0.75 [0.47-1.18],0.2152311713697979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP1,Rho GTPase-activating protein 1,48422,162,0.94 [0.69-1.27],0.6731954362758993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP25,Rho GTPase-activating protein 25,48422,162,1.14 [0.91-1.42],0.2471739717757201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP30,Rho GTPase-activating protein 30,42437,128,0.64 [0.36-1.13],0.1223919004664011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP45,Rho GTPase-activating protein 45,42273,122,0.88 [0.71-1.09],0.2415943173093614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP5,Rho GTPase-activating protein 5,41687,124,1.11 [0.90-1.36],0.3334611114952636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF1,Rho guanine nucleotide exchange factor 1,43118,128,1.00 [0.83-1.21],0.9621082916438012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF10,Rho guanine nucleotide exchange factor 10,43149,126,0.95 [0.79-1.14],0.573000207671122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF12,Rho guanine nucleotide exchange factor 12,49537,166,0.94 [0.82-1.07],0.3656288029182728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGEF5,Rho guanine nucleotide exchange factor 5,41816,123,1.04 [0.82-1.31],0.7550116604496481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID3A,AT-rich interactive domain-containing protein 3A,41816,123,1.01 [0.66-1.55],0.9603809049066409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARID4B,AT-rich interactive domain-containing protein 4B,48439,166,0.93 [0.66-1.31],0.6698694286534046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL13B,ADP-ribosylation factor-like protein 13B,41815,123,0.96 [0.74-1.24],0.7564477315687207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,41815,123,0.85 [0.54-1.32],0.4593080704903177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARMCX2,Armadillo repeat-containing X-linked protein 2,41816,123,1.14 [0.89-1.47],0.2892383176068464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNT,Aryl hydrocarbon receptor nuclear translocator,48668,162,0.87 [0.58-1.30],0.5042722560749962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,41815,123,1.05 [0.77-1.43],0.7679483368616649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSA,Arylsulfatase A,49619,166,0.98 [0.73-1.33],0.906663118245442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARSB,Arylsulfatase B,49371,166,1.09 [0.86-1.40],0.4748776155422245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART3,Ecto-ADP-ribosyltransferase 3,49806,167,0.98 [0.67-1.44],0.9155426398665706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ART5,Ecto-ADP-ribosyltransferase 5,41816,123,1.04 [0.80-1.35],0.7910730959511871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARTN,Artemin,48668,162,1.06 [0.79-1.42],0.688911711021631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH1,Acid ceramidase,42830,130,0.87 [0.60-1.27],0.4762427284022402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASAH2,Neutral ceramidase,49224,166,0.84 [0.66-1.06],0.1326445869209876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR1,Asialoglycoprotein receptor 1,49224,166,1.76 [1.15-2.71],0.0097279209485127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASGR2,Asialoglycoprotein receptor 2,43258,128,1.41 [0.75-2.63],0.2821051444373241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPN,Asporin,43226,128,0.85 [0.45-1.59],0.6039463167591361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASPSCR1,Tether containing UBX domain for GLUT4,43149,126,0.89 [0.69-1.15],0.3611925488197949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASRGL1,Isoaspartyl peptidase/L-asparaginase,42083,123,0.94 [0.79-1.12],0.5184863021802537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ASS1,Argininosuccinate synthase,41815,123,1.01 [0.80-1.26],0.9479163031867064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF2,Cyclic AMP-dependent transcription factor ATF-2,48439,166,0.85 [0.66-1.09],0.1958472277393619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATF4,Cyclic AMP-dependent transcription factor ATF-4,41687,124,0.98 [0.58-1.64],0.9370467628948864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG16L1,Autophagy-related protein 16-1,43035,128,0.95 [0.78-1.15],0.5917249252202266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATG4A,Cysteine protease ATG4A,48422,162,1.16 [0.92-1.45],0.2091981803511353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATOX1,Copper transport protein ATOX1,49753,165,1.11 [0.91-1.35],0.3069294605355296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,41815,123,0.97 [0.67-1.41],0.8684064381424983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,41815,123,1.27 [0.80-2.00],0.3127606527470322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,41815,123,0.83 [0.51-1.35],0.451049702832733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP1B4,Protein ATP1B4,41687,124,0.71 [0.44-1.12],0.1393083967285951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP2B4,Plasma membrane calcium-transporting ATPase 4,41815,123,0.89 [0.64-1.22],0.4602358400076907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5F1D,"ATP synthase subunit delta, mitochondrial",41815,123,1.13 [0.85-1.51],0.4016920653332937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5IF1,"ATPase inhibitor, mitochondrial",49821,165,1.01 [0.89-1.14],0.8750686229027187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP5PO,"ATP synthase subunit O, mitochondrial",48439,166,0.74 [0.52-1.05],0.0944769256247222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6AP2,Renin receptor,48422,162,1.21 [0.88-1.65],0.2440590034624725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1D,V-type proton ATPase subunit D,49371,166,1.20 [0.76-1.91],0.4311383385038004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1F,V-type proton ATPase subunit F,48356,166,0.90 [0.73-1.12],0.3546244225512629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G1,V-type proton ATPase subunit G 1,42083,123,1.02 [0.80-1.29],0.8873197584757694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATP6V1G2,V-type proton ATPase subunit G 2,41815,123,1.06 [0.89-1.26],0.5264493272655422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRAID,All-trans retinoic acid-induced differentiation factor,43035,128,1.48 [1.01-2.16],0.0428902955075807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATRN,"Attractin, Isoform 2",43287,129,1.01 [0.37-2.75],0.9909300553741636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN10,Ataxin-10,48439,166,1.10 [0.91-1.33],0.3371507093495809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2,Ataxin-2,41816,123,1.05 [0.90-1.22],0.539004183838896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN2L,Ataxin-2-like protein,43149,126,1.07 [0.75-1.52],0.7165907019271782
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN3,Ataxin-3,43118,128,0.87 [0.66-1.14],0.319108428816191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXIN1,Axin-1,49537,166,0.98 [0.85-1.14],0.8359637469404957
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AXL,Tyrosine-protein kinase receptor UFO,49806,167,1.05 [0.65-1.72],0.8339973785028183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZI2,5-azacytidine-induced protein 2,43149,126,0.89 [0.64-1.22],0.4657648895858322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AZU1,Azurocidin,48108,162,1.14 [0.97-1.34],0.1138337189529681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,43287,129,1.51 [1.15-1.98],0.0028771557370637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,41815,123,1.06 [0.45-2.51],0.8894025161875614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",42083,123,1.41 [0.88-2.27],0.1520093682239613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",49821,165,2.27 [1.43-3.61],0.0005326756483951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GAT1,"Beta-1,4-glucuronyltransferase 1",49619,166,1.03 [0.59-1.82],0.9072995460571904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BABAM1,BRISC and BRCA1-A complex member 1,41967,124,0.96 [0.52-1.77],0.8974069290267633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BACH1,Transcription regulator protein BACH1,49537,166,0.97 [0.80-1.18],0.765953907714921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG3,BAG family molecular chaperone regulator 3,49142,166,0.99 [0.71-1.38],0.9547169807417832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG4,BAG family molecular chaperone regulator 4,41967,124,0.96 [0.67-1.37],0.80696862372442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAG6,Large proline-rich protein BAG6,48693,163,0.99 [0.67-1.46],0.96162264713241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,48422,162,1.34 [1.10-1.62],0.0037077982589924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAMBI,BMP and activin membrane-bound inhibitor homolog,48422,162,1.61 [1.06-2.46],0.0272198172141632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BANK1,B-cell scaffold protein with ankyrin repeats,49537,166,0.94 [0.83-1.07],0.3289573411946657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAP18,Chromatin complexes subunit BAP18,43118,128,1.10 [0.88-1.38],0.4095930996153456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BATF,Basic leucine zipper transcriptional factor ATF-like,42038,121,0.99 [0.80-1.22],0.9186986456678649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BAX,Apoptosis regulator BAX,48361,166,1.06 [0.91-1.24],0.4694632578619662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAM,Basal cell adhesion molecule,49619,166,1.97 [1.15-3.37],0.0136108561799292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,49224,166,0.55 [0.37-0.81],0.0023849133211702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",43226,128,1.24 [0.73-2.11],0.4304419929306435
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",41816,123,0.78 [0.53-1.14],0.2009707029228615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,42461,125,0.53 [0.33-0.88],0.0133331876181787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2,Apoptosis regulator Bcl-2,43035,128,1.14 [0.87-1.50],0.3420825896105098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L1,Bcl-2-like protein 1,43118,128,0.98 [0.82-1.16],0.7892181943841295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",49537,166,0.94 [0.68-1.29],0.695580347626531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL2L15,Bcl-2-like protein 15,41967,124,1.23 [0.95-1.59],0.121922815200303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7A,B-cell CLL/lymphoma 7 protein family member A,41687,124,1.07 [0.82-1.38],0.6328025909903996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7B,B-cell CLL/lymphoma 7 protein family member B,43021,127,0.68 [0.43-1.07],0.096183044283738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCR,Breakpoint cluster region protein,49537,166,0.96 [0.83-1.12],0.6353381360744765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BDNF,Brain-derived neurotrophic factor,43224,130,0.96 [0.79-1.18],0.724313659798729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BECN1,Beclin-1,42083,123,0.91 [0.67-1.22],0.5240355462406505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BEX3,Protein BEX3,41687,124,0.99 [0.68-1.45],0.966564146712423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGLAP,Osteocalcin,43224,130,1.19 [0.99-1.44],0.0699939636106179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BGN,Biglycan,48342,162,0.90 [0.80-1.02],0.0919084847070944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHLHE40,Class E basic helix-loop-helix protein 40,41816,123,0.96 [0.75-1.23],0.7600746363569385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,41815,123,1.00 [0.51-1.97],0.999348875693592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BID,BH3-interacting domain death agonist,49537,166,1.14 [0.94-1.39],0.1821564941714907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIN2,Bridging integrator 2,49619,166,0.99 [0.85-1.15],0.8894791535639395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BIRC2,Baculoviral IAP repeat-containing protein 2,48422,162,1.05 [0.84-1.31],0.6674114119376646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLMH,Bleomycin hydrolase,50221,168,1.08 [0.70-1.66],0.7166016085851112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLNK,B-cell linker protein,41967,124,0.90 [0.57-1.41],0.6391138698880693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,41816,123,0.91 [0.71-1.18],0.4840272673514167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,43118,128,0.89 [0.58-1.38],0.6017912160796086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BLVRB,Flavin reductase,49619,166,1.05 [0.86-1.28],0.6494937542461692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP10,Bone morphogenetic protein 10,42273,122,1.19 [0.65-2.21],0.5706500358992104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP4,Bone morphogenetic protein 4,49142,166,1.01 [0.74-1.36],0.9731638462017284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMP6,Bone morphogenetic protein 6,48616,163,1.06 [0.75-1.50],0.7357665488218044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BMPER,BMP-binding endothelial regulator protein,42273,122,2.07 [1.05-4.08],0.0354041969507859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,43226,128,1.06 [0.64-1.75],0.8197905211005305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,41967,124,1.13 [0.77-1.66],0.540600031012754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOC,Brother of CDO,48693,163,1.57 [0.86-2.85],0.1389589550034784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA1,BolA-like protein 1,41816,123,1.15 [0.85-1.56],0.3692169140117118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOLA2_BOLA2B,BolA-like protein 2,42083,123,0.87 [0.63-1.20],0.3851768525077627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFA2,BPI fold-containing family A member 2,40583,120,0.93 [0.79-1.09],0.3916114771980591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB1,BPI fold-containing family B member 1,49501,167,1.18 [0.95-1.46],0.1354956922177131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BPIFB2,BPI fold-containing family B member 2,43143,128,1.11 [0.87-1.41],0.4029258947366039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRAP,BRCA1-associated protein,42650,128,0.96 [0.82-1.12],0.576750242757745
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD1,Bromodomain-containing protein 1,42437,128,0.75 [0.40-1.38],0.3482158323623392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD2,Bromodomain-containing protein 2,41816,123,0.71 [0.40-1.27],0.2446806970712859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRD3,Bromodomain-containing protein 3,41815,123,1.25 [0.97-1.61],0.0898428699205807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRDT,Bromodomain testis-specific protein,41815,123,0.90 [0.56-1.46],0.6747419616143744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRK1,Protein BRICK1,48439,166,1.21 [0.89-1.63],0.2206758364059253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRME1,Break repair meiotic recombinase recruitment factor 1,41816,123,0.93 [0.60-1.46],0.765972018832113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BRSK2,Serine/threonine-protein kinase BRSK2,43149,126,1.10 [0.70-1.72],0.67596496619783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSG,Basigin,50075,166,2.20 [1.15-4.22],0.0174592443738733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BSND,Barttin,41687,124,1.38 [0.94-2.03],0.0987689521535021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,50052,168,1.32 [0.93-1.88],0.1201950754559081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BST2,Bone marrow stromal antigen 2,50052,168,1.29 [1.02-1.64],0.0323802258977687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTC,Probetacellulin,48422,162,1.11 [0.93-1.33],0.2532342271807698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTD,Biotinidase,43287,129,0.70 [0.31-1.56],0.3821064436651615
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTLA,B- and T-lymphocyte attenuator,41687,124,0.93 [0.74-1.16],0.5071205610580479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN1A1,Butyrophilin subfamily 1 member A1,42940,127,1.27 [0.89-1.82],0.1946366299485373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN2A1,Butyrophilin subfamily 2 member A1,49821,165,1.82 [1.14-2.91],0.0126583414741976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN3A2,Butyrophilin subfamily 3 member A2,49537,166,1.38 [0.99-1.92],0.0589217754418649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTNL10,Butyrophilin-like protein 10,41687,124,1.37 [1.03-1.82],0.0278706745518179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C19orf12,Protein C19orf12,48439,166,1.22 [1.03-1.46],0.0250172014361015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1GALT1C1,C1GALT1-specific chaperone 1,41815,123,1.22 [0.74-1.99],0.4393883008874389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,49911,166,2.91 [1.66-5.11],0.0001976490506861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",43149,126,0.92 [0.70-1.20],0.5243605541922368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QL2,Complement C1q-like protein 2,41967,124,0.77 [0.51-1.17],0.215712861264173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,49806,167,1.18 [0.87-1.62],0.291948727779757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,42273,122,1.13 [0.70-1.81],0.6138973368761249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,43149,126,0.84 [0.48-1.47],0.5468938570170891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,42194,122,0.75 [0.54-1.04],0.0813272194112308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1R,Complement C1r subcomponent,43287,129,2.23 [1.28-3.89],0.0047463785725501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1RL,Complement C1r subcomponent-like protein,43213,128,1.42 [0.59-3.39],0.4356666732232148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1S,Complement C1s subcomponent,43287,129,2.02 [0.92-4.39],0.0779750000713945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2,Complement C2,49726,167,1.31 [0.69-2.49],0.4043715395487568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2CD2L,Phospholipid transfer protein C2CD2L,48356,166,1.21 [0.90-1.64],0.2132548634024628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C2orf69,UPF0565 protein C2orf69,42038,121,0.97 [0.71-1.32],0.82471771218809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C3,Complement C3,41075,122,1.41 [1.04-1.92],0.0288643205113684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C4BPB,C4b-binding protein beta chain,49753,165,1.06 [0.75-1.50],0.7281632198879184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C5,Complement C5,43287,129,2.66 [0.97-7.31],0.0580838950319362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,42241,127,3.55 [2.18-5.77],3.22577567220592e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7orf50,Uncharacterized protein C7orf50,43118,128,0.93 [0.44-1.99],0.8602349867159438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C8B,Complement component C8 beta chain,43287,129,1.22 [0.70-2.13],0.4796628249686003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9,Complement component C9,43258,128,1.04 [0.76-1.41],0.8210255390664422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C9orf40,Uncharacterized protein C9orf40,43035,128,0.99 [0.80-1.22],0.9210838943756282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA1,Carbonic anhydrase 1,48519,164,1.07 [0.85-1.34],0.5719474382323249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA11,Carbonic anhydrase-related protein 11,48422,162,0.88 [0.54-1.42],0.6032971591629612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA12,Carbonic anhydrase 12,49371,166,1.71 [1.16-2.51],0.0065615347460498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA13,Carbonic anhydrase 13,49061,164,1.02 [0.90-1.17],0.7274107623331538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA14,Carbonic anhydrase 14,50024,168,0.72 [0.49-1.05],0.088747144657591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA2,Carbonic anhydrase 2,49464,165,1.14 [0.94-1.38],0.1758774903586789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA3,Carbonic anhydrase 3,50138,168,1.22 [0.99-1.52],0.0671393839813811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA4,Carbonic anhydrase 4,50221,168,1.02 [0.59-1.79],0.933921065306062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA5A,"Carbonic anhydrase 5A, mitochondrial",48693,163,1.13 [0.97-1.30],0.1126944919368427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA6,Carbonic anhydrase 6,49465,166,0.82 [0.66-1.02],0.0736032300664803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA7,Carbonic anhydrase 7,42437,128,0.66 [0.37-1.15],0.1433065228559853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA8,Carbonic anhydrase-related protein,41967,124,1.54 [1.04-2.29],0.0331521092369543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA9,Carbonic anhydrase 9,50024,168,1.17 [0.90-1.54],0.2466645551546033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CABP2,Calcium-binding protein 2,42038,121,0.83 [0.61-1.12],0.2291517029220821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,41816,123,0.60 [0.32-1.11],0.1039700439556425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,41815,123,0.77 [0.53-1.13],0.1858376696994241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,41816,123,0.93 [0.69-1.26],0.6287239057235094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,43149,126,1.11 [0.91-1.36],0.2949753037690235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CACYBP,Calcyclin-binding protein,42194,122,0.96 [0.81-1.14],0.6532140055548803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CADPS,Calcium-dependent secretion activator 1,42038,121,0.76 [0.46-1.25],0.2804252650676683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB1,Calbindin,49371,166,1.42 [1.05-1.94],0.0249690673040572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB2,Calretinin,48439,166,1.36 [1.02-1.80],0.0351026530640985
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCA,Calcitonin,49141,166,1.07 [0.87-1.32],0.5043908016217722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCB,Calcitonin gene-related peptide 2,43118,128,1.19 [0.80-1.75],0.3910610379756322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,49869,168,0.93 [0.82-1.07],0.3089481028036487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,42083,123,0.92 [0.73-1.16],0.4768234250764411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALY,Neuron-specific vesicular protein calcyon,41815,123,1.10 [0.71-1.70],0.6753574630962818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,48422,162,1.33 [0.99-1.78],0.0577625395257562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,42038,121,1.00 [0.73-1.39],0.9846213388770064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,43149,126,0.94 [0.80-1.10],0.4469338004151646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CANT1,Soluble calcium-activated nucleotidase 1,49462,166,1.30 [0.67-2.54],0.4406862709353562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,49235,166,1.41 [1.14-1.75],0.0016770436613578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPN3,Calpain-3,43021,127,1.42 [1.03-1.96],0.0348336504200063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPS,Calcyphosin,43118,128,0.96 [0.80-1.16],0.6808695315833841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CARHSP1,Calcium-regulated heat-stable protein 1,48439,166,1.11 [0.86-1.44],0.4194894763494066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASC3,Protein CASC3,42038,121,0.86 [0.56-1.33],0.5056873579468626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP1,Caspase-1,48439,166,1.08 [0.90-1.31],0.4091343209180244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP10,Caspase-10,48439,166,1.08 [0.89-1.31],0.426912463711249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP2,Caspase-2,49537,166,1.01 [0.82-1.24],0.9230204935495888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP3,Caspase-3,50221,168,0.99 [0.85-1.16],0.902815575327376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP4,Caspase-4,42437,128,1.03 [0.93-1.13],0.5630050089724442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP7,Caspase-7,43118,128,0.95 [0.77-1.16],0.5969687888266677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP8,Caspase-8,49878,168,1.11 [0.90-1.38],0.336848380531664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASP9,Caspase-9,41967,124,1.07 [0.81-1.40],0.6474751058028136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CASQ2,Calsequestrin-2,41815,123,0.99 [0.68-1.43],0.9436758621096552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAT,Catalase,42625,126,0.89 [0.64-1.22],0.4570749904834595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLIF,Cobalamin binding intrinsic factor,49536,166,1.20 [1.00-1.43],0.0460992147192995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN1,Cerebellin-1,41816,123,0.92 [0.75-1.13],0.4311406778526842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBLN4,Cerebellin-4,50024,168,0.72 [0.47-1.10],0.1240292114736658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBS,Cystathionine beta-synthase,42083,123,0.98 [0.70-1.38],0.910179747447757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CBX2,Chromobox protein homolog 2,41815,123,1.09 [0.72-1.64],0.6815092265229569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,49224,166,1.06 [0.88-1.28],0.5479748398294363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCAR2,Cell cycle and apoptosis regulator protein 2,43118,128,0.92 [0.66-1.30],0.6475768110318909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC134,Coiled-coil domain-containing protein 134,43021,127,1.37 [1.02-1.84],0.0346376713306705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC28A,Coiled-coil domain-containing protein 28A,42038,121,1.11 [0.62-2.01],0.7188583746191154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC50,Coiled-coil domain-containing protein 50,43149,126,1.26 [1.05-1.49],0.0104251609382806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,49610,166,2.18 [1.57-3.01],2.677376029670745e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,42083,123,1.33 [1.03-1.72],0.0285690946190421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL11,Eotaxin,50157,167,1.64 [1.14-2.36],0.0081875274135562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL13,C-C motif chemokine 13,50074,166,1.00 [0.82-1.22],0.9894780459515816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL14,C-C motif chemokine 14,49482,167,1.39 [1.03-1.88],0.0317839587537252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL15,C-C motif chemokine 15,50221,168,1.40 [1.05-1.86],0.022992071178074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL16,C-C motif chemokine 16,50221,168,1.31 [1.00-1.71],0.0480428174788478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL17,C-C motif chemokine 17,49503,165,1.16 [1.00-1.34],0.0521540587073117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL18,C-C motif chemokine 18,48932,165,1.15 [0.96-1.37],0.1427965979111428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL19,C-C motif chemokine 19,50052,168,1.06 [0.96-1.17],0.2273965014523923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL2,C-C motif chemokine 2,49142,166,0.99 [0.77-1.29],0.963783472638754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL20,C-C motif chemokine 20,50157,167,1.17 [1.03-1.34],0.020147542259239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,49821,165,1.52 [1.21-1.93],0.000431583486675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL22,C-C motif chemokine 22,49100,165,1.38 [1.08-1.76],0.0094814374104948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL23,C-C motif chemokine 23,49821,165,1.71 [1.25-2.34],0.0008121879670209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL24,C-C motif chemokine 24,49744,165,1.07 [0.90-1.25],0.4505649865484582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,50157,167,1.69 [1.28-2.23],0.0001937920751468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL26,C-C motif chemokine 26,49537,166,0.93 [0.80-1.09],0.379205600490179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL27,C-C motif chemokine 27,49610,166,0.97 [0.77-1.21],0.7737891978822911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL28,C-C motif chemokine 28,49377,166,1.25 [1.00-1.55],0.0469963724715895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL3,C-C motif chemokine 3,49537,166,1.10 [0.92-1.33],0.305965879338402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL4,C-C motif chemokine 4,49660,165,1.24 [1.06-1.45],0.0077466309390691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL5,C-C motif chemokine 5,49806,167,1.02 [0.89-1.16],0.8249297180619373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL7,C-C motif chemokine 7,49537,166,1.21 [0.98-1.49],0.0727814864880673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL8,C-C motif chemokine 8,49953,168,1.25 [1.00-1.56],0.0545571036345335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN1,CCN family member 1,49290,166,1.14 [0.94-1.38],0.178199974511013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN2,CCN family member 2,49587,164,1.12 [0.88-1.43],0.3737929974019186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN3,CCN family member 3,50140,168,1.65 [1.15-2.39],0.0071951002201251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN4,CCN family member 4,50024,168,1.15 [0.83-1.61],0.4009262740301452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCN5,CCN family member 5,49619,166,1.73 [1.23-2.45],0.0016667595151385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCND2,G1/S-specific cyclin-D2,42437,128,1.35 [0.84-2.17],0.2105204691416256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCNE1,G1/S-specific cyclin-E1,41967,124,0.92 [0.74-1.16],0.4895371413378689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCS,Copper chaperone for superoxide dismutase,49224,166,1.01 [0.75-1.34],0.9683440252636316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCT5,T-complex protein 1 subunit epsilon,48422,162,1.13 [0.83-1.53],0.4401514275146815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD101,Immunoglobulin superfamily member 2,43035,128,0.94 [0.64-1.40],0.7659817555716131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD109,CD109 antigen,49619,166,1.14 [0.76-1.73],0.5257900841636804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD14,Monocyte differentiation antigen CD14,48607,165,1.73 [1.28-2.33],0.0003307662438702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD160,CD160 antigen,50157,167,1.16 [0.88-1.53],0.300168077321865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD163,Scavenger receptor cysteine-rich type 1 protein M130,49806,167,1.12 [0.82-1.53],0.4800020818212439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164,Sialomucin core protein 24,49619,166,1.34 [0.90-1.99],0.1498374566440951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD164L2,CD164 sialomucin-like 2 protein,42038,121,1.03 [0.64-1.67],0.8883765471325988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD177,CD177 antigen,49537,166,1.05 [0.94-1.18],0.3607581560113074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD1C,T-cell surface glycoprotein CD1c,49753,165,0.75 [0.44-1.30],0.3107345637568675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2,T-cell surface antigen CD2,41815,123,0.97 [0.62-1.54],0.9099850485556884
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200,OX-2 membrane glycoprotein,49537,166,1.32 [0.81-2.15],0.2679140399668395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD200R1,Cell surface glycoprotein CD200 receptor 1,49375,165,0.90 [0.61-1.34],0.6182931476496809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD207,C-type lectin domain family 4 member K,48521,161,1.36 [0.95-1.94],0.0914865414837453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD209,CD209 antigen,49740,166,1.14 [0.81-1.62],0.4499633239547191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD22,B-cell receptor CD22,50157,167,0.84 [0.61-1.16],0.2834649707380898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD226,CD226 antigen,41967,124,0.99 [0.66-1.50],0.9770507757163358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD244,Natural killer cell receptor 2B4,50157,167,1.05 [0.64-1.74],0.8489314351787337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD248,Endosialin,43224,130,0.96 [0.64-1.45],0.8514117370431771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD27,CD27 antigen,49753,165,1.55 [1.15-2.09],0.004395701382013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD274,Programmed cell death 1 ligand 1,49224,166,1.73 [1.22-2.46],0.0021392697071787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,49581,165,2.62 [1.78-3.85],9.00770073767278e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD28,T-cell-specific surface glycoprotein CD28,48422,162,1.30 [0.93-1.83],0.1238904059261285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD2AP,CD2-associated protein,49610,166,0.99 [0.80-1.23],0.9054648034803516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300A,CMRF35-like molecule 8,42273,122,1.44 [0.82-2.53],0.2063440154539079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300C,CMRF35-like molecule 6,50052,168,1.53 [1.06-2.21],0.0230203187354454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300E,CMRF35-like molecule 2,49865,168,1.48 [1.09-2.03],0.0128299049122734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LF,CMRF35-like molecule 1,50024,168,1.28 [1.01-1.62],0.0404236884091335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LG,CMRF35-like molecule 9,49619,166,1.20 [0.84-1.73],0.3139914457563501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,49371,166,1.93 [1.30-2.86],0.0011021503816041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD33,Myeloid cell surface antigen CD33,49753,165,0.94 [0.79-1.11],0.4364453422086874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD34,Hematopoietic progenitor cell antigen CD34,49891,168,0.66 [0.37-1.17],0.1529856859804375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD36,Platelet glycoprotein 4,41967,124,1.16 [0.80-1.68],0.4378982931373283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,49371,166,0.94 [0.62-1.44],0.7889215144094164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3D,T-cell surface glycoprotein CD3 delta chain,41816,123,0.86 [0.50-1.48],0.5867224983374824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3E,T-cell surface glycoprotein CD3 epsilon chain,42437,128,0.94 [0.57-1.55],0.8190863665511972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD3G,T-cell surface glycoprotein CD3 gamma chain,41967,124,0.88 [0.69-1.11],0.2824595442086569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD4,T-cell surface glycoprotein CD4,49456,166,1.56 [1.10-2.22],0.0122451143849617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40,Tumor necrosis factor receptor superfamily member 5,49583,165,1.18 [0.90-1.54],0.2329943735310282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD40LG,CD40 ligand,50157,167,1.04 [0.87-1.23],0.6937145367289166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD46,Membrane cofactor protein,49320,167,1.26 [0.79-2.01],0.3285604222905312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD48,CD48 antigen,49744,165,1.79 [1.16-2.76],0.0090247140109699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5,T-cell surface glycoprotein CD5,49953,168,1.09 [0.74-1.60],0.6534156684017327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD55,Complement decay-accelerating factor,47887,160,1.28 [0.77-2.14],0.3360945484018764
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD58,Lymphocyte function-associated antigen 3,49497,165,1.10 [0.51-2.40],0.8093612071166079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD59,CD59 glycoprotein,47829,159,2.02 [1.21-3.35],0.0069556020351263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5L,CD5 antigen-like,43056,128,1.68 [1.19-2.37],0.0031647645683673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD6,T-cell differentiation antigen CD6,50075,166,0.84 [0.65-1.09],0.1811489356694037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD63,CD63 antigen,49142,166,1.01 [0.77-1.33],0.9328302618553976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD69,Early activation antigen CD69,49364,166,1.00 [0.85-1.16],0.958755871111848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,41886,124,1.80 [1.30-2.48],0.0003415247356015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD70,CD70 antigen,49537,166,1.23 [0.90-1.69],0.1948025465580854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD72,B-cell differentiation antigen CD72,42273,122,1.02 [0.68-1.54],0.9081775791039576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD74,HLA class II histocompatibility antigen gamma chain,50052,168,1.81 [1.25-2.61],0.001576606194761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,50157,167,1.55 [1.19-2.03],0.0011951233396214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD80,T-lymphocyte activation antigen CD80,43226,128,1.29 [0.80-2.09],0.2962229959190244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD82,CD82 antigen,42437,128,1.15 [0.79-1.66],0.4707825036691071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD83,CD83 antigen,49537,166,1.29 [0.87-1.90],0.2086397897080076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD84,SLAM family member 5,49537,166,0.96 [0.62-1.48],0.8534632189682454
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD86,T-lymphocyte activation antigen CD86,43035,128,0.92 [0.53-1.60],0.7653479246443029
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD8A,T-cell surface glycoprotein CD8 alpha chain,50052,168,0.81 [0.62-1.06],0.1297902271675854
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD93,Complement component C1q receptor,47750,157,1.33 [0.85-2.07],0.2089392893030221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99,CD99 antigen,49619,166,2.36 [1.23-4.54],0.0102070401009918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99L2,CD99 antigen-like protein 2,49619,166,1.71 [0.98-2.97],0.0594949976182885
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDA,Cytidine deaminase,43151,128,0.82 [0.57-1.18],0.2851433269058979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDAN1,Codanin-1,43118,128,0.72 [0.32-1.59],0.4144846801349177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC123,Cell division cycle protein 123 homolog,41687,124,0.91 [0.68-1.22],0.5349498398815736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC25A,M-phase inducer phosphatase 1,41687,124,1.06 [0.69-1.65],0.7845303529271459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC26,Anaphase-promoting complex subunit CDC26,42951,128,1.04 [0.81-1.33],0.7682361851692712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC27,Cell division cycle protein 27 homolog,48422,162,1.05 [0.84-1.32],0.668042787331401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC37,Hsp90 co-chaperone Cdc37,49753,165,1.06 [0.90-1.25],0.4690667733214201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDC42BPB,Serine/threonine-protein kinase MRCK beta,43035,128,0.94 [0.80-1.12],0.4975075161786823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDCP1,CUB domain-containing protein 1,49224,166,1.09 [0.85-1.40],0.4745092751984803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH1,Cadherin-1,47971,160,1.38 [1.02-1.87],0.0356693777011853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH15,Cadherin-15,49969,168,1.13 [0.93-1.37],0.2175318890913566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH17,Cadherin-17,49610,166,1.03 [0.85-1.25],0.7599253847209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH2,Cadherin-2,49610,166,1.37 [0.93-2.00],0.1068847245372923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH22,Cadherin-22,42437,128,0.72 [0.37-1.37],0.3135014102223781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH23,Cadherin-23,43118,128,0.56 [0.28-1.10],0.0918046096296298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH3,Cadherin-3,50052,168,1.22 [0.85-1.76],0.289615619466158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH4,Cadherin-4,41816,123,0.77 [0.51-1.15],0.2041138317458111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH5,Cadherin-5,50221,168,0.99 [0.63-1.55],0.9733326473901202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH6,Cadherin-6,49610,166,1.54 [1.09-2.17],0.0133716965020133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR1,Cadherin-related family member 1,48439,166,0.80 [0.56-1.13],0.208423902422829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR2,Cadherin-related family member 2,49371,166,1.15 [0.94-1.41],0.1786586142851206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDHR5,Cadherin-related family member 5,49610,166,0.87 [0.62-1.23],0.4415554219904651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK1,Cyclin-dependent kinase 1,41687,124,1.35 [0.84-2.16],0.2105710217538694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,43149,126,1.06 [0.81-1.41],0.6574250440519963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKL5,Cyclin-dependent kinase-like 5,41816,123,0.97 [0.69-1.36],0.8697386370990999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN1A,Cyclin-dependent kinase inhibitor 1,49371,166,1.05 [0.92-1.19],0.4776440375615565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,49371,166,1.04 [0.90-1.21],0.5666367853271126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDNF,Cerebral dopamine neurotrophic factor,49371,166,1.08 [0.72-1.62],0.7106792880206032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,49664,165,1.31 [0.77-2.22],0.3279237711441972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDSN,Corneodesmosin,50000,166,1.34 [0.98-1.82],0.065974933038937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,49675,165,2.42 [1.32-4.46],0.0044320536136737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,43035,128,0.77 [0.62-0.95],0.0129620407204614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,42437,128,0.82 [0.61-1.10],0.1921408418056798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,43035,128,1.05 [0.69-1.60],0.8303396603988439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,42437,128,1.10 [0.76-1.58],0.6233861000364294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,49537,166,1.23 [1.06-1.43],0.00754603508196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,48422,162,1.06 [0.80-1.41],0.6673106783876993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,47798,162,1.20 [0.97-1.48],0.0921375661846164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,43224,130,1.51 [1.16-1.97],0.0024559437912194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,48693,163,1.66 [1.31-2.11],3.364000311244422e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPA,CCAAT/enhancer-binding protein alpha,41967,124,1.13 [0.73-1.75],0.5953789042963853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEBPB,CCAAT/enhancer-binding protein beta,48693,163,1.46 [1.06-2.02],0.0213214871088058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA2A,Chymotrypsin-like elastase family member 2A,43224,130,0.96 [0.74-1.24],0.7511092695370877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELA3A,Chymotrypsin-like elastase family member 3A,50137,167,1.06 [0.84-1.33],0.6360629908277731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,42273,122,0.97 [0.54-1.76],0.9247437101997384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEMIP2,Cell surface hyaluronidase,41967,124,0.91 [0.52-1.60],0.749786346802372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEND1,Cell cycle exit and neuronal differentiation protein 1,41816,123,1.14 [0.90-1.46],0.2755694568745016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPF,Centromere protein F,42437,128,0.82 [0.60-1.14],0.2448992191957583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPJ,Centromere protein J,42437,128,0.90 [0.69-1.17],0.4365912309752068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP112,Centrosomal protein of 112 kDa,41815,123,1.03 [0.71-1.51],0.8650623310747503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP152,Centrosomal protein of 152 kDa,41687,124,1.08 [0.73-1.60],0.7125609166438927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP164,Centrosomal protein of 164 kDa,48668,162,0.97 [0.78-1.22],0.8209744924683852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP170,Centrosomal protein of 170 kDa,42083,123,0.87 [0.68-1.11],0.2644250490683612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP20,Centrosomal protein 20,48422,162,1.13 [0.94-1.35],0.20479356428666
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP290,Centrosomal protein of 290 kDa,42437,128,1.31 [1.03-1.68],0.0277482168076061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP350,Centrosome-associated protein 350,41687,124,1.04 [0.66-1.64],0.8693784376851721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP43,Centrosomal protein 43,48302,159,1.04 [0.84-1.27],0.7386752635349428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP85,Centrosomal protein of 85 kDa,48422,162,0.99 [0.79-1.24],0.9383694921809028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CERT,Ceramide transfer protein,48439,166,1.05 [0.84-1.32],0.6512249127473118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES1,Liver carboxylesterase 1,49732,167,0.92 [0.78-1.09],0.335828174904388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES2,Cocaine esterase,49371,166,1.07 [0.84-1.37],0.566162625232596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CES3,Carboxylesterase 3,49371,166,0.93 [0.75-1.15],0.4913647634314474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN2,Centrin-2,48439,166,1.06 [0.87-1.30],0.561726852812061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CETN3,Centrin-3,43035,128,1.00 [0.81-1.25],0.980868343638648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFB,Complement factor B,42499,127,1.70 [1.00-2.89],0.0505458766020507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFC1,Cryptic protein,48422,162,1.23 [0.93-1.63],0.1495202666126324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFD,Complement factor D,43287,129,2.33 [1.32-4.14],0.0037640495496489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFH,Complement factor H,40765,122,1.51 [0.71-3.24],0.2851295388098744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR2,Complement factor H-related protein 2,42965,128,1.01 [0.75-1.37],0.9264370462498794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR4,Complement factor H-related protein 4,43205,129,0.95 [0.75-1.19],0.6483598024035009
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFHR5,Complement factor H-related protein 5,42699,126,1.27 [0.83-1.92],0.2692649046320272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFI,Complement factor I,43287,129,1.94 [0.83-4.55],0.1289532235692675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFP,Properdin,43287,129,0.80 [0.36-1.78],0.5898756270296388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGA,Glycoprotein hormones alpha chain,49619,166,1.12 [0.91-1.39],0.2696477752397753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,43258,128,0.91 [0.58-1.42],0.6792051304730977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGN,Cingulin,42038,121,0.95 [0.60-1.50],0.8178033455082298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGREF1,Cell growth regulator with EF hand domain protein 1,49610,166,1.27 [0.93-1.74],0.1373965727208555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,48422,162,1.02 [0.81-1.29],0.8818580400899473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHAD,Chondroadherin,42273,122,1.15 [0.81-1.63],0.4410173485634622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",43118,128,1.96 [1.40-2.73],7.437752739440814e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD6,MICOS complex subunit MIC25,43021,127,1.86 [1.22-2.83],0.0038525120420604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHEK2,Serine/threonine-protein kinase Chk2,48693,163,0.72 [0.47-1.12],0.1435516137109515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGA,Chromogranin-A,43224,130,1.19 [1.02-1.40],0.0309581465591622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHGB,Secretogranin-1,49889,168,1.34 [0.97-1.84],0.0727878218926538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,48519,164,1.33 [1.14-1.54],0.000199564962348
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHIT1,Chitotriosidase-1,49815,168,0.99 [0.91-1.08],0.8559105585422245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHL1,Neural cell adhesion molecule L1-like protein,49729,166,1.37 [0.89-2.12],0.1488992175825087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHM,Rab proteins geranylgeranyltransferase component A 1,42038,121,0.84 [0.62-1.13],0.2479903971481069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP1A,Charged multivesicular body protein 1a,49224,166,1.08 [0.90-1.29],0.4034057411237088
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHMP6,Charged multivesicular body protein 6,43226,128,0.93 [0.69-1.25],0.6106253959862402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHP1,Calcineurin B homologous protein 1,41816,123,1.03 [0.82-1.30],0.7937955687285466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL1,Chordin-like protein 1,49744,165,2.02 [1.34-3.06],0.0008713955098345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRDL2,Chordin-like protein 2,49610,166,1.05 [0.80-1.40],0.7104083934250296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHRM1,Muscarinic acetylcholine receptor M1,42038,121,1.08 [0.69-1.70],0.7309706258843597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIAPIN1,Anamorsin,49753,165,1.11 [0.89-1.38],0.3728277585980628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CILP,Cartilage intermediate layer protein 1,43224,130,1.48 [1.08-2.05],0.016171510052738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CINP,Cyclin-dependent kinase 2-interacting protein,42437,128,0.54 [0.33-0.88],0.0131375505513835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIRBP,Cold-inducible RNA-binding protein,43035,128,0.94 [0.79-1.12],0.458692068437063
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CIT,Citron Rho-interacting kinase,42038,121,0.90 [0.60-1.34],0.5943416146013727
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,49915,166,2.25 [1.56-3.26],1.5560000578147658e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,43224,130,1.74 [1.32-2.28],8.31864820527501e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",49416,165,1.06 [0.86-1.31],0.5769099533949593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLASP1,CLIP-associating protein 1,41687,124,0.93 [0.73-1.19],0.5741310897562633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLC,Galectin-10,49534,166,1.22 [1.01-1.48],0.0420498653391433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC10A,C-type lectin domain family 10 member A,49224,166,0.84 [0.57-1.23],0.3636996678833172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC11A,C-type lectin domain family 11 member A,49536,166,1.55 [1.16-2.06],0.0025884425060648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC12A,C-type lectin domain family 12 member A,41967,124,1.17 [0.50-2.74],0.7214301708343138
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC14A,C-type lectin domain family 14 member A,49619,166,1.56 [1.04-2.34],0.0323153697658251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1A,C-type lectin domain family 1 member A,48693,163,1.36 [0.91-2.03],0.1354709235767776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC1B,C-type lectin domain family 1 member B,50052,168,0.97 [0.84-1.12],0.6430552280466321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC2L,C-type lectin domain family 2 member L,42038,121,0.73 [0.47-1.14],0.1646077782446964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC3B,Tetranectin,42276,127,0.49 [0.22-1.10],0.0823606746960956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4A,C-type lectin domain family 4 member A,49537,166,0.82 [0.56-1.21],0.3197957224285904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4C,C-type lectin domain family 4 member C,49537,166,0.80 [0.60-1.06],0.1155712348859388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,49537,166,1.46 [1.18-1.79],0.0003711033407835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4G,C-type lectin domain family 4 member G,49537,166,1.34 [0.89-2.01],0.1640346687824365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4M,C-type lectin domain family 4 member M,43148,130,0.83 [0.59-1.17],0.2991652989005981
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,49448,166,2.04 [1.33-3.12],0.0010560822655655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC6A,C-type lectin domain family 6 member A,48422,162,1.51 [1.15-1.98],0.0027510043619775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC7A,C-type lectin domain family 7 member A,50157,167,1.14 [0.89-1.47],0.2931496441422064
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLGN,Calmegin,42038,121,1.13 [0.79-1.63],0.4960798714765351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIC5,Chloride intracellular channel protein 5,42038,121,0.72 [0.39-1.32],0.2924108556516851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLINT1,Clathrin interactor 1,41687,124,1.18 [0.86-1.61],0.3096987071319383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLIP2,CAP-Gly domain-containing linker protein 2,49537,166,1.02 [0.91-1.15],0.7212393481075869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,50024,168,2.73 [1.55-4.83],0.0005393182369352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLNS1A,Methylosome subunit pICln,42038,121,0.64 [0.36-1.12],0.1205657819549986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",49141,166,1.05 [0.91-1.21],0.5429669009288759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLPS,Colipase,49538,165,0.99 [0.82-1.20],0.9190901707112652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSPN,Claspin,48356,166,1.16 [0.83-1.62],0.3965320429008883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN1,Calsyntenin-1,48439,166,1.07 [0.83-1.37],0.6090116432307083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,50157,167,1.88 [1.42-2.47],8.558636118693356e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN3,Calsyntenin-3,43118,128,1.41 [0.83-2.39],0.2080374838369388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLTA,Clathrin light chain A,48693,163,1.14 [0.86-1.52],0.3721415107094831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLU,Clusterin,43287,129,1.54 [1.10-2.17],0.0124641512684058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLUL1,Clusterin-like protein 1,49529,166,1.08 [0.80-1.46],0.5968477262273439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMC1,COX assembly mitochondrial protein homolog,43226,128,0.99 [0.82-1.19],0.884794074765536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CMIP,C-Maf-inducing protein,43021,127,0.95 [0.78-1.17],0.6434069505267153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNDP1,Beta-Ala-His dipeptidase,49806,167,0.95 [0.71-1.26],0.7018693335118555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNGB3,Cyclic nucleotide-gated cation channel beta-3,41816,123,0.69 [0.45-1.06],0.0924718951986478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",42005,123,0.93 [0.75-1.16],0.538863993017848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY2,Protein canopy homolog 2,48693,163,0.99 [0.78-1.24],0.9148212967539988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNPY4,Protein canopy homolog 4,49371,166,1.08 [0.90-1.30],0.4182666827393165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNST,Consortin,49610,166,0.96 [0.85-1.09],0.5409347693107636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTF,Ciliary neurotrophic factor,41816,123,0.86 [0.52-1.44],0.5684689367778828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN1,Contactin-1,50221,168,1.22 [0.74-2.01],0.4411786022834714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN2,Contactin-2,50024,168,1.25 [0.93-1.70],0.1406332470367448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN3,Contactin-3,49619,166,0.83 [0.53-1.28],0.3998316298732927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN4,Contactin-4,49619,166,1.43 [0.80-2.54],0.2240044602045461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTN5,Contactin-5,49736,168,0.72 [0.50-1.05],0.0883474073186562
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP2,Contactin-associated protein-like 2,49537,166,1.26 [0.92-1.73],0.1539314164923621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CNTNAP4,Contactin-associated protein-like 4,42038,121,1.02 [0.87-1.20],0.8108896603912723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COCH,Cochlin,43226,128,1.05 [0.73-1.50],0.7861866866050429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL15A1,Collagen alpha-1(XV) chain,43224,130,1.42 [0.78-2.57],0.2523605695013189
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,49816,167,3.75 [2.17-6.49],2.238715174130019e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL1A1,Collagen alpha-1(I) chain,50221,168,1.62 [0.94-2.79],0.0801792852861553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL24A1,Collagen alpha-1(XXIV) chain,43035,128,1.14 [0.85-1.55],0.3842754816162597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL28A1,Collagen alpha-1(XXVIII) chain,42038,121,0.91 [0.73-1.14],0.4210476226861943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL2A1,Collagen alpha-1(II) chain,42083,123,0.89 [0.71-1.11],0.2918730491468667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL3A1,Collagen alpha-1(III) chain,43224,130,2.03 [1.06-3.88],0.0318877316208922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,49610,166,2.04 [1.49-2.80],8.173604783828979e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A4,Collagen alpha-4(IV) chain,42366,128,0.88 [0.65-1.19],0.3986241547946569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL5A1,Collagen alpha-1(V) chain,42273,122,1.35 [0.90-2.04],0.1497821182960652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,50221,168,2.22 [1.61-3.07],1.2349860097341336e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A1,Collagen alpha-1(IX) chain,49537,166,1.25 [0.95-1.65],0.1127728387478374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A2,Collagen alpha-2(IX) chain,42437,128,1.06 [0.73-1.54],0.753894838173554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,49581,165,2.21 [1.38-3.53],0.0009905289172489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD1,COMM domain-containing protein 1,42083,123,0.99 [0.74-1.32],0.9396268955903432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMMD9,COMM domain-containing protein 9,43021,127,0.93 [0.60-1.44],0.7366836715525437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMP,Cartilage oligomeric matrix protein,49080,163,1.00 [0.66-1.51],0.9966855215936652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COMT,Catechol O-methyltransferase,48168,162,1.05 [0.88-1.24],0.6003269945232446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPB2,Coatomer subunit beta',41815,123,1.08 [0.73-1.60],0.6874638949756947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COPE,Coatomer subunit epsilon,48439,166,0.87 [0.63-1.19],0.3803877509723361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",42083,123,1.16 [0.80-1.69],0.441677566177251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO1A,Coronin-1A,48608,161,1.07 [0.92-1.24],0.4033007478760866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,41816,123,1.61 [1.13-2.30],0.0087176114524177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",49371,166,1.10 [0.90-1.33],0.354193882393646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COX6B1,Cytochrome c oxidase subunit 6B1,43226,128,1.01 [0.60-1.69],0.975214656242987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA1,Carboxypeptidase A1,50221,168,1.06 [0.86-1.31],0.5942375542302658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA2,Carboxypeptidase A2,49887,168,1.10 [0.90-1.34],0.3681386746643403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPA4,Carboxypeptidase A4,41436,120,0.92 [0.61-1.38],0.6774821551769681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB1,Carboxypeptidase B,50221,168,1.01 [0.81-1.26],0.9550814232837868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPB2,Carboxypeptidase B2,43204,129,0.99 [0.47-2.10],0.9805458362006328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPE,Carboxypeptidase E,49636,168,1.02 [0.72-1.45],0.921788797470252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPLX2,Complexin-2,41687,124,0.82 [0.46-1.48],0.5136235689843469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPM,Carboxypeptidase M,49812,167,1.55 [1.06-2.27],0.023269193177698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",41967,124,1.24 [0.68-2.26],0.4791389534630184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPPED1,Serine/threonine-protein phosphatase CPPED1,50052,168,1.10 [0.90-1.35],0.3483208789361958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPQ,Carboxypeptidase Q,43145,130,1.22 [0.77-1.93],0.4064919568540291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPTP,Ceramide-1-phosphate transfer protein,41815,123,1.20 [0.80-1.80],0.385872686360824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPVL,Probable serine carboxypeptidase CPVL,49941,168,1.38 [0.98-1.95],0.0677881379667292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM1,Probable carboxypeptidase X1,49753,165,1.08 [0.89-1.31],0.4331499601965145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,43226,128,2.19 [1.36-3.52],0.0012362769541757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR1,Complement receptor type 1,43104,128,1.18 [0.73-1.89],0.4984987536439095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CR2,Complement receptor type 2,49806,167,1.14 [0.86-1.52],0.3591530815291647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,48422,162,1.00 [0.85-1.18],0.9902828668551104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRADD,Death domain-containing protein CRADD,49141,166,1.06 [0.88-1.27],0.5439542316924821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREB3,Cyclic AMP-responsive element-binding protein 3,41687,124,0.87 [0.62-1.22],0.4157469330960552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREBZF,CREB/ATF bZIP transcription factor,41687,124,1.26 [0.67-2.36],0.4708551243383881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CREG1,Protein CREG1,48959,160,1.15 [0.82-1.63],0.4141888439581689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD1,Protein disulfide isomerase CRELD1,42273,122,1.24 [0.78-1.97],0.3654351890289405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRELD2,Protein disulfide isomerase CRELD2,49744,165,1.12 [0.86-1.46],0.389808538695504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRH,Corticoliberin,48341,162,1.03 [0.87-1.21],0.7282561163922836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHBP,Corticotropin-releasing factor-binding protein,49581,165,1.55 [0.95-2.54],0.0811131073536368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRHR1,Corticotropin-releasing factor receptor 1,48693,163,1.05 [0.84-1.31],0.6587235328842267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,49821,165,2.28 [1.19-4.36],0.0132405318907807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIP2,Cysteine-rich protein 2,49224,166,1.69 [1.30-2.21],0.0001116017449097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP2,Cysteine-rich secretory protein 2,50024,168,0.94 [0.74-1.18],0.5761461727284861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRISP3,Cysteine-rich secretory protein 3,42854,127,0.79 [0.43-1.47],0.4604010674783338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRKL,Crk-like protein,49660,165,1.05 [0.92-1.19],0.4926416337533291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRLF1,Cytokine receptor-like factor 1,49821,165,1.76 [1.02-3.04],0.0428918107555964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRNN,Cornulin,48166,162,1.01 [0.82-1.24],0.9109298744515228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAC1,Cartilage acidic protein 1,50221,168,1.04 [0.67-1.64],0.8513583272073272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAM,Cytotoxic and regulatory T-cell molecule,49224,166,1.17 [0.90-1.54],0.2428161591369433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRTAP,Cartilage-associated protein,42038,121,0.91 [0.62-1.34],0.6305804595091863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRX,Cone-rod homeobox protein,48693,163,1.05 [0.93-1.18],0.4411748050172914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB1,Beta-crystallin B1,43226,128,0.97 [0.75-1.26],0.8245088222938852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYBB2,Beta-crystallin B2,43118,128,0.89 [0.68-1.15],0.3562083556315325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYGD,Gamma-crystallin D,43118,128,1.05 [0.88-1.25],0.5752704332993188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYM,Ketimine reductase mu-crystallin,41816,123,0.86 [0.67-1.12],0.2633886949824415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRYZL1,Quinone oxidoreductase-like protein 1,42083,123,0.96 [0.79-1.16],0.6574684558787555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSDE1,Cold shock domain-containing protein E1,41815,123,0.90 [0.77-1.07],0.2251138251892924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,49821,165,2.99 [1.89-4.71],2.5722231901906906e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1R,Macrophage colony-stimulating factor 1 receptor,43258,128,1.03 [0.68-1.58],0.8764845820449186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2,Granulocyte-macrophage colony-stimulating factor,41815,123,0.91 [0.55-1.49],0.702289204540926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,49224,166,1.18 [0.95-1.46],0.131232823964404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF2RB,Cytokine receptor common subunit beta,41967,124,0.93 [0.62-1.39],0.7165333101012903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3,Granulocyte colony-stimulating factor,48668,162,0.88 [0.66-1.18],0.4010105057378651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF3R,Granulocyte colony-stimulating factor receptor,41967,124,1.27 [0.75-2.17],0.3755206995603839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSH1,Chorionic somatomammotropin hormone 1,43258,128,0.67 [0.37-1.20],0.1780020950263571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK1D,Casein kinase I isoform delta,41967,124,1.02 [0.77-1.34],0.899053793018395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSNK2A1,Casein kinase II subunit alpha,43149,126,0.92 [0.63-1.35],0.6772698841479694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG4,Chondroitin sulfate proteoglycan 4,43224,130,1.28 [0.77-2.12],0.3402703736219521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSPG5,Chondroitin sulfate proteoglycan 5,41816,123,1.11 [0.80-1.55],0.5425512311098784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,41815,123,1.27 [1.10-1.47],0.0008785757886675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST1,Cystatin-SN,37512,112,0.94 [0.78-1.13],0.5040706443674412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,49726,167,2.20 [1.45-3.33],0.0001964952618159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST5,Cystatin-D,48673,165,1.05 [0.82-1.34],0.7021285040873739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST6,Cystatin-M,48314,162,1.02 [0.77-1.35],0.8966178739376006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,49660,165,1.20 [1.07-1.35],0.0013703186120648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSTB,Cystatin-B,48934,165,1.81 [1.35-2.43],6.521853336181524e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTAG1A_CTAG1B,Cancer/testis antigen 1,42358,128,0.72 [0.50-1.03],0.0699990982260922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTBS,Di-N-acetylchitobiase,42641,126,1.12 [0.59-2.13],0.737190817899497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTF1,Cardiotrophin-1,48693,163,1.00 [0.85-1.18],0.9798463092004293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTHRC1,Collagen triple helix repeat-containing protein 1,43224,130,1.40 [0.79-2.48],0.2475680982458306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTLA4,Cytotoxic T-lymphocyte protein 4,43224,130,1.02 [0.59-1.76],0.948289295057724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTNNA1,Catenin alpha-1,41816,123,0.46 [0.23-0.93],0.0302468175199604
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRB1,Chymotrypsinogen B,49619,166,1.04 [0.82-1.32],0.7643442571685117
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRC,Chymotrypsin-C,49585,164,1.03 [0.84-1.28],0.7542042703663139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTRL,Chymotrypsin-like protease CTRL-1,43118,128,0.98 [0.77-1.24],0.837145323677163
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,49661,168,1.47 [1.16-1.87],0.0016312506244003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSC,Dipeptidyl peptidase 1,49498,163,1.13 [0.83-1.54],0.4381938746447075
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSD,Cathepsin D,46398,156,1.21 [0.88-1.66],0.2480826861747234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSE,Cathepsin E,42273,122,0.99 [0.71-1.38],0.9585717378803515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSF,Cathepsin F,49753,165,0.98 [0.69-1.38],0.910636008379292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSH,Pro-cathepsin H,48532,161,1.04 [0.86-1.25],0.7024761889496376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSL,Cathepsin L1,49610,166,2.05 [1.20-3.48],0.008507314410148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSO,Cathepsin O,50157,167,1.31 [0.85-2.02],0.2133585940461771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,38986,133,3.01 [1.56-5.82],0.0010634311570636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSV,Cathepsin L2,49858,168,0.75 [0.54-1.06],0.1012627650292491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSZ,Cathepsin Z,49644,166,1.27 [0.84-1.94],0.259082062601762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CUZD1,CUB and zona pellucida-like domain-containing protein 1,42038,121,0.93 [0.58-1.49],0.7571433528005967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CWC15,Spliceosome-associated protein CWC15 homolog,42791,127,0.93 [0.69-1.25],0.6416709117802336
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CX3CL1,Fractalkine,49224,166,1.47 [0.99-2.17],0.0567138261140568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,49537,166,1.47 [1.15-1.88],0.0020206368617942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL1,Growth-regulated alpha protein,49508,165,1.03 [0.89-1.18],0.7264992480391996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL10,C-X-C motif chemokine 10,49821,165,1.25 [1.04-1.51],0.0200749161179146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL11,C-X-C motif chemokine 11,50052,168,1.12 [0.96-1.32],0.1458850960749944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL12,Stromal cell-derived factor 1,48668,162,1.12 [0.79-1.58],0.530567785017992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL13,C-X-C motif chemokine 13,50052,168,1.20 [1.01-1.43],0.036111609138159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL14,C-X-C motif chemokine 14,48668,162,0.99 [0.77-1.26],0.909717283591818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,50140,168,2.97 [1.72-5.14],9.91455994573761e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,50157,167,1.57 [1.18-2.09],0.001839196628054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL3,C-X-C motif chemokine 3,49583,165,1.03 [0.89-1.19],0.7319232499962705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL5,C-X-C motif chemokine 5,49447,166,0.97 [0.86-1.10],0.6583065901368284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL6,C-X-C motif chemokine 6,50157,167,1.09 [0.91-1.30],0.3416000179705355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL8,Interleukin-8,49218,166,1.19 [1.00-1.41],0.0437301406387648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL9,C-X-C motif chemokine 9,49821,165,1.40 [1.17-1.68],0.0002153830362103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5A,Cytochrome b5,41687,124,0.86 [0.66-1.13],0.2889129353664681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYB5R2,NADH-cytochrome b5 reductase 2,42551,128,1.24 [0.93-1.64],0.1425106390274304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",41815,123,0.91 [0.72-1.14],0.3975330659715153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTH3,Cytohesin-3,41687,124,1.14 [0.92-1.40],0.2368440812550333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CYTL1,Cytokine-like protein 1,43224,130,1.27 [0.65-2.48],0.479304972380405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAAM1,Disheveled-associated activator of morphogenesis 1,42273,122,0.88 [0.71-1.10],0.2632117971858286
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAB2,Disabled homolog 2,50024,168,1.01 [0.89-1.14],0.9211553093800317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAG1,Dystroglycan,49821,165,1.13 [0.84-1.51],0.4248862851197732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAND5,DAN domain family member 5,41967,124,1.22 [0.97-1.54],0.0893007483105772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPK2,Death-associated protein kinase 2,41967,124,1.20 [0.91-1.57],0.1981330073420581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,49537,166,1.02 [0.91-1.14],0.7671898127987995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DARS1,"Aspartate--tRNA ligase, cytoplasmic",49141,166,1.02 [0.84-1.23],0.8702750165972373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBH,Dopamine beta-hydroxylase,43183,128,1.04 [0.89-1.22],0.6066339892520921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBI,Acyl-CoA-binding protein,49381,165,1.19 [1.00-1.42],0.0518055092931891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBN1,Drebrin,41967,124,1.02 [0.72-1.44],0.9294026380027351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DBNL,Drebrin-like protein,49821,165,1.02 [0.88-1.19],0.7619424902162627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",49753,165,1.50 [1.03-2.19],0.0364320995796352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCC,Netrin receptor DCC,42038,121,0.52 [0.21-1.31],0.1670759574487796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCDC2C,Doublecortin domain-containing protein 2C,41687,124,0.84 [0.62-1.14],0.25778291550326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCLRE1C,Protein artemis,41687,124,0.65 [0.36-1.17],0.1501574105416852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCN,Decorin,48693,163,1.64 [0.93-2.89],0.0890853827416089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTD,Deoxycytidylate deaminase,42273,122,0.94 [0.79-1.13],0.5236141709331632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN1,Dynactin subunit 1,50024,168,0.97 [0.78-1.20],0.7731128103630202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN2,Dynactin subunit 2,49371,166,0.98 [0.84-1.14],0.765485785497427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTN6,Dynactin subunit 6,48439,166,0.98 [0.80-1.19],0.812598605926052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCTPP1,dCTP pyrophosphatase 1,49610,166,1.39 [0.90-2.15],0.1334263814476474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D1,DCN1-like protein 1,41816,123,0.88 [0.68-1.15],0.3434563210185363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCUN1D2,DCN1-like protein 2,41687,124,1.06 [0.86-1.31],0.5761387590366478
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DCXR,L-xylulose reductase,49753,165,1.12 [0.87-1.45],0.3618836118252576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDA1,DET1- and DDB1-associated protein 1,41815,123,0.72 [0.43-1.19],0.2031155269095041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",49371,166,1.40 [1.05-1.86],0.0231814271174082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDC,Aromatic-L-amino-acid decarboxylase,49536,166,1.03 [0.78-1.38],0.8156528663057248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDHD2,Phospholipase DDHD2,43149,126,0.92 [0.71-1.19],0.5125572572558941
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDI2,Protein DDI1 homolog 2,42273,122,0.94 [0.75-1.18],0.6017464102316112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,50052,168,2.34 [1.36-4.04],0.0022831472408947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDT,D-dopachrome decarboxylase,43224,130,1.04 [0.70-1.55],0.8390725397553354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX1,ATP-dependent RNA helicase DDX1,43035,128,1.00 [0.70-1.41],0.9811976908065408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX25,ATP-dependent RNA helicase DDX25,42038,121,0.76 [0.44-1.30],0.314276691395555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX39A,ATP-dependent RNA helicase DDX39A,41967,124,1.19 [0.60-2.38],0.6161196207352984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX4,Probable ATP-dependent RNA helicase DDX4,41967,124,0.95 [0.68-1.32],0.7584547080382722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX53,Probable ATP-dependent RNA helicase DDX53,42038,121,0.86 [0.52-1.42],0.5635601613239921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDX58,Antiviral innate immune response receptor RIG-I,48422,162,1.11 [0.89-1.39],0.3705652886946867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",49537,166,0.99 [0.86-1.14],0.8615471163372967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFA1_DEFA1B,Neutrophil defensin 1,48619,163,1.33 [1.07-1.66],0.0099267508080776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB103A_DEFB103B,Beta-defensin 103,41663,123,1.27 [0.91-1.78],0.1649235726056276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB104A_DEFB104B,Beta-defensin 104,41816,123,1.00 [0.72-1.37],0.9767360642092516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB116,Beta-defensin 116,41816,123,1.04 [0.83-1.30],0.7499204667518109
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,41816,123,1.34 [1.10-1.63],0.0030706348963534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB4A_DEFB4B,Beta-defensin 4A,48898,166,1.06 [0.97-1.17],0.1813083077572056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENND2B,DENN domain-containing protein 2B,41815,123,1.19 [0.89-1.59],0.241368901808737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DENR,Density-regulated protein,41967,124,0.97 [0.71-1.32],0.8271140741574569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DFFA,DNA fragmentation factor subunit alpha,50157,167,1.07 [0.87-1.31],0.5257530714785403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGCR6,Protein DGCR6,41816,123,0.87 [0.56-1.37],0.5506854373941799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKA,Diacylglycerol kinase alpha,41967,124,1.08 [0.79-1.48],0.6444068875636322
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DGKZ,Diacylglycerol kinase zeta,48668,162,1.12 [0.76-1.66],0.5542619132815199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHODH,Dihydroorotate dehydrogenase,41815,123,1.19 [0.86-1.66],0.296275663612849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHPS,Deoxyhypusine synthase,43021,127,1.04 [0.69-1.56],0.8581262122348301
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,43118,128,1.12 [0.80-1.57],0.5095405944274788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIABLO,"Diablo homolog, mitochondrial",49448,166,1.01 [0.89-1.15],0.8353923798503715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK1C,Divergent protein kinase domain 1C,42038,121,1.09 [0.73-1.64],0.6650782805918785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DIPK2B,Divergent protein kinase domain 2B,42273,122,0.73 [0.39-1.37],0.3269398338917115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK1,Dickkopf-related protein 1,50052,168,0.98 [0.78-1.23],0.840413121584743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK3,Dickkopf-related protein 3,50221,168,1.51 [0.97-2.37],0.0686881895289244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK4,Dickkopf-related protein 4,49143,166,1.42 [1.09-1.85],0.0104727847820622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKKL1,Dickkopf-like protein 1,49371,166,1.04 [0.89-1.23],0.605716984397215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLG4,Disks large homolog 4,43118,128,0.79 [0.61-1.01],0.062380344024737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLGAP5,Disks large-associated protein 5,43149,126,1.05 [0.77-1.43],0.7647937588799048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLK1,Protein delta homolog 1,50221,168,0.80 [0.63-1.02],0.069324082539312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,49753,165,1.94 [1.27-2.96],0.0021560147825255
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL4,Delta-like protein 4,42083,123,0.98 [0.80-1.20],0.8574799207781159
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMD,Dystrophin,42083,123,1.29 [0.96-1.74],0.090364938356354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DMP1,Dentin matrix acidic phosphoprotein 1,42083,123,0.94 [0.70-1.25],0.6490042404083141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA1,DnaJ homolog subfamily A member 1,41687,124,0.81 [0.53-1.24],0.3251837952634375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA2,DnaJ homolog subfamily A member 2,49997,167,0.99 [0.84-1.17],0.8981138602186642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJA4,DnaJ homolog subfamily A member 4,43118,128,0.92 [0.73-1.17],0.4943623809480448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB1,DnaJ homolog subfamily B member 1,49371,166,1.03 [0.88-1.20],0.7465578058288613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB14,DnaJ homolog subfamily B member 14,43035,128,0.98 [0.75-1.28],0.9010261444854868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB2,DnaJ homolog subfamily B member 2,42273,122,0.83 [0.60-1.16],0.2754393297371123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB6,DnaJ homolog subfamily B member 6,41889,120,0.95 [0.77-1.17],0.6275233448677053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJB8,DnaJ homolog subfamily B member 8,48693,163,0.99 [0.77-1.27],0.9388992064040106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC21,DnaJ homolog subfamily C member 21,43118,128,0.79 [0.50-1.26],0.3198736885099245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC6,Putative tyrosine-protein phosphatase auxilin,42083,123,0.96 [0.78-1.18],0.7080986685839832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNAJC9,DnaJ homolog subfamily C member 9,43035,128,1.02 [0.82-1.27],0.8605662928822406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNER,Delta and Notch-like epidermal growth factor-related receptor,49501,164,0.91 [0.53-1.56],0.7415102906914814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNLZ,DNL-type zinc finger protein,41816,123,0.95 [0.77-1.17],0.6397457847972312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM1,Dynamin-1,43035,128,1.05 [0.90-1.21],0.5445331958099744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNM3,Dynamin-3,43149,126,1.05 [0.77-1.42],0.7596725241922625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNMBP,Dynamin-binding protein,49224,166,1.06 [0.84-1.33],0.6428773308515704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPEP,Aspartyl aminopeptidase,43118,128,1.06 [0.78-1.43],0.7057801762364999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,49737,165,1.29 [1.00-1.68],0.0526635598232251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOC2B,Double C2-like domain-containing protein beta,42038,121,1.20 [0.79-1.82],0.398657662532787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOCK9,Dedicator of cytokinesis protein 9,41816,123,0.99 [0.86-1.15],0.9382309904691236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK1,Docking protein 1,43118,128,0.96 [0.85-1.09],0.5380523364264278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DOK2,Docking protein 2,49610,166,1.00 [0.90-1.12],0.9398984885783472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP1,Dipeptidase 1,49141,166,0.92 [0.70-1.22],0.5782875447695122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPEP2,Dipeptidase 2,49371,166,1.42 [0.90-2.22],0.1289809366730555
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP10,Inactive dipeptidyl peptidase 10,49537,166,1.20 [0.84-1.72],0.323112074958619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP4,Dipeptidyl peptidase 4,48692,163,0.97 [0.59-1.59],0.9067461888171118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP6,Dipeptidyl aminopeptidase-like protein 6,49371,166,0.94 [0.63-1.41],0.7790656814086047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPP7,Dipeptidyl peptidase 2,49204,165,1.04 [0.83-1.30],0.7402700476727491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,50221,168,2.81 [1.58-4.97],0.000409098088761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPY30,Protein dpy-30 homolog,49866,168,1.32 [1.08-1.61],0.0065474839749442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRAXIN,Draxin,49224,166,1.29 [0.94-1.77],0.113387425312493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DRG2,Developmentally-regulated GTP-binding protein 2,49371,166,0.99 [0.78-1.27],0.9433611844024572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,49059,165,1.89 [1.33-2.69],0.0003609845060719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSCAM,Down syndrome cell adhesion molecule,43149,126,0.78 [0.49-1.27],0.3193635247367693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG2,Desmoglein-2,49619,166,1.65 [1.01-2.69],0.0439775841310776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG3,Desmoglein-3,49861,168,1.35 [0.92-1.98],0.1271042940183765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG4,Desmoglein-4,49214,166,0.80 [0.61-1.05],0.1038707644487855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTD1,D-aminoacyl-tRNA deacylase 1,42273,122,0.99 [0.81-1.22],0.9563236304708642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,42937,127,1.81 [1.29-2.54],0.0005463149089627
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX2,Probable E3 ubiquitin-protein ligase DTX2,42038,121,1.06 [0.80-1.39],0.7049972404544915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,49371,166,2.53 [1.61-3.95],5.064236460341719e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTYMK,Thymidylate kinase,43226,128,0.91 [0.71-1.17],0.4540599659686538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUOX2,Dual oxidase 2,48693,163,0.88 [0.70-1.09],0.246693853184567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP13,Dual specificity protein phosphatase 13 isoform A,43021,127,1.11 [0.75-1.64],0.589571058455051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP29,Dual specificity phosphatase 29,42038,121,1.16 [0.93-1.46],0.1969484131597439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUSP3,Dual specificity protein phosphatase 3,48439,166,1.02 [0.87-1.19],0.8177584525602211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",43035,128,1.00 [0.85-1.17],0.9862343946346566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DXO,Decapping and exoribonuclease protein,43118,128,0.80 [0.54-1.17],0.2435590115958501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,43021,127,0.79 [0.52-1.21],0.2808659776015868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT1,Dynein light chain Tctex-type 1,42038,121,0.79 [0.62-1.02],0.0677286046885124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DYNLT3,Dynein light chain Tctex-type 3,43021,127,0.94 [0.64-1.39],0.7712687802959852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,49224,166,1.07 [0.92-1.23],0.3754657634161032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,49949,168,1.76 [1.15-2.70],0.0092120061525698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECE1,Endothelin-converting enzyme 1,48439,166,1.02 [0.69-1.51],0.9041613152575828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",43226,128,1.19 [0.96-1.47],0.1140088354450356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECHS1,"Enoyl-CoA hydratase, mitochondrial",42083,123,0.98 [0.82-1.17],0.8243699614538692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECI2,Enoyl-CoA delta isomerase 2,41815,123,1.18 [0.92-1.53],0.1949728270889989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECM1,Extracellular matrix protein 1,42108,125,1.50 [0.91-2.47],0.1115000618162676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECSCR,Endothelial cell-specific chemotaxis regulator,41816,123,0.51 [0.30-0.85],0.0095160509576172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,50024,168,2.39 [1.77-3.23],1.3370411019877394e-08
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDAR,Tumor necrosis factor receptor superfamily member EDAR,49537,166,1.00 [0.86-1.17],0.9536388453490492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDDM3B,Epididymal secretory protein E3-beta,43021,127,0.85 [0.61-1.16],0.3044279018593743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,41815,123,0.84 [0.50-1.41],0.5066119210975938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDF1,Endothelial differentiation-related factor 1,43149,126,0.98 [0.76-1.26],0.8882288639696609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,48693,163,1.52 [1.05-2.21],0.0266934662509906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,42083,123,2.72 [1.59-4.64],0.0002460237490802
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDNRB,Endothelin receptor type B,41967,124,1.11 [0.77-1.60],0.5787444626005889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EEF1D,Elongation factor 1-delta,43226,128,0.91 [0.76-1.10],0.3456525426142973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB14,EF-hand calcium-binding domain-containing protein 14,43035,128,1.59 [1.04-2.42],0.0311611670365051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFCAB2,Dynein regulatory complex protein 8,42437,128,0.91 [0.56-1.50],0.7219015128262067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,49726,167,1.96 [1.30-2.94],0.0012485229628817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFHD1,EF-hand domain-containing protein D1,43149,126,1.32 [0.85-2.05],0.2155667887346183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,49537,165,1.98 [1.29-3.04],0.0017940568319596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,49142,166,1.83 [1.25-2.68],0.0017534853859776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNB2,Ephrin-B2,42038,121,0.84 [0.60-1.18],0.3194007810094937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGF,Pro-epidermal growth factor,49502,164,0.98 [0.86-1.12],0.7672868249922349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFL7,Epidermal growth factor-like protein 7,48422,162,1.29 [0.93-1.81],0.1320547804238189
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFLAM,Pikachurin,43035,128,1.30 [0.77-2.17],0.3235153637144136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGFR,Epidermal growth factor receptor,50221,168,0.34 [0.15-0.78],0.0109496171517427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EGLN1,Egl nine homolog 1,49537,166,1.19 [0.97-1.46],0.0868410974488688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHBP1,EH domain-binding protein 1,43226,128,0.95 [0.75-1.19],0.6522446301746643
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EHD3,EH domain-containing protein 3,42083,123,0.93 [0.81-1.08],0.3622281214916367
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",43118,128,0.76 [0.53-1.10],0.1454293349486343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",42877,128,1.03 [0.88-1.20],0.7211930357970635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,41815,123,0.90 [0.68-1.20],0.4725780744272188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,42083,123,0.77 [0.49-1.21],0.2546415990693971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4B,Eukaryotic translation initiation factor 4B,49224,166,1.05 [0.82-1.33],0.7207703631555468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4E,Eukaryotic translation initiation factor 4E,41967,124,0.98 [0.81-1.20],0.8744600564892553
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,49610,166,1.26 [1.03-1.54],0.0220137321151878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,50157,167,0.98 [0.85-1.13],0.7764589888973092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,43149,126,0.95 [0.72-1.23],0.6782976782540565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5,Eukaryotic translation initiation factor 5,41815,123,0.85 [0.56-1.30],0.4544346783504226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EIF5A,Eukaryotic translation initiation factor 5A-1,48668,162,1.25 [0.82-1.91],0.3092005380943821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAC1,Zinc phosphodiesterase ELAC protein 1,43149,126,0.99 [0.81-1.21],0.9010656504405368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELAVL4,ELAV-like protein 4,41816,123,1.03 [0.83-1.26],0.8145114040452774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,43226,128,2.27 [1.44-3.57],0.0003831553998875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOA,Elongin-A,49371,166,1.25 [1.03-1.52],0.0265789551393201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELOB,Elongin-B,41815,123,0.86 [0.53-1.39],0.5319351217340975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,48668,162,1.47 [1.13-1.92],0.0037246292088933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENDOU,Poly(U)-specific endoribonuclease,39908,117,1.19 [0.86-1.64],0.2976320550941753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENG,Endoglin,50221,168,2.03 [0.94-4.38],0.0704926338413531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO1,Alpha-enolase,49562,168,1.06 [0.89-1.26],0.5371973356443048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO2,Gamma-enolase,50052,168,1.02 [0.83-1.26],0.8471336862109595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENO3,Beta-enolase,42083,123,0.95 [0.71-1.28],0.7445872112021207
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOPH1,Enolase-phosphatase E1,43021,127,0.84 [0.58-1.22],0.3645348859705347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,41815,123,0.99 [0.53-1.84],0.9668434156460164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPEP,Glutamyl aminopeptidase,41815,123,0.99 [0.67-1.47],0.9564651416109528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,50221,168,1.28 [0.78-2.11],0.3271950789764434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,49821,165,1.02 [0.73-1.42],0.9017593210720364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,42083,123,0.97 [0.60-1.56],0.903598673031474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,48082,161,1.09 [0.93-1.29],0.2963009359334532
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENSA,Alpha-endosulfine,43021,127,1.21 [0.91-1.61],0.1814247803081135
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,48422,162,1.05 [0.76-1.45],0.7556604687236979
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,48693,163,1.28 [0.67-2.45],0.4600651679666597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,48693,163,2.01 [1.14-3.54],0.0151956807439814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTR1,Endosome-associated-trafficking regulator 1,42083,123,0.83 [0.61-1.14],0.2549987951728811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EP300,Histone acetyltransferase p300,41967,124,1.16 [0.69-1.95],0.5665795656691408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPB41L5,Band 4.1-like protein 5,42038,121,1.09 [0.85-1.41],0.4885110270217576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPCAM,Epithelial cell adhesion molecule,49581,164,0.98 [0.85-1.13],0.781089126427467
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPGN,Epigen,43021,127,1.04 [0.72-1.49],0.8434113334486824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA1,Ephrin type-A receptor 1,49737,165,1.47 [0.96-2.25],0.0730599465273924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA10,Ephrin type-A receptor 10,48439,166,0.99 [0.80-1.23],0.9504261237061744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,47811,157,2.12 [1.53-2.94],6.26542512636392e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA4,Ephrin type-A receptor 4,42273,122,0.98 [0.54-1.78],0.9496711112215428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,50221,168,2.25 [1.39-3.63],0.0009465862358668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,49141,166,1.86 [1.25-2.78],0.0024332238551158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHX2,Bifunctional epoxide hydrolase 2,48693,163,0.99 [0.79-1.24],0.919321214969136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,42437,128,0.46 [0.27-0.79],0.0050945614636545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPO,Erythropoietin,49537,166,1.10 [0.92-1.31],0.2992098542699524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPPK1,Epiplakin,42083,123,1.18 [0.95-1.48],0.1406674371299315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,49941,168,1.63 [1.07-2.46],0.0215057480200487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB2,Receptor tyrosine-protein kinase erbB-2,49753,165,0.95 [0.54-1.69],0.8670051893835014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB3,Receptor tyrosine-protein kinase erbB-3,49419,165,1.07 [0.53-2.17],0.8531180063155559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBB4,Receptor tyrosine-protein kinase erbB-4,49753,165,0.90 [0.51-1.61],0.7269738443082778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERBIN,Erbin,49371,166,0.98 [0.86-1.12],0.771929469977541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERC2,ERC protein 2,42038,121,0.95 [0.74-1.21],0.6565661301059819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERCC1,DNA excision repair protein ERCC-1,41687,124,1.37 [0.95-1.97],0.0897870867010427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EREG,Proepiregulin,49141,166,1.04 [0.88-1.24],0.6365547647074332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERI1,3'-5' exoribonuclease 1,42437,128,0.64 [0.37-1.09],0.1017620237418173
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERMAP,Erythroid membrane-associated protein,41967,124,0.97 [0.66-1.44],0.8817477836063278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,43021,127,1.29 [0.84-1.98],0.2427550227498405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP29,Endoplasmic reticulum resident protein 29,42273,122,0.98 [0.85-1.13],0.7861831606220073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERP44,Endoplasmic reticulum resident protein 44,49290,166,1.06 [0.62-1.82],0.8200511087676225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,41815,123,1.08 [0.74-1.58],0.7026435929463922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESAM,Endothelial cell-selective adhesion molecule,50221,168,1.42 [0.94-2.13],0.092372950830958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESM1,Endothelial cell-specific molecule 1,49581,165,1.45 [0.97-2.15],0.0678816971862106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESPL1,Separin,41687,124,1.03 [0.77-1.39],0.8371302304208238
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESR1,Estrogen receptor,41967,124,1.08 [0.81-1.45],0.6066388270330003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ESYT2,Extended synaptotagmin-2,43118,128,0.95 [0.77-1.17],0.6064777753088051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI2B,Protein EVI2B,41687,124,1.42 [1.05-1.91],0.022122550727225
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI5,Ecotropic viral integration site 5 protein homolog,41967,124,0.91 [0.75-1.11],0.3631859236087784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVPL,Envoplakin,42437,128,0.78 [0.45-1.36],0.3807660146060935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXOSC10,Exosome component 10,41815,123,0.97 [0.71-1.32],0.8429029599683524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EXTL1,Exostosin-like 1,41815,123,0.75 [0.49-1.14],0.1808459779559232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EZR,Ezrin,50052,168,0.95 [0.54-1.67],0.8697528511409613
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F10,Coagulation factor X,43258,128,1.06 [0.59-1.92],0.849940966349847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11,Coagulation factor XI,42669,127,1.34 [0.88-2.06],0.1750991948173055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11R,Junctional adhesion molecule A,49619,166,1.02 [0.80-1.31],0.8723382373988156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F12,Coagulation factor XII,43287,129,1.38 [0.91-2.10],0.1333292215025409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F13B,Coagulation factor XIII B chain,43056,128,0.90 [0.47-1.74],0.760856181442777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2,Prothrombin,43287,129,0.80 [0.26-2.47],0.7007182408300839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F2R,Proteinase-activated receptor 1,49744,165,1.13 [0.88-1.44],0.3414334265229528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F3,Tissue factor,49716,167,1.12 [0.68-1.84],0.6684673295468848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F7,Coagulation factor VII,49724,167,0.71 [0.46-1.08],0.1094615514468784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F9,Coagulation factor IX,49726,167,1.07 [0.51-2.28],0.8501630972394254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP1,"Fatty acid-binding protein, liver",49581,165,1.19 [1.04-1.37],0.0130171152774456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP2,"Fatty acid-binding protein, intestinal",49610,166,0.99 [0.84-1.18],0.9512443365951898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",43226,128,1.53 [1.16-2.02],0.0027198697319576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",50221,168,1.60 [1.25-2.04],0.0001563181523232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP5,Fatty acid-binding protein 5,49888,167,1.23 [1.01-1.49],0.042938096779983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP6,Gastrotropin,48616,162,1.10 [0.88-1.39],0.4059861268834284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP9,Fatty acid-binding protein 9,49537,166,0.77 [0.60-0.99],0.0416426009523753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FADD,FAS-associated death domain protein,49610,166,1.06 [0.88-1.27],0.5414410437383828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM13A,Protein FAM13A,43035,128,0.97 [0.75-1.26],0.8385927079136398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171A2,Protein FAM171A2,43149,126,1.10 [1.00-1.21],0.0451620741911191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM171B,Protein FAM171B,43021,127,1.06 [0.57-1.95],0.8588814212158126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM172A,Cotranscriptional regulator FAM172A,42083,123,0.89 [0.67-1.19],0.4352527857918463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM20A,Pseudokinase FAM20A,43226,128,1.69 [0.98-2.92],0.0615425334297591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3B,Protein FAM3B,49371,166,1.26 [0.85-1.86],0.2448900035532247
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,49536,166,2.09 [1.37-3.20],0.0006504287055471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3D,Protein FAM3D,43035,128,1.05 [0.86-1.28],0.6341840905388025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAP,Prolyl endopeptidase FAP,50221,168,0.82 [0.50-1.35],0.4450160313306384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FARSA,Phenylalanine--tRNA ligase alpha subunit,42038,121,0.68 [0.50-0.92],0.0120854528104886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAS,Tumor necrosis factor receptor superfamily member 6,50058,168,1.35 [0.98-1.86],0.0703155665366005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FASLG,Tumor necrosis factor ligand superfamily member 6,50157,167,0.83 [0.57-1.19],0.3111414388134323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBLN2,Fibulin-2,43224,130,1.60 [0.97-2.63],0.0672676977221658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBN2,Fibrillin-2,42038,121,1.20 [0.89-1.60],0.2302477416407262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FBP1,"Fructose-1,6-bisphosphatase 1",49610,166,0.98 [0.81-1.18],0.8325472828876582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,43226,128,1.08 [0.86-1.37],0.4910934624809796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCAR,Immunoglobulin alpha Fc receptor,49537,166,1.21 [0.91-1.60],0.1804958448707995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,43149,126,1.29 [0.64-2.60],0.4834776367548165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCER2,Low affinity immunoglobulin epsilon Fc receptor,49619,166,1.03 [0.79-1.34],0.8377318552571701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,49403,166,1.04 [0.82-1.32],0.7428047342761677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,48422,162,0.95 [0.74-1.21],0.6701104930024617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,49648,167,1.08 [0.82-1.43],0.5948657590953659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN1,Ficolin-1,43183,128,1.31 [0.94-1.81],0.110713038771383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCN2,Ficolin-2,49398,166,0.90 [0.65-1.25],0.5230524673160126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL1,Fc receptor-like protein 1,49610,166,0.85 [0.62-1.15],0.2782918315148583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL2,Fc receptor-like protein 2,49921,166,1.27 [0.99-1.62],0.061091947678818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL3,Fc receptor-like protein 3,48668,162,0.96 [0.74-1.23],0.7418242565409139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL5,Fc receptor-like protein 5,49619,166,1.21 [0.96-1.52],0.1119501931251823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL6,Fc receptor-like protein 6,49537,166,0.93 [0.76-1.13],0.4616262110884783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,48422,162,1.31 [1.10-1.56],0.0021360050186791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX1,"Adrenodoxin, mitochondrial",41815,123,1.35 [1.10-1.66],0.003925561627849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FDX2,"Ferredoxin-2, mitochondrial",41815,123,1.25 [0.96-1.63],0.1015548409922146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FEN1,Flap endonuclease 1,48422,162,1.19 [1.01-1.40],0.0384296391979845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FES,Tyrosine-protein kinase Fes/Fps,48422,162,1.16 [0.88-1.51],0.2920870545989253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FETUB,Fetuin-B,49726,167,1.11 [0.72-1.71],0.6318344344212836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGA,Fibrinogen alpha chain,42257,124,1.67 [0.98-2.87],0.0614965018824034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",43149,126,0.99 [0.80-1.22],0.915418410484768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF12,Fibroblast growth factor 12,41967,124,1.11 [0.81-1.52],0.5144461650474556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF16,Fibroblast growth factor 16,41967,124,0.91 [0.61-1.34],0.6204454452972407
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF19,Fibroblast growth factor 19,49821,165,1.09 [0.92-1.30],0.3333359258030409
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF2,Fibroblast growth factor 2,49537,166,1.16 [0.95-1.40],0.1452250658824251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF20,Fibroblast growth factor 20,41967,124,1.08 [0.74-1.58],0.6746759936088307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF21,Fibroblast growth factor 21,49949,168,1.16 [1.03-1.29],0.0102931217781396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,49945,168,1.47 [1.22-1.76],4.402618267323449e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF3,Fibroblast growth factor 3,41967,124,1.10 [0.64-1.87],0.7285842211450091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF5,Fibroblast growth factor 5,48668,162,1.66 [1.14-2.43],0.0089684784188408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF6,Fibroblast growth factor 6,41967,124,1.21 [0.85-1.72],0.2867653233806587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF7,Fibroblast growth factor 7,41687,124,1.08 [0.89-1.32],0.4348983622214395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF9,Fibroblast growth factor 9,41614,124,0.84 [0.55-1.28],0.4191710605568239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP1,Fibroblast growth factor-binding protein 1,49753,165,0.85 [0.56-1.29],0.446627944824215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP2,Fibroblast growth factor-binding protein 2,43224,130,0.92 [0.66-1.28],0.6179307928977218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFBP3,Fibroblast growth factor-binding protein 3,43118,128,0.89 [0.56-1.42],0.6342307025990868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR2,Fibroblast growth factor receptor 2,49753,165,2.17 [1.22-3.85],0.0085108704049201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR4,Fibroblast growth factor receptor 4,42273,122,1.19 [0.86-1.64],0.3014846137879077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,43258,128,1.50 [1.17-1.92],0.0015613230820364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGR,Tyrosine-protein kinase Fgr,48439,166,1.26 [1.06-1.50],0.0078459729764674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FH,"Fumarate hydratase, mitochondrial",41816,123,0.91 [0.72-1.16],0.446908793990705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIP2A,FHF complex subunit HOOK interacting protein 2A,41815,123,0.64 [0.42-0.98],0.0396465994142932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIT,Bis(5'-adenosyl)-triphosphatase,48439,166,1.06 [0.88-1.29],0.5237232597133785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FIS1,Mitochondrial fission 1 protein,49576,165,1.07 [0.89-1.28],0.461238013866564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,43149,126,1.01 [0.85-1.19],0.9437669871684428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,49760,164,0.99 [0.87-1.12],0.8139389438783545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,49224,166,1.29 [0.93-1.77],0.1225682600062586
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,49224,166,1.08 [0.93-1.25],0.3213265976063026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,48356,166,1.18 [0.92-1.51],0.2010282352770907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FKBPL,FK506-binding protein-like,43035,128,0.85 [0.63-1.14],0.2715453954304657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLI1,Friend leukemia integration 1 transcription factor,48422,162,1.05 [0.93-1.19],0.417062487974808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,49224,166,2.01 [1.28-3.15],0.0025035765365634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,49289,166,2.22 [1.47-3.36],0.000157094069635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3,Receptor-type tyrosine-protein kinase FLT3,48422,162,1.11 [0.72-1.72],0.6227275359483246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT3LG,Fms-related tyrosine kinase 3 ligand,50157,167,1.39 [0.94-2.07],0.1010409050463388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT4,Vascular endothelial growth factor receptor 3,49753,165,1.12 [0.74-1.70],0.5789804813745765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMNL1,Formin-like protein 1,48439,166,1.15 [0.97-1.37],0.0995401795676155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FMR1,Synaptic functional regulator FMR1,48422,162,0.89 [0.60-1.32],0.5576153853938708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FN1,Fibronectin,43287,129,0.81 [0.43-1.53],0.5255118845864171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNDC1,Fibronectin type III domain-containing protein 1,43118,128,1.03 [0.72-1.48],0.8760973356161457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,43021,127,1.08 [0.68-1.72],0.7556177993227184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLH1,Glutamate carboxypeptidase 2,41967,124,1.03 [0.88-1.22],0.6950059582368933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR1,Folate receptor alpha,49535,165,1.46 [0.93-2.30],0.1018295895531132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR2,Folate receptor beta,50052,168,1.79 [1.14-2.80],0.0114724599069875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR3,Folate receptor gamma,49596,165,1.03 [0.96-1.10],0.3916805729020274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOS,Proto-oncogene c-Fos,41614,124,1.01 [0.63-1.65],0.9543006546616992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOSB,Protein fosB,48439,166,1.19 [0.88-1.61],0.2615587300451668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXJ3,Forkhead box protein J3,41967,124,0.86 [0.56-1.29],0.4595864488695313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO1,Forkhead box protein O1,49537,166,1.01 [0.86-1.18],0.9455286350156968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOXO3,Forkhead box protein O3,48422,162,0.99 [0.85-1.15],0.9037103264400788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD4B,FERM domain-containing protein 4B,41815,123,0.88 [0.67-1.15],0.3411630174387481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRMD7,FERM domain-containing protein 7,42038,121,1.25 [0.79-2.00],0.3410785208272338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FRZB,Secreted frizzled-related protein 3,49060,166,0.95 [0.55-1.63],0.8534909426748026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSHB,Follitropin subunit beta,42083,123,1.15 [0.83-1.58],0.3982261257361693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FST,Follistatin,49744,165,1.01 [0.76-1.34],0.934977633002212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL1,Follistatin-related protein 1,42083,123,1.47 [0.69-3.15],0.3220258199722907
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,49505,165,2.36 [1.63-3.42],5.026410824341792e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FTCD,Formimidoyltransferase-cyclodeaminase,43034,128,1.08 [0.89-1.31],0.4289908921121538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUCA1,Tissue alpha-L-fucosidase,49913,167,0.92 [0.79-1.08],0.3061004813949278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUOM,Fucose mutarotase,42273,122,1.00 [0.76-1.32],0.990009044122569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FURIN,Furin,49753,165,0.94 [0.62-1.44],0.7909513918189887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUS,RNA-binding protein FUS,48344,162,1.37 [0.99-1.88],0.055570465941187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",42356,128,0.83 [0.61-1.13],0.2265912886036816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,50052,168,1.23 [0.92-1.64],0.1561890460331104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FUT8,"Alpha-(1,6)-fucosyltransferase",49224,166,0.97 [0.76-1.22],0.7824943816769953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXN,"Frataxin, mitochondrial",50024,168,1.09 [0.90-1.31],0.3772452217947059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FXYD5,FXYD domain-containing ion transport regulator 5,48668,162,1.06 [0.86-1.32],0.573679791825132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FYB1,FYN-binding protein 1,49538,165,0.98 [0.85-1.14],0.8080004812986177
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD10,Frizzled-10,42038,121,1.00 [0.74-1.34],0.9770287590842296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FZD8,Frizzled-8,41816,123,0.86 [0.56-1.33],0.5008454977980491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAP,Gamma-aminobutyric acid receptor-associated protein,43021,127,1.43 [1.09-1.87],0.0101816144076705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,42437,128,0.81 [0.60-1.11],0.1914924690266341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,41816,123,0.90 [0.67-1.21],0.4820663609866996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD1,Glutamate decarboxylase 1,41687,124,1.31 [0.68-2.53],0.4189189467418492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAD2,Glutamate decarboxylase 2,41967,124,1.19 [0.89-1.61],0.2460675999518372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,42437,128,0.84 [0.55-1.28],0.4207689954584958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,42083,123,1.04 [0.75-1.45],0.8025262442239651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAGE2A,G antigen 2A,41687,124,1.10 [0.87-1.40],0.4384526655805831
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAL,Galanin peptides,49821,165,0.97 [0.78-1.19],0.7439247969970492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,49371,166,1.75 [1.08-2.83],0.023847893393252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,50024,168,0.73 [0.44-1.21],0.216354054290308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,48668,162,0.95 [0.68-1.32],0.7483360698517321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,43226,128,1.01 [0.56-1.83],0.9766856356167456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT7,N-acetylgalactosaminyltransferase 7,49371,166,1.32 [0.68-2.54],0.4082927974657828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAMT,Guanidinoacetate N-methyltransferase,41815,123,0.82 [0.48-1.41],0.4676786929610544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,41357,118,0.99 [0.57-1.73],0.9853482862875786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GART,Trifunctional purine biosynthetic protein adenosine-3,43149,126,0.92 [0.47-1.80],0.8118965146073308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS2,Growth arrest-specific protein 2,42437,128,0.77 [0.52-1.14],0.1935424496440987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAS6,Growth arrest-specific protein 6,49899,168,2.31 [1.35-3.95],0.0022927919051198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GASK1A,Golgi-associated kinase 1A,41815,123,0.80 [0.53-1.21],0.2911078964065977
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GAST,Gastrin,43118,128,1.06 [0.95-1.19],0.3075167815183603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,41687,124,0.65 [0.34-1.26],0.2045888279725235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",42083,123,0.99 [0.79-1.24],0.9236641394540552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBA,Lysosomal acid glucosylceramidase,42038,121,1.17 [0.86-1.58],0.3153889062010097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP1,Guanylate-binding protein 1,43040,127,0.99 [0.76-1.29],0.9463434269090184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP2,Guanylate-binding protein 2,48668,162,0.97 [0.76-1.23],0.785526083732272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP4,Guanylate-binding protein 4,48439,166,0.90 [0.67-1.21],0.486069632710849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GBP6,Guanylate-binding protein 6,41815,123,0.92 [0.60-1.40],0.6916824709730187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GC,Vitamin D-binding protein,43287,129,1.36 [0.72-2.58],0.3475536796190567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCC1,GRIP and coiled-coil domain-containing protein 1,43118,128,0.98 [0.84-1.14],0.775294043822141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCG,Pro-glucagon,48422,162,1.16 [1.04-1.29],0.0082987522000963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,41246,118,1.19 [0.85-1.66],0.3035007504956567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCLM,Glutamate--cysteine ligase regulatory subunit,41815,123,1.09 [0.77-1.56],0.6224539290251949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",49371,166,1.20 [0.81-1.78],0.3668532944781995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,50221,168,2.18 [1.79-2.66],1.393996242741746e-14
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF2,Growth/differentiation factor 2,49610,166,1.26 [0.86-1.84],0.2366575898933484
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDNF,Glial cell line-derived neurotrophic factor,48439,166,1.24 [0.88-1.76],0.2232883253714283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GET3,ATPase GET3,43226,128,1.30 [1.00-1.69],0.0491095020782188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,48344,161,1.91 [1.47-2.49],1.2549378834276944e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFER,FAD-linked sulfhydryl oxidase ALR,48422,162,1.22 [0.98-1.51],0.0725846068351714
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,48422,162,0.91 [0.79-1.04],0.1482023467147822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,49949,168,3.33 [2.22-5.01],7.0811353222989165e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA2,GDNF family receptor alpha-2,49371,166,1.39 [0.74-2.63],0.3048904391263042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA3,GDNF family receptor alpha-3,49072,166,1.35 [0.83-2.17],0.2258175735188974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRAL,GDNF family receptor alpha-like,41842,126,1.16 [0.89-1.50],0.2816812733688031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGA1,ADP-ribosylation factor-binding protein GGA1,48439,166,0.90 [0.71-1.13],0.3468437393867271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGACT,Gamma-glutamylaminecyclotransferase,43226,128,0.92 [0.72-1.17],0.5115473806476093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGCT,Gamma-glutamylcyclotransferase,43146,128,0.92 [0.64-1.32],0.64903894908358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGH,Gamma-glutamyl hydrolase,48779,162,1.10 [0.74-1.65],0.6321455171964848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT1,Glutathione hydrolase 1 proenzyme,49537,165,1.45 [1.14-1.85],0.0028316845360331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GGT5,Glutathione hydrolase 5 proenzyme,49224,166,1.55 [0.88-2.74],0.1300849795303039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH1,Somatotropin,49536,166,0.98 [0.91-1.06],0.668953318787849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GH2,Growth hormone variant,48422,162,0.98 [0.90-1.07],0.6769170734473315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHR,Growth hormone receptor,42273,122,0.56 [0.30-1.03],0.0609889462634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRHR,Growth hormone-releasing hormone receptor,48439,166,1.09 [0.86-1.37],0.4795836238668489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GHRL,Appetite-regulating hormone,49610,166,1.05 [0.89-1.23],0.5726151802567656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GID8,Glucose-induced degradation protein 8 homolog,43149,126,0.88 [0.50-1.55],0.6576218284305506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIGYF2,GRB10-interacting GYF protein 2,43149,126,1.00 [0.80-1.26],0.984866037592844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP7,GTPase IMAP family member 7,42273,122,0.72 [0.40-1.30],0.2731358281248116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIMAP8,GTPase IMAP family member 8,41687,124,1.10 [0.79-1.53],0.5703861222226324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIP,Gastric inhibitory polypeptide,42083,123,1.30 [0.97-1.73],0.0760638799307145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC2,PDZ domain-containing protein GIPC2,43118,128,2.05 [1.25-3.35],0.0042387618879049
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC3,PDZ domain-containing protein GIPC3,43035,128,0.96 [0.81-1.13],0.599148694072263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPR,Gastric inhibitory polypeptide receptor,41967,124,0.90 [0.60-1.35],0.6147295133770759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIT1,ARF GTPase-activating protein GIT1,41967,124,0.94 [0.79-1.13],0.5268686566336893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GJA8,Gap junction alpha-8 protein,41687,124,0.86 [0.63-1.18],0.3561103861487517
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GKN1,Gastrokine-1,47516,162,1.07 [0.64-1.78],0.8058968272900668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLA,Alpha-galactosidase A,42194,122,0.84 [0.53-1.35],0.4703321636234623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLB1,Beta-galactosidase,49224,166,1.03 [0.74-1.43],0.8803009485353743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLI2,Zinc finger protein GLI2,41967,124,1.08 [0.64-1.83],0.7674392411457822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLO1,Lactoylglutathione lyase,48693,163,1.30 [1.03-1.64],0.0260544289896606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLOD4,Glyoxalase domain-containing protein 4,49499,165,1.37 [0.92-2.03],0.1204345006521169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLP1R,Glucagon-like peptide 1 receptor,41816,123,0.79 [0.47-1.32],0.3720326861426635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX,Glutaredoxin-1,49289,165,1.13 [0.89-1.43],0.3015053080874327
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",42273,122,1.00 [0.82-1.22],0.961617316151646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,48439,166,0.80 [0.56-1.14],0.2193249516975526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLYR1,Putative oxidoreductase GLYR1,43021,127,1.04 [0.78-1.39],0.7809398705606188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GM2A,Ganglioside GM2 activator,42180,128,1.41 [1.04-1.93],0.0283997113887342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMFG,Glia maturation factor gamma,43226,128,0.98 [0.77-1.24],0.8479013069820149
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR,GMP reductase 1,50157,167,1.11 [0.84-1.47],0.4512818158734952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GMPR2,GMP reductase 2,42273,122,0.85 [0.65-1.10],0.2214778927125655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNAS,Neuroendocrine secretory protein 55,43149,126,0.98 [0.80-1.20],0.8427244239803664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,48422,162,1.12 [0.91-1.38],0.2766362823028688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,42038,121,0.83 [0.56-1.24],0.3607463327587072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNLY,Granulysin,49619,166,0.88 [0.69-1.14],0.330202181332215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA1,Glucosamine-6-phosphate isomerase 1,42083,123,0.79 [0.44-1.41],0.4294057699833488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GNPDA2,Glucosamine-6-phosphate isomerase 2,42273,122,0.88 [0.54-1.41],0.5865327661275211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLGA3,Golgin subfamily A member 3,43149,126,0.91 [0.72-1.14],0.4083068033675403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOLM2,Protein GOLM2,50052,168,1.50 [0.87-2.57],0.1408480214375852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,49537,166,0.97 [0.85-1.11],0.6796468145181879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GORASP2,Golgi reassembly-stacking protein 2,43035,128,0.86 [0.60-1.24],0.4275605272874393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GOT1,"Aspartate aminotransferase, cytoplasmic",43224,130,1.27 [0.89-1.83],0.1927875426799316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BA,Platelet glycoprotein Ib alpha chain,49399,165,0.91 [0.60-1.39],0.67451816511891
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP1BB,Platelet glycoprotein Ib beta chain,41815,123,1.01 [0.78-1.31],0.923451441275408
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,48062,163,1.21 [1.05-1.41],0.0100698317268226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP5,Platelet glycoprotein V,42273,122,0.70 [0.45-1.10],0.1224440288705377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP6,Platelet glycoprotein VI,49538,165,1.02 [0.87-1.20],0.78465020320061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPA33,Cell surface A33 antigen,49371,166,0.95 [0.86-1.05],0.3554187037794395
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC1,Glypican-1,50024,168,1.33 [0.84-2.09],0.2266773850461204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPC5,Glypican-5,49224,166,0.92 [0.72-1.18],0.5022533929899755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPD1,Glycerol-3-phosphate dehydrogenase,43021,127,1.52 [1.14-2.01],0.0040766381108059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPHA2,Glycoprotein hormone alpha-2,43035,128,0.75 [0.48-1.18],0.2178859045204092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPI,Glucose-6-phosphate isomerase,43258,128,1.03 [0.72-1.47],0.8776744663959949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,43035,128,1.03 [0.81-1.31],0.7967628322527616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPKOW,G-patch domain and KOW motifs-containing protein,48439,166,1.18 [0.78-1.76],0.4348811882009903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPNMB,Transmembrane glycoprotein NMB,48259,162,1.25 [0.77-2.02],0.3752561144073094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR101,Probable G-protein coupled receptor 101,41816,123,0.72 [0.49-1.06],0.1002028902363283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR158,Probable G-protein coupled receptor 158,43149,126,1.15 [0.73-1.83],0.5488603722641132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR15L,Protein GPR15L,43035,128,1.04 [0.79-1.36],0.7893271815411974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR37,Prosaposin receptor GPR37,48693,163,1.32 [1.07-1.63],0.0096696012799202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPRC5C,G-protein coupled receptor family C group 5 member C,43021,127,1.45 [1.16-1.82],0.0010396166262472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRAP2,GRB2-related adapter protein 2,49610,166,1.00 [0.90-1.11],0.9875658910256792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,43226,128,1.00 [0.77-1.31],0.9918151434651828
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIK2,"Glutamate receptor ionotropic, kainate 2",43149,126,1.17 [0.82-1.68],0.3783932749063147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",41816,123,0.81 [0.55-1.19],0.2821317939214104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRK5,G protein-coupled receptor kinase 5,48693,163,1.02 [0.77-1.34],0.9047162360382708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRN,Progranulin,49373,164,1.89 [1.11-3.23],0.019980261534303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRP,Gastrin-releasing peptide,42083,123,1.11 [0.80-1.52],0.5344691981886227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRPEL1,"GrpE protein homolog 1, mitochondrial",49371,166,1.33 [1.08-1.64],0.0072609975188214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GRSF1,G-rich sequence factor 1,41467,124,1.00 [0.81-1.24],0.9956315848978105
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSAP,Gamma-secretase-activating protein,48422,162,0.94 [0.78-1.13],0.5003637618885928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSN,Gelsolin,43094,128,0.80 [0.33-1.93],0.6163915782027278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSR,"Glutathione reductase, mitochondrial",43022,128,0.96 [0.45-2.06],0.921080962856642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA1,Glutathione S-transferase A1,49534,166,0.94 [0.79-1.11],0.4560192269394626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTA3,Glutathione S-transferase A3,48422,162,0.94 [0.78-1.14],0.5476649063437835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTM4,Glutathione S-transferase Mu 4,41815,123,1.09 [0.88-1.35],0.4385745044254465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTP1,Glutathione S-transferase P,48138,165,0.83 [0.67-1.04],0.1002407481712545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GSTT2B,Glutathione S-transferase theta-2B,43118,128,0.98 [0.91-1.05],0.5307139700187338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,42437,128,0.98 [0.76-1.26],0.8840368488559908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GTPBP2,GTP-binding protein 2,42038,121,0.94 [0.75-1.17],0.5607660780543713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCA2A,Guanylin,49377,165,1.41 [0.96-2.07],0.0769156946303119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUCY2C,Heat-stable enterotoxin receptor,42437,128,1.17 [0.97-1.40],0.0974773916903037
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUK1,Guanylate kinase,41815,123,1.09 [0.71-1.69],0.6892698478497523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GUSB,Beta-glucuronidase,49833,167,1.09 [0.88-1.36],0.432111103678697
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GYS1,"Glycogen [starch] synthase, muscle",48693,163,1.11 [0.96-1.29],0.1610957404568946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMA,Granzyme A,50157,167,0.79 [0.53-1.19],0.2583191904142942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMB,Granzyme B,49537,166,0.88 [0.70-1.10],0.2442016835056596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMH,Granzyme H,48693,163,0.98 [0.82-1.18],0.8560667879279481
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,H2AP,Huntingtin-interacting protein M,41687,124,1.01 [0.71-1.43],0.9510531801608824
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",41815,123,0.82 [0.59-1.14],0.2324875813493436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",49878,168,1.02 [0.85-1.23],0.8118529924645256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAO1,Hydroxyacid oxidase 1,50024,168,1.06 [0.95-1.18],0.3039099371206953
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HARS1,"Histidine--tRNA ligase, cytoplasmic",49619,166,1.10 [0.92-1.31],0.3112998803347083
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,49953,168,1.37 [1.13-1.67],0.0015245959010577
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,49619,166,1.84 [1.30-2.62],0.0006600284921059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBEGF,Proheparin-binding EGF-like growth factor,49878,168,0.91 [0.76-1.09],0.3158004667745089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBQ1,Hemoglobin subunit theta-1,50024,168,1.13 [0.91-1.40],0.2652615508074469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HBZ,Hemoglobin subunit zeta,43226,128,0.97 [0.82-1.13],0.6619664584018533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCG22,Protein PBMUCL2,41815,123,1.10 [0.85-1.43],0.4500097077172869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HCLS1,Hematopoietic lineage cell-specific protein,50157,167,1.16 [0.91-1.49],0.2401083922828686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC8,Histone deacetylase 8,41967,124,0.85 [0.60-1.20],0.3547415768169503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC9,Histone deacetylase 9,41816,123,0.92 [0.69-1.22],0.5481824920236815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDDC2,5'-deoxynucleotidase HDDC2,43035,128,1.08 [0.74-1.58],0.6744132939551573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGF,Hepatoma-derived growth factor,49953,167,1.22 [1.06-1.42],0.0063683800791121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDGFL2,Hepatoma-derived growth factor-related protein 2,43118,128,0.99 [0.75-1.29],0.9215420348275406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEBP1,Heme-binding protein 1,48693,163,0.88 [0.66-1.16],0.348002646236258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEG1,Protein HEG homolog 1,42273,122,1.34 [0.71-2.53],0.3673172835533584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPACAM2,HEPACAM family member 2,43118,128,1.23 [0.83-1.82],0.3040433196921825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEPH,Hephaestin,43226,128,1.43 [0.74-2.76],0.2864655793400124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HEXIM1,Protein HEXIM1,49537,166,0.97 [0.81-1.15],0.7074606817314779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,50157,167,2.35 [1.69-3.27],4.691546823677549e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGFAC,Hepatocyte growth factor activator,42853,127,0.83 [0.46-1.51],0.5410684047867304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,48422,162,1.08 [0.90-1.29],0.4035122286004071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HHEX,Hematopoietically-expressed homeobox protein HHEX,43118,128,1.11 [0.89-1.39],0.336010527919633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIF1A,Hypoxia-inducible factor 1-alpha,41967,124,1.06 [0.82-1.37],0.6696046787218325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1,Huntingtin-interacting protein 1,41815,123,1.02 [0.61-1.70],0.946927723018712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HIP1R,Huntingtin-interacting protein 1-related protein,43035,128,1.15 [0.83-1.60],0.3877819331469074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HJV,Hemojuvelin,43149,126,1.07 [0.73-1.57],0.723709489072557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HK2,Hexokinase-2,48693,163,0.89 [0.54-1.49],0.6651432262808965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-A,"HLA class I histocompatibility antigen, A alpha chain",43149,126,1.12 [0.67-1.87],0.6719572764496078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",49386,165,0.92 [0.63-1.35],0.6737697753840812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HLA-E,"HLA class I histocompatibility antigen, alpha chain E",49537,166,1.44 [0.92-2.24],0.1099158993555967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMBS,Porphobilinogen deaminase,50024,168,1.24 [0.90-1.70],0.1919630429633618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMCN2,Hemicentin-2,42197,122,1.14 [0.84-1.55],0.402132225022012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",42083,123,0.99 [0.70-1.42],0.9771910428403926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",41815,123,0.93 [0.62-1.40],0.7427591755498032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMMR,Hyaluronan mediated motility receptor,41604,124,0.91 [0.62-1.33],0.6276521873772276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX1,Heme oxygenase 1,49048,164,0.85 [0.64-1.14],0.2874650116794524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HMOX2,Heme oxygenase 2,48439,166,1.31 [1.01-1.69],0.0382135681577526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNF1A,Hepatocyte nuclear factor 1-alpha,42038,121,0.75 [0.54-1.04],0.0884279575408543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNMT,Histamine N-methyltransferase,48991,166,1.17 [0.88-1.56],0.2774549140609256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,48532,163,1.07 [0.90-1.28],0.444888377655119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,43149,126,0.97 [0.68-1.37],0.848545788410563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPCAL1,Hippocalcin-like protein 1,50157,167,1.05 [0.87-1.26],0.6086268828509489
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPGDS,Hematopoietic prostaglandin D synthase,48422,162,0.64 [0.44-0.94],0.0229480322561778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HPSE,Heparanase,42670,130,0.99 [0.83-1.19],0.9480777690149256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRAS,GTPase Hras,42360,128,1.07 [0.91-1.25],0.4181591895687702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,42083,123,1.14 [0.71-1.83],0.5801844389397011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HRG,Histidine-rich glycoprotein,43056,128,1.06 [0.63-1.79],0.8217184773837919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS1BP3,HCLS1-binding protein 3,42083,123,1.02 [0.84-1.24],0.8612132811640592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,49371,166,0.83 [0.58-1.20],0.3271526869667926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,50024,168,1.13 [0.77-1.64],0.5392755506839715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,41967,124,0.92 [0.56-1.52],0.7566359862416281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSBP1,Heat shock factor-binding protein 1,42083,123,1.11 [0.93-1.33],0.2592910882832493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,49537,166,1.35 [0.96-1.90],0.0861332967410085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,43118,128,1.17 [0.89-1.54],0.2495989626044196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B3,Testosterone 17-beta-dehydrogenase 3,41815,123,0.69 [0.46-1.03],0.0717835103019273
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,42083,123,0.94 [0.65-1.36],0.7504284780375646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSP90B1,Endoplasmin,48204,165,1.04 [0.85-1.28],0.7004343742202199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA1A,Heat shock 70 kDa protein 1A,49737,165,1.17 [0.97-1.41],0.0952713503222224
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPA2,Heat shock-related 70 kDa protein 2,43021,127,1.13 [0.70-1.82],0.6078099519244079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB1,Heat shock protein beta-1,48814,165,0.98 [0.81-1.20],0.8580105326142058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,50024,168,2.06 [1.52-2.79],3.6046100861874655e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,49240,165,1.66 [1.04-2.65],0.0329707125538794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1A,5-hydroxytryptamine receptor 1A,41816,123,1.09 [0.88-1.34],0.4307839905398323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1B,5-hydroxytryptamine receptor 1B,41816,123,0.53 [0.32-0.88],0.0136868495715915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTRA2,"Serine protease HTRA2, mitochondrial",49753,165,1.08 [0.87-1.36],0.4816092409298795
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYAL1,Hyaluronidase-1,49334,166,1.61 [0.92-2.82],0.0976616779809312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HYOU1,Hypoxia up-regulated protein 1,50221,168,1.28 [0.71-2.29],0.41178209888883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICA1,Islet cell autoantigen 1,48668,162,0.93 [0.77-1.11],0.4094439067868713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM1,Intercellular adhesion molecule 1,49399,166,1.77 [1.13-2.76],0.0123588283437411
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM2,Intercellular adhesion molecule 2,50221,168,1.52 [0.99-2.33],0.0562269473367718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM3,Intercellular adhesion molecule 3,50221,168,1.56 [0.95-2.56],0.0802180819167898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM4,Intercellular adhesion molecule 4,49537,166,1.04 [0.80-1.36],0.762405426368115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICAM5,Intercellular adhesion molecule 5,49610,166,1.11 [0.82-1.50],0.4815773076611288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ICOSLG,ICOS ligand,49371,166,0.99 [0.48-2.02],0.9677667013498724
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ID4,DNA-binding protein inhibitor ID-4,42437,128,0.91 [0.60-1.38],0.6647470191666691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDI2,Isopentenyl-diphosphate delta-isomerase 2,48439,166,1.23 [0.95-1.60],0.1112732363560576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDO1,"Indoleamine 2,3-dioxygenase 1",42083,123,1.09 [0.84-1.43],0.5117474599405916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDS,Iduronate 2-sulfatase,50157,167,1.42 [0.29-6.84],0.6651528476814252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDUA,Alpha-L-iduronidase,50024,168,1.14 [0.85-1.53],0.3704952314486671
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,41993,126,1.63 [1.10-2.41],0.0157643135260402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,42437,128,0.84 [0.59-1.20],0.3377034239662194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,42437,128,1.04 [0.67-1.62],0.856928186663809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNAR1,Interferon alpha/beta receptor 1,43035,128,0.99 [0.51-1.92],0.9684498648145716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNG,Interferon gamma,48668,162,1.08 [0.95-1.23],0.2175782227653864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,49821,165,2.23 [1.28-3.91],0.0048373585698776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR2,Interferon gamma receptor 2,49224,166,0.93 [0.71-1.21],0.5878152658385256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL1,Interferon lambda-1,48439,166,1.08 [0.80-1.45],0.6282304301280468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNL2,Interferon lambda-2,41816,123,0.77 [0.54-1.10],0.1490139263687814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNLR1,Interferon lambda receptor 1,49537,166,0.88 [0.59-1.32],0.5325566817339055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNW1,Interferon omega-1,41815,123,1.36 [0.96-1.93],0.0868432350784835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFT20,Intraflagellar transport protein 20 homolog,42038,121,0.92 [0.61-1.40],0.7081118019984578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGBP1,Immunoglobulin-binding protein 1,43149,126,0.97 [0.74-1.29],0.841826466707145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,41816,123,0.95 [0.66-1.37],0.7814563002173558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,43224,130,1.11 [0.60-2.07],0.7404786902590054
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF1R,Insulin-like growth factor 1 receptor,49371,166,1.14 [0.61-2.14],0.6760674945528631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,41815,123,0.63 [0.39-1.02],0.0606309242335677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2R,Cation-independent mannose-6-phosphate receptor,49619,166,1.99 [1.11-3.56],0.0200450714481229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP1,Insulin-like growth factor-binding protein 1,50138,168,1.13 [1.01-1.26],0.0386813679994131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,50142,168,1.82 [1.46-2.28],1.30700909553332e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP3,Insulin-like growth factor-binding protein 3,49806,167,0.77 [0.51-1.14],0.1926764578602839
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,48983,164,1.91 [1.49-2.44],2.697301453159196e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP6,Insulin-like growth factor-binding protein 6,49401,166,1.37 [0.91-2.07],0.1328807049974495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,50221,168,2.19 [1.68-2.85],6.9829053390233124e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,49610,166,1.99 [1.39-2.84],0.000176378453537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFL4,Insulin growth factor-like family member 4,41967,124,0.89 [0.68-1.17],0.4145437492227529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGHMBP2,DNA-binding protein SMUBP-2,41815,123,0.97 [0.70-1.33],0.8300558996059789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,43212,129,1.84 [1.30-2.59],0.0005146292994789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLON5,IgLON family member 5,41687,124,1.04 [0.88-1.24],0.6337527484105983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF21,Immunoglobulin superfamily member 21,42083,123,0.73 [0.45-1.18],0.1989298388548995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF3,Immunoglobulin superfamily member 3,49371,166,1.47 [1.06-2.05],0.0200724296888495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF8,Immunoglobulin superfamily member 8,49610,166,1.15 [0.74-1.80],0.5269021713504937
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGSF9,Protein turtle homolog A,43226,128,1.06 [0.87-1.29],0.5774416784456324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKBKG,NF-kappa-B essential modulator,49537,166,0.93 [0.80-1.09],0.3657774479416086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IKZF2,Zinc finger protein Helios,48422,162,0.90 [0.75-1.08],0.2690920596387706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10,Interleukin-10,48668,162,1.05 [0.89-1.24],0.5803097426050623
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RA,Interleukin-10 receptor subunit alpha,48668,162,0.93 [0.72-1.21],0.5946930697905917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL10RB,Interleukin-10 receptor subunit beta,49821,165,1.41 [0.90-2.21],0.1291716745764926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL11,Interleukin-11,48668,162,0.96 [0.76-1.21],0.7431756192953115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12A_IL12B,Interleukin-12,49371,166,1.13 [0.95-1.34],0.1668502146584933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12B,Interleukin-12 subunit beta,50157,167,1.13 [0.88-1.44],0.3308254269474504
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB1,Interleukin-12 receptor subunit beta-1,48668,162,1.31 [0.91-1.88],0.1509866408735667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL12RB2,Interleukin-12 receptor subunit beta-2,41967,124,1.07 [0.71-1.61],0.751972443745521
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13,Interleukin-13,48668,162,1.14 [0.90-1.45],0.2774505725518167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA1,Interleukin-13 receptor subunit alpha-1,48991,163,0.59 [0.33-1.07],0.0843824567270978
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL13RA2,Interleukin-13 receptor subunit alpha-2,41816,123,1.06 [0.58-1.95],0.8387278832009295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,49537,166,2.22 [1.56-3.18],1.1207615754968632e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15RA,Interleukin-15 receptor subunit alpha,48668,162,1.58 [1.06-2.34],0.02325878011368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL16,Pro-interleukin-16,50157,167,0.97 [0.71-1.34],0.8605346316242837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17A,Interleukin-17A,48592,162,1.24 [0.93-1.63],0.1370649117575861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17C,Interleukin-17C,48668,162,1.23 [1.04-1.46],0.0159278895077834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17D,Interleukin-17D,48668,162,1.38 [1.04-1.85],0.0275270939118918
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17F,Interleukin-17F,48668,162,1.00 [0.83-1.20],0.9758309810266096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RA,Interleukin-17 receptor A,49619,166,1.04 [0.77-1.42],0.7857925323171349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17RB,Interleukin-17 receptor B,48910,166,1.00 [0.77-1.29],0.9711704974720182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18,Interleukin-18,49417,165,1.48 [1.12-1.95],0.005755094758282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18BP,Interleukin-18-binding protein,49806,167,1.70 [1.14-2.53],0.0095584608924261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18R1,Interleukin-18 receptor 1,50157,167,1.22 [0.81-1.83],0.3405934610289665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL18RAP,Interleukin-18 receptor accessory protein,48912,166,1.05 [0.97-1.14],0.2093896265347752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL19,Interleukin-19,48372,162,1.24 [1.04-1.48],0.017355715499741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1A,Interleukin-1 alpha,48668,162,1.03 [0.83-1.29],0.7709891707561649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,48430,160,1.45 [1.19-1.76],0.0002363691263759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,49537,165,2.72 [1.58-4.68],0.0003247472852258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R2,Interleukin-1 receptor type 2,49499,165,1.72 [0.86-3.44],0.1219890486143477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RAP,Interleukin-1 receptor accessory protein,49619,166,1.16 [0.86-1.57],0.3285119397812364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL1,Interleukin-1 receptor-like 1,50058,168,1.19 [0.88-1.60],0.2598110928404774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL2,Interleukin-1 receptor-like 2,48668,162,0.78 [0.54-1.11],0.1696606450159916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,49492,165,1.47 [1.20-1.82],0.0002637989044068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2,Interleukin-2,48668,162,1.00 [0.64-1.55],0.9883555307461098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20,Interleukin-20,48668,162,1.21 [0.95-1.54],0.1181112814349626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RA,Interleukin-20 receptor subunit alpha,48668,162,0.80 [0.56-1.16],0.2409695795554815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL20RB,Interleukin-20 receptor subunit beta,41967,124,0.75 [0.49-1.14],0.1790956827447716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL21R,Interleukin-21 receptor,41967,124,1.03 [0.77-1.39],0.8232533878343975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22,Interleukin-22,43021,127,1.27 [1.01-1.59],0.0377112472804673
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL22RA1,Interleukin-22 receptor subunit alpha-1,48668,162,0.97 [0.71-1.34],0.8712092943429157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL24,Interleukin-24,48668,162,1.02 [0.78-1.35],0.8672287000104199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL25,Interleukin-25,41543,124,0.69 [0.42-1.13],0.1415125357502341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RA,Interleukin-2 receptor subunit alpha,49260,167,1.52 [1.12-2.06],0.0066581527018057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RB,Interleukin-2 receptor subunit beta,48668,162,0.87 [0.59-1.29],0.5024656273933786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RG,Cytokine receptor common subunit gamma,43021,127,1.43 [1.04-1.98],0.0271354458657335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3,Interleukin-3,41687,124,0.82 [0.65-1.04],0.0991282689236761
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31,Interleukin-31,41967,124,1.29 [1.02-1.64],0.0339099147061084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL31RA,Interleukin-31 receptor subunit alpha,41802,123,0.92 [0.58-1.45],0.7209981234390174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL32,Interleukin-32,49537,166,1.39 [1.05-1.86],0.0229109354062713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL33,Interleukin-33,48668,162,1.10 [0.77-1.57],0.6081756396812388
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL34,Interleukin-34,48361,166,1.18 [0.80-1.74],0.4126897213365365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36A,Interleukin-36 alpha,41967,124,0.93 [0.67-1.29],0.659842060860858
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL36G,Interleukin-36 gamma,41812,124,1.27 [1.05-1.54],0.0134485605778703
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL3RA,Interleukin-3 receptor subunit alpha,48668,162,0.91 [0.58-1.41],0.6679948586207183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4,Interleukin-4,48668,162,1.14 [0.96-1.36],0.1362224966354358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,49537,166,1.96 [1.43-2.70],3.5314474045349417e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5,Interleukin-5,48668,162,1.13 [1.04-1.22],0.0052679305544701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,49537,166,1.45 [1.15-1.82],0.001451269785495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,49371,166,1.27 [1.11-1.45],0.0006828777099538
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6R,Interleukin-6 receptor subunit alpha,49317,166,1.31 [0.88-1.94],0.1868474664374778
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6ST,Interleukin-6 receptor subunit beta,49610,166,2.60 [1.26-5.39],0.0100796694471141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7,Interleukin-7,49537,166,0.92 [0.74-1.14],0.4266595836269081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL7R,Interleukin-7 receptor subunit alpha,49619,166,0.76 [0.59-0.99],0.0384590104880649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL9,Interleukin-9,42437,128,0.67 [0.45-1.00],0.0487377804026883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,48364,166,1.23 [0.99-1.53],0.0615694397599016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMMT,MICOS complex subunit MIC60,43021,127,1.51 [1.11-2.04],0.0077545457419763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPA1,Inositol monophosphatase 1,49224,166,1.07 [0.85-1.34],0.5584696461417141
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPACT,Protein IMPACT,43118,128,0.94 [0.69-1.27],0.6809031318244341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IMPG1,Interphotoreceptor matrix proteoglycan 1,41816,123,0.75 [0.40-1.41],0.3664198130893652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ING1,Inhibitor of growth protein 1,48356,166,1.08 [0.81-1.42],0.6072581414555351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBB,Inhibin beta B chain,42273,122,1.47 [1.08-2.01],0.0148560120255065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INHBC,Inhibin beta C chain,49619,166,1.07 [0.76-1.51],0.6938306363437925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP1,Inositol polyphosphate 1-phosphatase,49371,166,1.02 [0.79-1.32],0.8720748241338292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",42083,123,0.89 [0.65-1.22],0.4709309603249222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",43149,126,0.63 [0.39-1.02],0.0599385912609695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",49371,166,0.98 [0.85-1.13],0.8251801836321916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL3,Insulin-like 3,43118,128,0.88 [0.72-1.07],0.1921253490077133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL4,Early placenta insulin-like peptide,43021,127,1.06 [0.76-1.48],0.7191463695613901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSL5,Insulin-like peptide INSL5,43035,128,1.09 [0.92-1.29],0.3323735089496185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,INSR,Insulin receptor,41967,124,1.26 [0.46-3.45],0.6550746971166042
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IPCEF1,Interactor protein for cytohesin exchange factors 1,49142,166,1.06 [0.90-1.23],0.4904582525324708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IQGAP2,Ras GTPase-activating-like protein IQGAP2,49371,166,1.00 [0.78-1.30],0.9813352754314124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",48693,163,0.99 [0.84-1.16],0.8815473659472516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK1,Interleukin-1 receptor-associated kinase 1,48668,162,0.92 [0.74-1.13],0.4197287769019757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IRAK4,Interleukin-1 receptor-associated kinase 4,49537,166,1.04 [0.91-1.19],0.56614524784575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,47747,163,0.95 [0.65-1.38],0.7866853965351861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM1,Isthmin-1,49537,166,0.88 [0.62-1.25],0.4717979644004682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ISM2,Isthmin-2,43224,130,1.15 [0.80-1.65],0.4563804832053123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IST1,IST1 homolog,42728,128,0.99 [0.83-1.18],0.9222237599113496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,49537,166,0.53 [0.36-0.79],0.0016831176854458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA2,Integrin alpha-2,42273,122,0.54 [0.33-0.89],0.0164797631225323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA5,Integrin alpha-5,49619,166,1.03 [0.59-1.78],0.9295112241922808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA6,Integrin alpha-6,49537,166,1.13 [0.87-1.46],0.3693145175500772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAL,Integrin alpha-L,41967,124,1.09 [0.72-1.63],0.6885815028545271
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAM,Integrin alpha-M,49619,166,0.66 [0.42-1.02],0.0637560858597094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAV,Integrin alpha-V,50024,168,0.32 [0.14-0.70],0.0047281559447947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGAX,Integrin alpha-X,42437,128,0.99 [0.72-1.37],0.95817451832477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1,Integrin beta-1,49562,167,0.99 [0.52-1.88],0.9706117575151468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP1,Integrin beta-1-binding protein 1,48422,162,1.53 [1.10-2.12],0.0114806205163057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB1BP2,Integrin beta-1-binding protein 2,48693,163,1.01 [0.89-1.14],0.922337554781081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB2,Integrin beta-2,49321,165,0.77 [0.47-1.27],0.3065715893051758
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB5,Integrin beta-5,49753,165,0.92 [0.63-1.33],0.645143602720242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB6,Integrin beta-6,48668,162,0.95 [0.60-1.51],0.8373976425485341
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGB7,Integrin beta-7,50024,168,1.05 [0.78-1.41],0.7544905506945448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGBL1,Integrin beta-like protein 1,43224,130,1.65 [1.14-2.38],0.0079791418949573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,43287,129,1.86 [0.79-4.35],0.1551515322758412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,49806,167,1.75 [1.22-2.51],0.0023594119566153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,43287,129,1.84 [1.06-3.18],0.0294959737390239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,43021,127,1.05 [0.73-1.52],0.7935798111074479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITM2A,Integral membrane protein 2A,49537,166,1.22 [0.98-1.52],0.0820009071799535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPA,Inosine triphosphate pyrophosphatase,41815,123,0.95 [0.73-1.23],0.6922404366286234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",42083,123,0.90 [0.69-1.18],0.4527799052079488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",41816,123,1.01 [0.68-1.50],0.9596909537419904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",48439,166,1.01 [0.76-1.33],0.9718998251677234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IZUMO1,Izumo sperm-egg fusion protein 1,41687,124,1.00 [0.70-1.44],0.9854277747074917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM2,Junctional adhesion molecule B,50052,168,1.70 [1.06-2.72],0.0276224880651913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JAM3,Junctional adhesion molecule C,42273,122,0.91 [0.64-1.31],0.617659352839203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JCHAIN,Immunoglobulin J chain,48668,162,1.21 [0.97-1.51],0.089490265471859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,41687,124,1.21 [0.94-1.56],0.1348111121362244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JPT2,Jupiter microtubule associated homolog 2,43035,128,0.98 [0.81-1.20],0.8779647518225304
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,JUN,Transcription factor AP-1,48668,162,1.29 [1.04-1.61],0.0231622681511181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,49371,166,1.17 [0.86-1.60],0.325896155579212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KAZN,Kazrin,43035,128,0.98 [0.83-1.15],0.7896367695840752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNC4,Potassium voltage-gated channel subfamily C member 4,41816,123,1.13 [0.86-1.50],0.3786893315247971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNH2,Potassium voltage-gated channel subfamily H member 2,42038,121,0.92 [0.71-1.18],0.5086154802791389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCNIP4,Kv channel-interacting protein 4,48439,166,0.98 [0.74-1.30],0.8884620209820505
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCTD5,BTB/POZ domain-containing protein KCTD5,42302,126,0.96 [0.65-1.41],0.8277114929843267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDM3A,Lysine-specific demethylase 3A,41967,124,1.01 [0.82-1.23],0.9519047227044272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KDR,Vascular endothelial growth factor receptor 2,49753,165,0.72 [0.42-1.23],0.2274499135980335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KEL,Kell blood group glycoprotein,48439,166,1.24 [0.85-1.81],0.2572950411342593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHDC3L,KH domain-containing protein 3,41687,124,0.83 [0.61-1.13],0.2357290181573218
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KHK,Ketohexokinase,42083,123,0.88 [0.67-1.16],0.3786268256137415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA0319,Dyslexia-associated protein KIAA0319,43118,128,1.21 [0.72-2.04],0.4756718945101499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549,UPF0606 protein KIAA1549,42437,128,0.80 [0.63-1.01],0.0639675097144404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549L,UPF0606 protein KIAA1549L,42437,128,0.57 [0.30-1.08],0.0869689888395958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA2013,Uncharacterized protein KIAA2013,43021,127,1.00 [0.72-1.37],0.986975398660626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF1C,Kinesin-like protein KIF1C,41815,123,1.09 [0.67-1.76],0.7267152668929131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF20B,Kinesin-like protein KIF20B,41816,123,1.03 [0.82-1.29],0.8213008344979594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIF22,Kinesin-like protein KIF22,41815,123,0.97 [0.85-1.12],0.7144935334193906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIFBP,KIF-binding protein,49371,166,1.00 [0.85-1.18],0.9941042841379566
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,43021,127,1.03 [0.85-1.24],0.7540050848975359
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,48422,162,0.95 [0.80-1.13],0.5731886860538343
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,43035,128,1.07 [0.97-1.18],0.1551859369686085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,48422,162,1.02 [0.91-1.14],0.7548090528534446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,41687,124,0.85 [0.66-1.10],0.2277254473766689
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL1,Kin of IRRE-like protein 1,41816,123,1.11 [0.85-1.45],0.4585952696529307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIRREL2,Kin of IRRE-like protein 2,48439,166,1.00 [0.71-1.41],0.9886319835704542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIT,Mast/stem cell growth factor receptor Kit,49726,167,0.74 [0.47-1.17],0.1947449192148614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KITLG,Kit ligand,49610,166,0.94 [0.65-1.35],0.7297081484170139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLB,Beta-klotho,48439,166,0.93 [0.77-1.12],0.4439220036172293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLF4,Krueppel-like factor 4,41816,123,1.35 [0.94-1.96],0.1084827354209474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLHL41,Kelch-like protein 41,43149,126,1.25 [0.92-1.69],0.1572900792719407
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK1,Kallikrein-1,49121,161,1.07 [0.96-1.18],0.2176391740820392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK10,Kallikrein-10,49603,163,1.24 [0.90-1.70],0.192236441379988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK11,Kallikrein-11,49275,162,1.46 [1.01-2.10],0.0426423640403857
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK12,Kallikrein-12,48422,162,0.92 [0.83-1.01],0.0824292156911915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK13,Kallikrein-13,48484,165,0.97 [0.72-1.31],0.8362018064150452
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK14,Kallikrein-14,50024,168,1.24 [0.94-1.65],0.1328190150819893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK15,Kallikrein-15,42944,127,1.20 [0.87-1.67],0.2638046065055731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK3,Prostate-specific antigen,43224,130,0.93 [0.79-1.09],0.3632741985164877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,50024,168,1.45 [1.20-1.74],9.838410571041502e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK6,Kallikrein-6,49671,165,0.87 [0.56-1.36],0.5535502568561358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK7,Kallikrein-7,41194,120,1.08 [0.69-1.69],0.7442301469059777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK8,Kallikrein-8,47949,154,1.22 [0.83-1.79],0.3079780175833281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLKB1,Plasma kallikrein,42413,127,1.23 [0.62-2.44],0.5596657813066634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRB1,Killer cell lectin-like receptor subfamily B member 1,50157,167,1.23 [0.88-1.73],0.2314639014457368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,41816,123,0.89 [0.65-1.23],0.4904894362569002
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRD1,Natural killer cells antigen CD94,50157,167,0.93 [0.70-1.25],0.6425776078592496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRF1,Killer cell lectin-like receptor subfamily F member 1,41967,124,0.99 [0.67-1.44],0.9440545089308888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLRK1,NKG2-D type II integral membrane protein,43118,128,1.02 [0.71-1.47],0.8941895698932154
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT14,"Keratin, type I cytoskeletal 14",46914,159,0.80 [0.48-1.35],0.4042686736013374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT17,"Keratin, type I cytoskeletal 17",41815,123,1.37 [0.94-1.99],0.0965206210675132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT18,"Keratin, type I cytoskeletal 18",49371,166,1.13 [0.96-1.32],0.1425039981564607
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT19,"Keratin, type I cytoskeletal 19",49458,166,1.24 [1.03-1.50],0.0261032381652324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT5,"Keratin, type II cytoskeletal 5",48439,166,0.92 [0.70-1.22],0.566070680176691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT6C,"Keratin, type II cytoskeletal 6C",41815,123,0.72 [0.42-1.24],0.2397251583364792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KRT8,"Keratin, type II cytoskeletal 8",41816,123,1.05 [0.86-1.27],0.6438139883104355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYAT1,Kynurenine--oxoglutarate transaminase 1,49529,166,1.06 [0.83-1.35],0.6447999688762212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KYNU,Kynureninase,50157,167,1.07 [0.79-1.44],0.679955416613027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L1CAM,Neural cell adhesion molecule L1,49753,165,0.89 [0.56-1.42],0.6170219592807014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,43226,128,0.99 [0.82-1.20],0.9361274595769368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACRT,Extracellular glycoprotein lacritin,42943,127,0.81 [0.55-1.21],0.305096181792906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LACTB2,Endoribonuclease LACTB2,49610,166,1.05 [0.85-1.29],0.6606282115187578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAG3,Lymphocyte activation gene 3 protein,49371,166,0.88 [0.62-1.24],0.4679990654680869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,49581,165,1.55 [1.18-2.04],0.0015951798727579
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,49224,166,1.14 [0.99-1.30],0.0668639651719634
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA1,Laminin subunit alpha-1,41815,123,0.94 [0.66-1.33],0.7164745694084915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMA4,Laminin subunit alpha-4,49821,165,1.40 [0.94-2.08],0.0979122779270807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMB1,Laminin subunit beta-1,42083,123,1.35 [0.76-2.39],0.3026597002674284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP1,Lysosome-associated membrane glycoprotein 1,42025,128,0.82 [0.41-1.63],0.56960296028124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP2,Lysosome-associated membrane glycoprotein 2,48105,161,1.90 [0.93-3.88],0.0797834803968446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP3,Lysosome-associated membrane glycoprotein 3,50075,166,1.54 [1.20-1.99],0.0007850135589113
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMTOR5,Ragulator complex protein LAMTOR5,43021,127,0.97 [0.64-1.49],0.9047329430793796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAP3,Cytosol aminopeptidase,48668,162,1.17 [0.89-1.54],0.2608069012527901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LARP1,La-related protein 1,43021,127,0.92 [0.70-1.23],0.585196513145708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT,Linker for activation of T-cells family member 1,50157,167,1.02 [0.85-1.22],0.8247438680611294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAT2,Linker for activation of T-cells family member 2,49371,166,1.01 [0.90-1.13],0.8694767008385437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LATS1,Serine/threonine-protein kinase LATS1,41967,124,1.02 [0.83-1.25],0.8562134883459076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAYN,Layilin,49141,166,1.62 [1.14-2.31],0.0074823708464775
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBP,Lipopolysaccharide-binding protein,49806,167,1.31 [1.04-1.65],0.0199657091013193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LBR,Delta(14)-sterol reductase LBR,50052,168,1.09 [0.90-1.31],0.3789994158165533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCAT,Phosphatidylcholine-sterol acyltransferase,43258,128,0.57 [0.28-1.16],0.1212715622231232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN15,Lipocalin-15,43149,126,1.18 [0.93-1.50],0.178187090816748
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCN2,Neutrophil gelatinase-associated lipocalin,48125,161,1.32 [0.95-1.84],0.100869438875384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LCP1,Plastin-2,43224,130,1.27 [0.92-1.74],0.1425395951133015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLR,Low-density lipoprotein receptor,49745,166,0.84 [0.64-1.10],0.1984015960912774
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLRAP1,Low density lipoprotein receptor adapter protein 1,43149,126,1.05 [0.88-1.25],0.5945806237239917
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LECT2,Leukocyte cell-derived chemotaxin-2,43226,128,1.45 [1.14-1.84],0.0021316486028946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEFTY2,Left-right determination factor 2,49949,168,1.03 [0.79-1.34],0.8282942418293733
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEG1,Protein LEG1 homolog,40839,120,1.00 [0.78-1.28],0.9841040971388262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LELP1,Late cornified envelope-like proline-rich protein 1,41816,123,0.87 [0.66-1.13],0.2937233626377206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEO1,RNA polymerase-associated protein LEO1,43149,126,1.13 [0.70-1.84],0.6100973802510206
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEP,Leptin,49610,166,1.09 [0.89-1.34],0.4142059364071151
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LEPR,Leptin receptor,49610,166,1.09 [0.70-1.68],0.7055631832553646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LETM1,Mitochondrial proton/calcium exchanger protein,43149,126,1.20 [0.89-1.62],0.2278114995063285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS1,Galectin-1,49610,166,1.58 [1.09-2.29],0.0158230311935292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3,Galectin-3,49743,168,1.36 [0.87-2.14],0.176224847949191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS3BP,Galectin-3-binding protein,43287,129,1.43 [0.89-2.27],0.136566381864488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS4,Galectin-4,49581,165,1.34 [1.06-1.68],0.0137978775248768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,49456,166,1.48 [1.15-1.92],0.0027270678376759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS8,Galectin-8,50052,168,0.96 [0.76-1.20],0.6952065398477545
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS9,Galectin-9,49583,165,1.78 [1.18-2.67],0.0056881345549477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGMN,Legumain,49821,165,1.15 [0.79-1.69],0.4563032629982471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHB,Lutropin subunit beta,48422,162,1.16 [1.02-1.33],0.0280002849706509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,49653,165,1.16 [0.93-1.45],0.1957777666976152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIF,Leukemia inhibitory factor,48439,166,0.90 [0.67-1.20],0.4767976073483414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIFR,Leukemia inhibitory factor receptor,49537,166,2.04 [1.19-3.50],0.009140197380649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,49619,166,1.09 [0.74-1.59],0.6672615895057494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,43224,130,1.00 [0.89-1.13],0.9875363029680616
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,41815,123,1.12 [0.81-1.53],0.4971407914256132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,49536,166,1.34 [0.88-2.04],0.1738403529805026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,43226,128,1.10 [0.88-1.39],0.3885262213295516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,50221,168,1.34 [0.82-2.18],0.25006337566637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,49979,168,1.60 [1.07-2.41],0.022409610744855
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,48668,162,1.54 [1.14-2.08],0.0044261558128955
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,50221,168,1.01 [0.83-1.23],0.8902468769457951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIPF,Gastric triacylglycerol lipase,42083,123,1.03 [0.78-1.36],0.84483850606949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB1,Lamin-B1,42956,128,1.10 [0.85-1.42],0.4570663516477767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMNB2,Lamin-B2,43118,128,1.29 [0.72-2.33],0.3930114203378164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,43149,126,2.10 [1.56-2.83],1.1681291556614828e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD2,Leiomodin-2,41816,123,0.78 [0.57-1.08],0.137595301627649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LONP1,"Lon protease homolog, mitochondrial",42083,123,0.96 [0.78-1.17],0.6749785564920849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPA,Apolipoprotein(a),42261,126,1.01 [0.92-1.11],0.8967777182813297
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPCAT2,Lysophosphatidylcholine acyltransferase 2,49371,166,1.14 [0.87-1.48],0.3417034165559069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPL,Lipoprotein lipase,49610,166,0.96 [0.72-1.28],0.7707886899711062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPO,Lactoperoxidase,47977,161,1.05 [0.83-1.32],0.685103510068398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LPP,Lipoma-preferred partner,41815,123,1.08 [0.83-1.40],0.580487509991281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,41815,123,1.05 [0.82-1.36],0.6975866043939456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,42038,121,0.91 [0.60-1.38],0.6513499790200501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRG1,Leucine-rich alpha-2-glycoprotein,43287,129,2.16 [1.18-3.95],0.012605437321621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,49878,168,1.33 [0.91-1.95],0.1472707213608698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,41819,124,1.80 [1.17-2.77],0.0073413887737102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP1,Prolow-density lipoprotein receptor-related protein 1,49371,166,1.14 [0.69-1.91],0.6071467672932014
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,49610,166,1.67 [1.17-2.39],0.0047026797483233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2,Low-density lipoprotein receptor-related protein 2,42038,121,0.73 [0.43-1.24],0.2497868068432781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP2BP,LRP2-binding protein,42038,121,0.88 [0.69-1.12],0.2900714656616187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,50052,168,1.00 [0.79-1.27],0.9708430912932384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC25,Leucine-rich repeat-containing protein 25,49371,166,1.39 [1.01-1.90],0.0408206257500911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC37A2,Leucine-rich repeat-containing protein 37A2,43035,128,1.40 [0.95-2.07],0.090682805565039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC38,Leucine-rich repeat-containing protein 38,42038,121,1.06 [0.74-1.51],0.7688485585214554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRC59,Leucine-rich repeat-containing protein 59,43226,128,0.98 [0.69-1.40],0.9108960461097252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,43021,127,0.91 [0.63-1.32],0.6269363539759608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,48668,162,0.56 [0.40-0.79],0.001105391318678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,42038,121,1.50 [1.11-2.01],0.0082105949849542
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,43149,126,0.49 [0.24-0.99],0.0459395623089667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM1,U6 snRNA-associated Sm-like protein LSm1,48422,162,1.03 [0.81-1.31],0.816353948916591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSM8,U6 snRNA-associated Sm-like protein LSm8,42437,128,0.81 [0.63-1.04],0.1038142374152337
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LSP1,Lymphocyte-specific protein 1,49537,166,1.25 [0.90-1.74],0.1914880768388511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA,Lymphotoxin-alpha,49537,166,0.86 [0.60-1.22],0.3872356691301992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTA4H,Leukotriene A-4 hydrolase,50024,168,1.02 [0.81-1.28],0.8613311103678092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTB,Lymphotoxin-beta,43021,127,0.92 [0.55-1.54],0.7508753798724974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,50221,168,2.43 [1.65-3.59],7.026865176683529e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP3,Latent-transforming growth factor beta-binding protein 3,48422,162,1.17 [0.92-1.48],0.2031375715839762
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,49336,165,2.02 [1.32-3.09],0.0011053930794107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTO1,Protein LTO1 homolog,48668,162,0.93 [0.65-1.32],0.6714450398133314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LUZP2,Leucine zipper protein 2,43021,127,1.01 [0.69-1.47],0.9561171935570308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LXN,Latexin,48990,165,1.09 [0.90-1.32],0.3844492661786461
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY6D,Lymphocyte antigen 6D,49330,164,1.48 [1.08-2.04],0.0145228236842737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY75,Lymphocyte antigen 75,49537,166,1.15 [0.80-1.64],0.4568069653284548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY9,T-lymphocyte surface antigen Ly-9,49045,166,1.30 [0.83-2.05],0.257730423079523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY96,Lymphocyte antigen 96,49224,166,1.34 [0.93-1.92],0.1112476216361032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYAR,Cell growth-regulating nucleolar protein,48422,162,0.90 [0.68-1.20],0.4817158630458208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYN,Tyrosine-protein kinase Lyn,49371,166,1.08 [0.92-1.27],0.3412547897216974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD1,Ly6/PLAUR domain-containing protein 1,48439,166,0.97 [0.77-1.22],0.7811400999442759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD3,Ly6/PLAUR domain-containing protein 3,49363,163,0.84 [0.56-1.27],0.4072274059131326
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPD8,Ly6/PLAUR domain-containing protein 8,48422,162,1.12 [0.87-1.44],0.387417632096773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYPLA2,Acyl-protein thioesterase 2,41816,123,0.96 [0.81-1.14],0.6598482253870095
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,42038,121,0.84 [0.69-1.03],0.0915444002981535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,43287,129,0.94 [0.40-2.22],0.884342285994529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LYZL2,Lysozyme-like protein 2,41687,124,0.66 [0.39-1.12],0.1233615449242913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LZTFL1,Leucine zipper transcription factor-like protein 1,42273,122,0.95 [0.74-1.22],0.7081561701419576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,M6PR,Cation-dependent mannose-6-phosphate receptor,42083,123,1.01 [0.66-1.56],0.960907697205136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,49058,166,1.28 [1.03-1.58],0.0227632698067791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAEA,E3 ubiquitin-protein transferase MAEA,48422,162,0.89 [0.61-1.30],0.5533568638097112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAG,Myelin-associated glycoprotein,42038,121,0.90 [0.63-1.29],0.558148195780739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGEA3,Melanoma-associated antigen 3,42437,128,0.82 [0.71-0.96],0.0108379457811642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGED1,Melanoma-associated antigen D1,48422,162,1.09 [0.82-1.45],0.5383572369528664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC2,MAM domain-containing protein 2,43226,128,1.37 [0.86-2.18],0.184283893923718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC4,Apical endosomal glycoprotein,43021,127,1.04 [0.77-1.40],0.793888990294229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",42083,123,1.27 [0.64-2.51],0.4908744467386263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAN2B2,Epididymis-specific alpha-mannosidase,43226,128,1.07 [0.80-1.41],0.6608067235418772
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",41687,124,0.86 [0.61-1.22],0.3996240843644308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANF,Mesencephalic astrocyte-derived neurotrophic factor,49821,165,1.02 [0.91-1.15],0.6980448512592938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC1,MANSC domain-containing protein 1,49753,165,1.81 [1.13-2.92],0.0144654481652016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC4,MANSC domain-containing protein 4,41815,123,1.02 [0.80-1.31],0.8589693432720251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,41816,123,0.74 [0.43-1.28],0.2797432565790637
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,41815,123,1.22 [1.01-1.49],0.0401378232491266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2,Microtubule-associated protein 2,43118,128,1.20 [0.85-1.69],0.2976093792817239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,43035,128,0.93 [0.71-1.21],0.5796120122825332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,49537,166,1.01 [0.88-1.16],0.8907655122935347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,48422,162,0.94 [0.81-1.09],0.4031563746632699
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,49141,166,1.02 [0.90-1.15],0.7945646598679257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK13,Mitogen-activated protein kinase 13,41687,124,1.15 [0.79-1.67],0.4597330176027119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPK9,Mitogen-activated protein kinase 9,49537,166,0.89 [0.64-1.23],0.4635394484621952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPKAPK2,MAP kinase-activated protein kinase 2,42437,128,0.90 [0.71-1.13],0.3557632467163182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPRE3,Microtubule-associated protein RP/EB family member 3,41687,124,0.93 [0.81-1.06],0.2737635050611351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPT,Microtubule-associated protein tau,48439,166,1.28 [0.98-1.69],0.0745985308495203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARCO,Macrophage receptor MARCO,49610,166,1.35 [0.80-2.29],0.2590084016738281
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MARS1,"Methionine--tRNA ligase, cytoplasmic",42194,122,0.92 [0.75-1.13],0.433325029577183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MASP1,Mannan-binding lectin serine protease 1,49141,166,1.34 [0.74-2.42],0.3267006971525799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,49664,165,2.40 [1.52-3.79],0.0001596449949036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN3,Matrilin-3,49142,166,1.31 [0.88-1.97],0.184747722970619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAVS,Mitochondrial antiviral-signaling protein,48422,162,0.99 [0.85-1.16],0.8969066093082235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAX,Protein max,48439,166,1.00 [0.88-1.14],0.9610101728744258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MB,Myoglobin,50221,168,1.24 [0.98-1.57],0.0731614359774183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MBL2,Mannose-binding protein C,42676,127,1.11 [0.95-1.30],0.1917740180172823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCAM,Cell surface glycoprotein MUC18,49806,167,1.23 [0.82-1.84],0.3132031947885939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",43149,126,1.11 [0.76-1.62],0.5748447145110707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCEMP1,Mast cell-expressed membrane protein 1,41967,124,1.16 [0.96-1.39],0.1194290549744792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCFD2,Multiple coagulation factor deficiency protein 2,49381,166,1.20 [0.88-1.64],0.2383749737488507
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MCTS1,Malignant T-cell-amplified sequence 1,43035,128,0.68 [0.33-1.39],0.2879496559332866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,49224,166,1.19 [0.98-1.46],0.0828666132518085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDH1,"Malate dehydrogenase, cytoplasmic",43027,128,0.93 [0.61-1.43],0.7428082937749434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDK,Midkine,49607,165,1.42 [1.15-1.75],0.0012482196497466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MDM1,Nuclear protein MDM1,42038,121,1.03 [0.58-1.81],0.9277260888387048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",42083,123,1.01 [0.83-1.22],0.9349909832174144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED18,Mediator of RNA polymerase II transcription subunit 18,48422,162,1.08 [0.90-1.30],0.402696167105571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MED21,Mediator of RNA polymerase II transcription subunit 21,41815,123,0.85 [0.57-1.28],0.4365121304791335
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF10,Multiple epidermal growth factor-like domains protein 10,49581,165,1.23 [0.86-1.75],0.260824609155987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF11,Multiple epidermal growth factor-like domains protein 11,41815,123,1.42 [0.91-2.20],0.1185092585313626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEGF9,Multiple epidermal growth factor-like domains protein 9,50058,168,0.87 [0.43-1.75],0.692870967466872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MELTF,Melanotransferrin,43226,128,1.34 [0.77-2.32],0.2995926932108682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MENT,Protein MENT,42273,122,1.02 [0.49-2.15],0.9566189175328912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1A,Meprin A subunit alpha,43035,128,1.04 [0.83-1.31],0.7381815058670511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEP1B,Meprin A subunit beta,49610,166,1.05 [0.93-1.18],0.4518995765516602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MEPE,Matrix extracellular phosphoglycoprotein,49581,165,0.83 [0.49-1.42],0.4960315762695835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MERTK,Tyrosine-protein kinase Mer,50157,167,2.43 [1.46-4.07],0.0007033412505582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MESD,LRP chaperone MESD,49619,166,1.04 [0.93-1.16],0.5132948171764258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MET,Hepatocyte growth factor receptor,49741,165,0.95 [0.48-1.90],0.888959848693077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1,Methionine aminopeptidase 1,48439,166,0.95 [0.59-1.53],0.840996669903399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",49537,166,1.03 [0.88-1.22],0.6863314647239708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,METAP2,Methionine aminopeptidase 2,49949,168,1.08 [0.85-1.38],0.5337377023547332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3,Microfibril-associated glycoprotein 3,48693,163,0.90 [0.66-1.21],0.4837562722617508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3L,Microfibrillar-associated protein 3-like,42038,121,0.75 [0.53-1.07],0.1093441936542688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP4,Microfibril-associated glycoprotein 4,42273,122,1.36 [0.80-2.32],0.2620259758637732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP5,Microfibrillar-associated protein 5,50221,168,1.09 [0.78-1.53],0.6016787688417866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFGE8,Lactadherin,49619,166,1.20 [0.88-1.62],0.2468619575093591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGLL,Monoglyceride lipase,49744,165,1.01 [0.87-1.19],0.8707552639427039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MGMT,Methylated-DNA--protein-cysteine methyltransferase,49537,166,1.04 [0.93-1.17],0.4638372981734969
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIA,Melanoma-derived growth regulatory protein,49753,165,1.05 [0.73-1.52],0.786984815081998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICALL2,MICAL-like protein 2,42038,121,0.87 [0.66-1.16],0.3455954696444722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,49537,166,1.00 [0.91-1.09],0.941930615596446
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MIF,Macrophage migration inhibitory factor,49536,166,1.12 [0.91-1.38],0.2670559625045742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MILR1,Allergin-1,48668,162,1.20 [0.92-1.57],0.1723312550966282
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,43021,127,1.01 [0.86-1.18],0.9359588300918822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MINK1,Misshapen-like kinase 1,43118,128,0.93 [0.78-1.12],0.4664300097877136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MITD1,MIT domain-containing protein 1,49224,166,1.03 [0.89-1.18],0.7251863349194896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MKI67,Proliferation marker protein Ki-67,41967,124,1.24 [0.86-1.79],0.2478547375668964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLLT1,Protein ENL,41687,124,0.85 [0.64-1.13],0.2680535192306102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MLN,Promotilin,49537,166,1.15 [0.98-1.34],0.0831440873663704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MME,Neprilysin,49371,166,1.17 [0.99-1.37],0.0633977735232116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP1,Interstitial collagenase,47821,159,1.11 [0.95-1.30],0.1987509237860405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP10,Stromelysin-2,49507,164,1.25 [1.00-1.56],0.0509179743952845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP12,Macrophage metalloelastase,49639,168,1.23 [0.97-1.57],0.0931016174309156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP13,Collagenase 3,48439,166,1.26 [0.82-1.93],0.284348055233472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP15,Matrix metalloproteinase-15,43226,128,0.84 [0.55-1.26],0.393731597427191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP3,Stromelysin-1,49619,166,1.15 [0.88-1.50],0.3136190335990784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,48615,163,1.79 [1.34-2.40],8.748843103505364e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,49969,168,1.44 [1.22-1.70],1.562710665910725e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,49545,166,1.57 [1.25-1.96],9.05978400479025e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",41815,123,1.42 [1.05-1.91],0.0209646935520116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MN1,Transcriptional activator MN1,42038,121,0.66 [0.45-0.96],0.0289236754019142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNAT1,CDK-activating kinase assembly factor MAT1,42437,128,1.20 [0.85-1.69],0.3055147197984362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MNDA,Myeloid cell nuclear differentiation antigen,49534,166,1.19 [1.06-1.33],0.0022333895525519
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOCS2,Molybdopterin synthase catalytic subunit,42273,122,0.94 [0.72-1.23],0.670273470553211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MOG,Myelin-oligodendrocyte glycoprotein,50024,168,1.08 [0.72-1.62],0.7019952080384193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORC3,MORC family CW-type zinc finger protein 3,43118,128,0.85 [0.44-1.62],0.6154018842666742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L1,Mortality factor 4-like protein 1,42437,128,1.31 [0.93-1.83],0.1206237785115378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORF4L2,Mortality factor 4-like protein 2,41687,124,0.90 [0.55-1.47],0.6813742467552351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MORN4,MORN repeat-containing protein 4,41687,124,1.01 [0.81-1.25],0.9327464600068646
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPHOSPH8,M-phase phosphoprotein 8,48693,163,1.02 [0.85-1.23],0.8218826226743439
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPI,Mannose-6-phosphate isomerase,49371,166,1.11 [0.95-1.31],0.1903150462276375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,49744,165,0.97 [0.81-1.16],0.7256554219206418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,49619,166,1.47 [1.14-1.89],0.0030581910021061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPRIP,Myosin phosphatase Rho-interacting protein,42940,127,0.96 [0.65-1.42],0.8319657950988804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRC1,Macrophage mannose receptor 1,43258,128,2.09 [1.20-3.66],0.0094519442945952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRI1,Methylthioribose-1-phosphate isomerase,42038,121,0.89 [0.69-1.16],0.3978650567781381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL24,"39S ribosomal protein L24, mitochondrial",41815,123,0.81 [0.49-1.35],0.42284989716849
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL28,"39S ribosomal protein L28, mitochondrial",43149,126,0.84 [0.49-1.45],0.5419118935765611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL46,"39S ribosomal protein L46, mitochondrial",48439,166,1.33 [0.85-2.08],0.2120709867423851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL52,"39S ribosomal protein L52, mitochondrial",41604,124,1.27 [0.76-2.13],0.3608433342152387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",43149,126,1.17 [0.95-1.43],0.1322352487783475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRPS16,"28S ribosomal protein S16, mitochondrial",41967,124,0.84 [0.43-1.64],0.6017344662561597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLN,Mesothelin,49290,166,1.17 [0.94-1.47],0.1578667386613938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSLNL,Mesothelin-like protein,42038,121,0.97 [0.60-1.55],0.892199533238531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSMB,Beta-microseminoprotein,49495,168,1.11 [0.92-1.34],0.2931972310998642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSR1,Macrophage scavenger receptor types I and II,50052,168,1.21 [0.90-1.62],0.2133185438349963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSRA,Mitochondrial peptide methionine sulfoxide reductase,49753,165,1.07 [0.89-1.30],0.464227415935198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MST1,Hepatocyte growth factor-like protein,42605,127,1.18 [0.86-1.61],0.311305257986198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MSTN,Growth/differentiation factor 8,48693,163,0.91 [0.70-1.18],0.4601898941321148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTDH,Protein LYRIC,41967,124,1.12 [0.93-1.34],0.2414954416602465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",43118,128,0.85 [0.42-1.72],0.653755347968568
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,42437,128,0.98 [0.84-1.14],0.8083833226241354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTIF3,"Translation initiation factor IF-3, mitochondrial",43035,128,0.99 [0.82-1.20],0.9015006675827956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTPN,Myotrophin,48693,163,0.84 [0.53-1.32],0.4508121080383248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTR,Methionine synthase,41815,123,0.88 [0.65-1.18],0.3818952165362866
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS1,Protein MTSS 1,43035,128,0.91 [0.78-1.05],0.2008233550304927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTSS2,Protein MTSS 2,43021,127,1.13 [0.95-1.34],0.1563111603941073
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MTUS1,Microtubule-associated tumor suppressor 1,42437,128,1.22 [0.93-1.60],0.1560790536681474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC13,Mucin-13,48439,166,1.32 [1.02-1.70],0.0344365363278291
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC16,Mucin-16,49371,166,1.00 [0.93-1.08],0.9472874480045248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUC2,Mucin-2,43224,130,0.98 [0.82-1.17],0.8237354801202176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MUCL3,Mucin-like protein 3,41687,124,1.00 [0.67-1.49],0.9915904595108632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MVK,Mevalonate kinase,48668,162,1.06 [0.90-1.26],0.4698445637652285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MXRA8,Matrix remodeling-associated protein 8,42273,122,0.65 [0.37-1.15],0.1390111103534306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC1,"Myosin-binding protein C, slow-type",43226,128,1.31 [1.06-1.61],0.0120354800728836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC2,"Myosin-binding protein C, fast-type",42083,123,1.14 [0.96-1.36],0.138080113387629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,43149,126,1.15 [0.90-1.46],0.2583228877979936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYDGF,Myeloid-derived growth factor,43226,128,1.01 [0.85-1.20],0.9117008905060106
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH4,Myosin-4,41815,123,0.88 [0.58-1.33],0.5368057285946601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH7B,Myosin-7B,41687,124,1.03 [0.70-1.52],0.8661061939547252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYH9,Myosin-9,43224,130,0.94 [0.81-1.09],0.4332781856630165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",41815,123,0.73 [0.44-1.21],0.2246733915919966
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL3,Myosin light chain 3,42083,123,1.20 [0.95-1.50],0.1223749659133919
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL4,Myosin light chain 4,42083,123,1.03 [0.75-1.41],0.8620749311128243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYL6B,Myosin light chain 6B,42038,121,0.83 [0.67-1.05],0.1152846326370043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",42038,121,1.17 [0.86-1.60],0.3252017638790773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO6,Unconventional myosin-VI,43149,126,1.15 [0.76-1.75],0.510535864911416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYO9B,Unconventional myosin-IXb,48668,162,0.89 [0.71-1.12],0.3320815750548792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOC,Myocilin,49619,166,1.13 [0.83-1.53],0.4460524485997617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM1,Myomesin-1,41816,123,0.90 [0.60-1.35],0.6219366711195524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM2,Myomesin-2,41815,123,1.13 [0.83-1.55],0.4416378948060888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM3,Myomesin-3,42273,122,1.15 [0.96-1.38],0.1337424822845015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZB1,Marginal zone B- and B1-cell-specific protein,49741,165,1.34 [1.04-1.73],0.0232789264296269
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MZT1,Mitotic-spindle organizing protein 1,48422,162,0.98 [0.74-1.30],0.9134819161415028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA10,N-alpha-acetyltransferase 10,41815,123,1.13 [0.80-1.59],0.4962723810368264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAA80,N-alpha-acetyltransferase 80,42038,121,1.00 [0.87-1.16],0.9681591903290546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAAA,N-acylethanolamine-hydrolyzing acid amidase,48991,165,0.86 [0.68-1.09],0.2036488451732356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NACC1,Nucleus accumbens-associated protein 1,43021,127,1.19 [0.90-1.59],0.2293785596693889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NADK,NAD kinase,49610,166,1.23 [1.00-1.53],0.0549937321966825
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGA,Alpha-N-acetylgalactosaminidase,41886,124,0.91 [0.65-1.28],0.5970114847920909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGK,N-acetyl-D-glucosamine kinase,42005,123,0.73 [0.53-1.00],0.0528998250675097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,42273,122,0.69 [0.31-1.50],0.3477719085392705
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAMPT,Nicotinamide phosphoribosyltransferase,48422,162,1.12 [0.90-1.41],0.3146706967065948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAP1L4,Nucleosome assembly protein 1-like 4,42951,128,0.80 [0.54-1.17],0.2521786332863499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAPRT,Nicotinate phosphoribosyltransferase,43118,128,0.85 [0.50-1.44],0.5498095251866129
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NARS1,"Asparagine--tRNA ligase, cytoplasmic",43149,126,0.80 [0.56-1.14],0.2183355838075148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,49753,165,2.28 [1.42-3.67],0.0006576251160166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBN,Nibrin,48668,162,0.96 [0.74-1.26],0.7871171902638728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM1,Neural cell adhesion molecule 1,49806,167,1.32 [0.86-2.03],0.2002753963156477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM2,Neural cell adhesion molecule 2,49619,166,1.79 [1.09-2.96],0.0224303032962594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAN,Neurocan core protein,50052,168,0.68 [0.48-0.97],0.0323983828843864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCF2,Neutrophil cytosol factor 2,49457,166,1.22 [1.07-1.40],0.004079520877958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCK2,Cytoplasmic protein NCK2,49821,165,1.05 [0.92-1.19],0.505353945182143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCLN,Nicalin,48668,162,0.87 [0.63-1.20],0.3859886058511158
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR1,Natural cytotoxicity triggering receptor 1,49469,165,1.20 [0.84-1.72],0.32420167704803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,43035,128,1.61 [1.01-2.59],0.0471869219029571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,50024,168,2.59 [1.64-4.09],4.658758498365724e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDRG1,Protein NDRG1,48439,166,0.93 [0.75-1.17],0.5576254454961864
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,43021,127,0.88 [0.65-1.20],0.4254713144357278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,41895,124,1.16 [0.71-1.89],0.5443414032545913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,43035,128,0.94 [0.78-1.14],0.52197798730353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",48422,162,1.09 [0.93-1.28],0.2980971865153629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEB,Nebulin,41815,123,1.24 [0.84-1.83],0.2712484382342403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECAP2,Adaptin ear-binding coat-associated protein 2,41815,123,1.10 [0.86-1.41],0.4496354158784578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN1,Nectin-1,41967,124,1.00 [0.59-1.69],0.992802773872516
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN2,Nectin-2,49536,166,1.90 [1.25-2.88],0.0026586900464752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NECTIN4,Nectin-4,49753,165,1.43 [0.97-2.10],0.0715148120092239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,41967,124,0.90 [0.64-1.28],0.5677696301695904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEDD9,Enhancer of filamentation 1,41967,124,1.12 [0.70-1.82],0.6310308399376006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,48287,165,1.85 [1.43-2.40],2.357209990151871e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEK7,Serine/threonine-protein kinase Nek7,42437,128,0.94 [0.74-1.20],0.6443446521336922
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL1,Protein kinase C-binding protein NELL1,49753,165,0.95 [0.69-1.31],0.7620645083742082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NELL2,Protein kinase C-binding protein NELL2,49821,165,0.78 [0.48-1.27],0.3185544981959611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NENF,Neudesin,43021,127,0.95 [0.81-1.12],0.5465744300570338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEO1,Neogenin,43149,126,1.01 [0.47-2.16],0.9733932826015296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEXN,Nexilin,43258,128,0.96 [0.75-1.23],0.7616059155791688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFASC,Neurofascin,50157,167,1.48 [0.94-2.35],0.0931829685048107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFAT5,Nuclear factor of activated T-cells 5,41967,124,0.87 [0.70-1.09],0.233587480736331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",49537,166,0.94 [0.81-1.08],0.3674142831463879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",48668,162,1.02 [0.81-1.29],0.8541141964134011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFE2,Transcription factor NF-E2 45 kDa subunit,42083,123,0.88 [0.69-1.12],0.3001875189910541
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFIC,Nuclear factor 1 C-type,43149,126,0.92 [0.61-1.40],0.6923546567125133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB1,Nuclear factor NF-kappa-B p105 subunit,41815,123,0.97 [0.76-1.23],0.7775161089657683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB2,Nuclear factor NF-kappa-B p100 subunit,42437,128,0.65 [0.41-1.03],0.0696307696311074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKBIE,NF-kappa-B inhibitor epsilon,48422,162,1.30 [0.99-1.70],0.059798341392741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",43035,128,1.02 [0.86-1.20],0.8244403916012633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFX1,Transcriptional repressor NF-X1,41815,123,0.96 [0.74-1.25],0.779527960172721
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFYA,Nuclear transcription factor Y subunit alpha,41815,123,1.10 [0.72-1.66],0.6590186976764892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGF,Beta-nerve growth factor,49224,166,0.75 [0.24-2.36],0.6292733573103878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGFR,Tumor necrosis factor receptor superfamily member 16,43226,128,0.73 [0.39-1.35],0.3140910240126912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NGRN,Neugrin,43118,128,1.12 [0.54-2.32],0.7676724347225319
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NHLRC3,NHL repeat-containing protein 3,41266,120,1.73 [0.99-3.04],0.0562720923943449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID1,Nidogen-1,49644,167,1.28 [0.90-1.83],0.1741968901689942
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NID2,Nidogen-2,49619,166,1.03 [0.86-1.24],0.7206326651643065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NINJ1,Ninjurin-1,48422,162,0.84 [0.62-1.14],0.2608818476622641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT1,Deaminated glutathione amidase,42083,123,0.77 [0.54-1.10],0.1456684707768031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NIT2,Omega-amidase NIT2,43062,127,0.97 [0.77-1.23],0.8126589672567176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN1,Neuroligin-1,42038,121,0.82 [0.59-1.13],0.2200076893802768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NLGN2,Neuroligin-2,41816,123,0.84 [0.55-1.28],0.4118362737746549
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME1,Nucleoside diphosphate kinase A,41967,124,0.71 [0.31-1.63],0.4148308135165257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NME3,Nucleoside diphosphate kinase 3,49664,165,1.23 [0.70-2.16],0.4674041583736695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMI,N-myc-interactor,42862,127,1.13 [0.90-1.42],0.2955561338643362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,49224,166,1.15 [0.99-1.35],0.0731682561944194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMRK2,Nicotinamide riboside kinase 2,41687,124,0.81 [0.49-1.33],0.4035272115566929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,43149,126,0.97 [0.74-1.26],0.8155495174972198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOMO1,Nodal modulator 1,49619,166,1.06 [0.59-1.92],0.8382685586210243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOP56,Nucleolar protein 56,41815,123,0.78 [0.63-0.97],0.0230906638752675
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS1,"Nitric oxide synthase, brain",48439,166,1.33 [1.05-1.68],0.0199774827623533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS2,"Nitric oxide synthase, inducible",41815,123,1.05 [0.68-1.63],0.8179246630416785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOS3,"Nitric oxide synthase, endothelial",48439,166,1.15 [0.91-1.45],0.2321782410621339
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH1,Neurogenic locus notch homolog protein 1,50221,168,1.18 [0.50-2.77],0.7060453426924892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH2,Neurogenic locus notch homolog protein 2,43224,130,1.20 [0.58-2.48],0.6302696431468495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH3,Neurogenic locus notch homolog protein 3,50221,168,1.57 [1.06-2.33],0.0257603053343835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,42501,128,1.83 [1.26-2.67],0.0016506745543058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,49610,166,2.12 [1.53-2.94],5.935912424768042e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS1,Nephrin,41967,124,0.91 [0.54-1.53],0.7226517994566488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPHS2,Podocin,41967,124,1.04 [0.89-1.22],0.6363641183922746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPL,N-acetylneuraminate lyase,43226,128,0.99 [0.69-1.42],0.9512790854659708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,48693,163,1.24 [1.12-1.37],3.104169465080527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPC,C-type natriuretic peptide,49537,166,1.10 [0.85-1.43],0.4751083195053016
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPR1,Atrial natriuretic peptide receptor 1,41815,123,1.20 [0.81-1.78],0.3501803924086317
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTN,Neuroplastin,48422,162,1.07 [0.91-1.26],0.3851518514018592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX1,Neuronal pentraxin-1,49619,166,1.00 [0.71-1.40],0.9770823472430664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTX2,Neuronal pentraxin-2,43224,130,1.08 [0.65-1.78],0.7721519008673731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPTXR,Neuronal pentraxin receptor,49610,166,0.99 [0.66-1.47],0.9464993816584522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPY,Pro-neuropeptide Y,50024,168,1.06 [0.86-1.31],0.563241142540362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRCAM,Neuronal cell adhesion molecule,49610,166,1.14 [0.71-1.84],0.584801401215834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRGN,Neurogranin,43258,128,1.02 [0.85-1.23],0.8252123537036837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRN1,Neuritin,43149,126,0.96 [0.59-1.55],0.8702129654277501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP1,Neuropilin-1,49891,167,1.95 [1.22-3.14],0.0057087806800894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRP2,Neuropilin-2,49619,166,1.42 [0.90-2.24],0.1286783756784486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRTN,Neurturin,48668,162,0.85 [0.64-1.15],0.2964605157738261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NRXN3,Neurexin-3,42038,121,1.11 [0.69-1.76],0.6690954108882596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NSFL1C,NSFL1 cofactor p47,50052,168,1.09 [0.89-1.35],0.3918603065639239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",43226,128,1.03 [0.81-1.30],0.8196167674962606
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,43118,128,2.06 [1.55-2.74],6.661245333316791e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C3A,Cytosolic 5'-nucleotidase 3A,49460,166,0.96 [0.82-1.13],0.6571570758754155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5E,5'-nucleotidase,49753,165,1.28 [1.01-1.61],0.039082064021147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF3,Neurotrophin-3,49537,166,1.28 [0.88-1.86],0.1933535167554294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTF4,Neurotrophin-4,48422,162,0.98 [0.67-1.42],0.90225296852642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK2,BDNF/NT-3 growth factors receptor,49610,166,1.29 [0.76-2.22],0.3468153519205552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTRK3,NT-3 growth factor receptor,50052,168,1.02 [0.54-1.91],0.9520596283432464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,49610,166,1.28 [1.15-1.42],8.121582010432101e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUB1,NEDD8 ultimate buster 1,49537,166,0.97 [0.82-1.15],0.7213150479825747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,43021,127,0.93 [0.77-1.12],0.4363063519191881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUCB2,Nucleobindin-2,49942,168,1.36 [0.95-1.95],0.0935621640205256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDC,Nuclear migration protein nudC,50157,167,0.98 [0.79-1.22],0.854062003663916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,42083,123,0.60 [0.26-1.36],0.2198768350166235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,41815,123,1.02 [0.73-1.43],0.9040001178957134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT16,U8 snoRNA-decapping enzyme,42964,127,1.10 [0.91-1.33],0.3318164340855645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],49371,166,1.00 [0.78-1.28],0.9953554670537494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUDT5,ADP-sugar pyrophosphatase,49619,166,1.21 [0.92-1.58],0.1670564413625633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUMB,Protein numb homolog,41967,124,0.97 [0.78-1.19],0.7535821161336055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NUP50,Nuclear pore complex protein Nup50,41815,123,0.98 [0.57-1.67],0.9287653358076752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPE4,NXPE family member 4,41815,123,1.19 [0.74-1.92],0.4728676718683817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH1,Neurexophilin-1,48439,166,0.99 [0.69-1.42],0.951227296748717
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NXPH3,Neurexophilin-3,41967,124,0.89 [0.50-1.57],0.6893362960234346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OBP2B,Odorant-binding protein 2b,49062,166,0.94 [0.75-1.17],0.5642826353413353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OCLN,Occludin,43149,126,1.63 [1.16-2.29],0.0049364097976725
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ODAM,Odontogenic ameloblast-associated protein,48361,166,1.02 [0.80-1.30],0.8563959331452189
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OFD1,Oral-facial-digital syndrome 1 protein,42437,128,1.10 [0.87-1.40],0.4227884204589015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGA,Protein O-GlcNAcase,43035,128,0.97 [0.76-1.24],0.8303892397979636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGFR,Opioid growth factor receptor,49371,166,1.08 [0.70-1.65],0.7330581737297523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,49619,166,1.65 [1.22-2.22],0.0011113100012923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,42437,128,0.85 [0.62-1.15],0.2945132146413834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLFM4,Olfactomedin-4,40699,118,0.99 [0.85-1.14],0.8660999721428431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,49134,164,1.43 [1.18-1.73],0.0002540140022082
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMD,Osteomodulin,49821,165,0.93 [0.68-1.29],0.6803461829888169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,49371,166,0.74 [0.61-0.91],0.0040677199202805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMP,Olfactory marker protein,41816,123,0.99 [0.69-1.41],0.9409129646104012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPHN1,Oligophrenin-1,43118,128,0.95 [0.81-1.11],0.4999730484188818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPLAH,5-oxoprolinase,42083,123,0.92 [0.71-1.20],0.5371522378283076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OPTC,Opticin,49371,166,0.97 [0.72-1.31],0.8619680624090502
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ORM1,Alpha-1-acid glycoprotein 1,43132,129,2.98 [1.36-6.53],0.0064090661045768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSBPL2,Oxysterol-binding protein-related protein 2,43118,128,0.62 [0.35-1.10],0.1055104241544701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSCAR,Osteoclast-associated immunoglobulin-like receptor,49664,165,1.76 [1.18-2.63],0.0052553015191276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,49303,166,1.43 [1.18-1.73],0.0002091537085777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSMR,Oncostatin-M-specific receptor subunit beta,49891,167,1.63 [0.84-3.19],0.151824306672357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSTN,Osteocrin,42038,121,0.89 [0.57-1.40],0.6073538686356899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTOA,Otoancorin,41816,123,0.95 [0.67-1.34],0.7615843633750533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD6B,Deubiquitinase OTUD6B,43035,128,0.92 [0.69-1.24],0.5927218886597094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OTUD7B,OTU domain-containing protein 7B,43149,126,1.05 [0.80-1.38],0.724106014339329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",42083,123,1.12 [0.88-1.43],0.3577162473966737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OXT,Oxytocin-neurophysin 1,50052,168,0.99 [0.90-1.09],0.783846167064949
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,P4HB,Protein disulfide-isomerase,49367,163,0.96 [0.67-1.38],0.8243379114927074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PACS2,Phosphofurin acidic cluster sorting protein 2,41815,123,1.01 [0.76-1.34],0.9588590872014868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI2,Protein-arginine deiminase type-2,48668,162,1.18 [0.97-1.43],0.1023918939007913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PADI4,Protein-arginine deiminase type-4,48361,166,1.02 [0.86-1.22],0.7920258626089374
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAEP,Glycodelin,49224,166,0.97 [0.85-1.11],0.6654124100942951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,43149,126,0.94 [0.80-1.10],0.4364580946760059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",42437,128,0.84 [0.59-1.20],0.3447472079570044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,48693,163,1.18 [0.93-1.49],0.1784309282636175
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAGR1,PAXIP1-associated glutamate-rich protein 1,42083,123,0.76 [0.49-1.18],0.2222084470816068
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,41614,124,0.64 [0.44-0.92],0.017789345790035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAK4,Serine/threonine-protein kinase PAK 4,48439,166,0.98 [0.78-1.24],0.8919427199888765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALLD,Palladin,41967,124,0.88 [0.55-1.42],0.604988215670737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM,Paralemmin-1,42800,128,1.08 [0.63-1.87],0.775637745932432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,43118,128,2.31 [1.64-3.26],1.7979873397288669e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM3,Paralemmin-3,41815,123,0.78 [0.56-1.07],0.1248377643280229
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAM,Peptidyl-glycine alpha-amidating monooxygenase,49979,168,1.97 [1.18-3.29],0.0093753717405812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAMR1,Inactive serine protease PAMR1,49619,166,1.10 [0.66-1.83],0.7140914621980656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAPPA,Pappalysin-1,48668,162,1.32 [0.98-1.78],0.0704742264298433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARD3,Partitioning defective 3 homolog,42437,128,0.72 [0.55-0.94],0.0167552096287252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARK7,Parkinson disease protein 7,49619,166,1.20 [0.92-1.56],0.1727783952674997
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARP1,Poly [ADP-ribose] polymerase 1,49537,166,1.08 [0.87-1.34],0.4996757737616534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAXX,Protein PAXX,42273,122,0.89 [0.60-1.32],0.5659008612146188
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBK,Lymphokine-activated killer T-cell-originated protein kinase,41687,124,1.09 [0.63-1.91],0.7520508921073121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBLD,Phenazine biosynthesis-like domain-containing protein,48439,166,0.92 [0.70-1.21],0.5619059733238084
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,43035,128,1.26 [0.75-2.13],0.383989727400952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCARE,Photoreceptor cilium actin regulator,41816,123,1.13 [0.95-1.34],0.171058611952823
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,42195,122,1.20 [0.85-1.70],0.3088484961421892
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCBP2,Poly(rC)-binding protein 2,43149,126,1.01 [0.80-1.28],0.934190620372794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH1,Protocadherin-1,49999,166,1.08 [0.58-2.04],0.8008169305967127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH12,Protocadherin-12,43149,126,1.02 [0.52-1.99],0.9592654182659506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH17,Protocadherin-17,49610,166,1.16 [0.80-1.68],0.425404538573277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH7,Protocadherin-7,43035,128,1.14 [0.73-1.78],0.5535263690836414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH9,Protocadherin-9,43035,128,0.63 [0.41-0.99],0.0431578981780303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDHB15,Protocadherin beta-15,43021,127,0.96 [0.63-1.46],0.8368552305135788
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCNA,Proliferating cell nuclear antigen,41687,124,0.98 [0.74-1.29],0.8722803957872443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK7,Proprotein convertase subtilisin/kexin type 7,43021,127,1.07 [0.75-1.52],0.7224973259782148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCSK9,Proprotein convertase subtilisin/kexin type 9,50221,168,1.28 [0.91-1.79],0.157933708572234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCYT2,Ethanolamine-phosphate cytidylyltransferase,43035,128,0.99 [0.79-1.24],0.9591397118772323
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDAP1,28 kDa heat- and acid-stable phosphoprotein,43226,128,1.00 [0.84-1.19],0.9872890061846086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1,Programmed cell death protein 1,49944,167,1.22 [0.89-1.65],0.2119755788091845
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD1LG2,Programmed cell death 1 ligand 2,49371,166,1.45 [0.96-2.21],0.0801273082344965
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD5,Programmed cell death protein 5,50052,168,1.17 [0.92-1.47],0.1960563346409381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCD6,Programmed cell death protein 6,49610,166,1.38 [1.07-1.77],0.0132615061705123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDCL2,Phosducin-like protein 2,41687,124,0.94 [0.67-1.32],0.7038017762159232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",41687,124,1.26 [0.98-1.60],0.0687373420203013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",41815,123,1.05 [0.79-1.39],0.7543171995619739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",42273,122,0.91 [0.78-1.08],0.278896008751021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFA,Platelet-derived growth factor subunit A,50221,168,1.01 [0.84-1.21],0.9415625930314696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFB,Platelet-derived growth factor subunit B,49821,165,0.99 [0.85-1.16],0.9249177074989036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFC,Platelet-derived growth factor C,48422,162,1.05 [0.64-1.73],0.833150470635751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRA,Platelet-derived growth factor receptor alpha,49610,166,1.70 [1.07-2.70],0.0249865326329473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRB,Platelet-derived growth factor receptor beta,50221,168,0.83 [0.57-1.22],0.3422851167572021
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA2,Protein disulfide-isomerase A2,41687,124,0.90 [0.57-1.42],0.6559565314789605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA3,Protein disulfide-isomerase A3,42273,122,1.74 [1.01-3.02],0.0467726344387178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA4,Protein disulfide-isomerase A4,43224,130,1.03 [0.78-1.36],0.8292011874319678
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDIA5,Protein disulfide-isomerase A5,41687,124,1.05 [0.80-1.39],0.7094238817215293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM5,PDZ and LIM domain protein 5,43149,126,0.94 [0.82-1.09],0.4211025341109259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDLIM7,PDZ and LIM domain protein 7,49821,165,1.01 [0.91-1.13],0.8056496502306894
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",48422,162,1.03 [0.78-1.36],0.8408408586471887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDRG1,p53 and DNA damage-regulated protein 1,42038,121,0.89 [0.62-1.28],0.5230766189506413
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,41687,124,0.86 [0.60-1.24],0.4324440042141482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZD2,PDZ domain-containing protein 2,41815,123,1.00 [0.74-1.35],0.9935026553691172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,41967,124,1.54 [1.11-2.12],0.0086897703620079
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEAR1,Platelet endothelial aggregation receptor 1,50221,168,1.34 [0.73-2.46],0.3460299555812185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEBP1,Phosphatidylethanolamine-binding protein 1,49619,166,1.22 [0.96-1.54],0.0967835104553025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECAM1,Platelet endothelial cell adhesion molecule,49619,166,0.86 [0.54-1.37],0.5355434918655176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PECR,Peroxisomal trans-2-enoyl-CoA reductase,42083,123,0.91 [0.48-1.70],0.7589046706809216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PENK,Proenkephalin-A,42273,122,1.25 [0.73-2.13],0.4176464079988531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,43258,128,0.46 [0.25-0.87],0.0175563246798653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PER3,Period circadian protein homolog 3,41967,124,1.00 [0.86-1.15],0.9461006172261596
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PF4,Platelet factor 4,42965,129,1.13 [0.95-1.34],0.16949004563737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN2,Prefoldin subunit 2,48439,166,1.15 [0.90-1.47],0.2629306202274193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN4,Prefoldin subunit 4,41687,124,1.16 [0.87-1.56],0.3116128514025365
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFDN6,Prefoldin subunit 6,42038,121,0.91 [0.68-1.23],0.5441613666375784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",49290,166,1.05 [0.88-1.25],0.5832294661718334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGA4,Pepsin A-4,43258,128,1.18 [0.94-1.47],0.1454624220302925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",43226,128,1.06 [0.77-1.45],0.7278767069620012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,50157,167,2.19 [1.44-3.34],0.0002556925259929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,49979,168,1.65 [1.26-2.17],0.0003350437461451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,42748,127,1.26 [0.70-2.25],0.437904753256201
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP4,Peptidoglycan recognition protein 4,41815,123,1.19 [0.93-1.52],0.1702583335902179
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGM2,Phosphoglucomutase-2,42038,121,0.86 [0.61-1.21],0.393793418426799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGR,Progesterone receptor,41967,124,0.99 [0.82-1.18],0.8745847032097118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHACTR2,Phosphatase and actin regulator 2,43149,126,0.96 [0.82-1.11],0.5518713070291352
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB1,Pleckstrin homology-like domain family B member 1,43035,128,1.08 [0.78-1.50],0.638298430131039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHLDB2,Pleckstrin homology-like domain family B member 2,41687,124,1.06 [0.89-1.26],0.5275089562333006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,49224,166,2.03 [1.29-3.19],0.0022533035241642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,42273,122,0.94 [0.62-1.43],0.7726918222991098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI16,Peptidase inhibitor 16,43258,128,0.92 [0.47-1.82],0.8132811897431719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,48970,166,1.49 [1.21-1.83],0.0002026420421798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",43149,126,0.97 [0.78-1.21],0.7727892784551216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,48977,164,2.38 [1.69-3.34],5.842701491125715e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,49537,166,1.04 [0.83-1.30],0.7255190744431972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,49619,166,1.96 [1.28-3.00],0.0018213774403264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,41967,124,0.83 [0.58-1.17],0.282379250663283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRA,Paired immunoglobulin-like type 2 receptor alpha,49619,166,1.71 [1.23-2.37],0.0012493090814729
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PILRB,Paired immunoglobulin-like type 2 receptor beta,49610,166,1.36 [1.06-1.75],0.0168141589776361
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,42273,122,0.99 [0.77-1.26],0.912826195079506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PITHD1,PITH domain-containing protein 1,41614,124,1.12 [0.92-1.36],0.2604857431605391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD1,Polycystin-1,43226,128,1.40 [0.74-2.66],0.2984547875644385
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD2,Polycystin-2,41815,123,1.34 [1.04-1.74],0.0260466789632783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKLR,Pyruvate kinase PKLR,49660,165,1.21 [0.99-1.47],0.061031457213952
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKN3,Serine/threonine-protein kinase N3,42437,128,0.91 [0.72-1.16],0.4594833680538349
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G10,Group 10 secretory phospholipase A2,49224,166,1.03 [0.81-1.31],0.7973058731516844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G15,Phospholipase A2 group XV,49753,165,2.23 [1.38-3.59],0.0010183876446463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G1B,Phospholipase A2,50139,168,1.04 [0.77-1.41],0.7781608589740097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G2A,"Phospholipase A2, membrane associated",49510,167,1.23 [0.99-1.53],0.0614815577310397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G4A,Cytosolic phospholipase A2,49821,165,1.04 [0.89-1.22],0.6011527048376814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G7,Platelet-activating factor acetylhydrolase,49619,166,0.95 [0.63-1.43],0.8080638646125435
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAT,Tissue-type plasminogen activator,50058,168,1.04 [0.80-1.37],0.7499043115013888
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAU,Urokinase-type plasminogen activator,49619,166,1.29 [0.88-1.90],0.1930318233586768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,49265,165,4.02 [2.67-6.06],2.6814439370395044e-11
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLB1,"Phospholipase B1, membrane-associated",43118,128,0.85 [0.64-1.12],0.2455013468319371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",41967,124,1.28 [0.91-1.80],0.1616649134752605
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",43118,128,0.98 [0.82-1.16],0.7924528379661364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLEKHO1,Pleckstrin homology domain-containing family O member 1,43118,128,0.95 [0.74-1.21],0.6684095236933035
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLG,Plasminogen,42189,127,2.42 [1.29-4.52],0.0056232704087215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN1,Perilipin-1,48439,166,1.43 [1.02-2.01],0.0405185933639946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLIN3,Perilipin-3,49610,166,1.19 [0.87-1.64],0.2706001057748047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLPBP,Pyridoxal phosphate homeostasis protein,49610,166,1.03 [0.84-1.27],0.7551535654539056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLSCR3,Phospholipid scramblase 3,43037,128,1.08 [0.81-1.46],0.5881175675029611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLTP,Phospholipid transfer protein,50059,168,0.85 [0.59-1.22],0.3721381873756296
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC1,Plexin domain-containing protein 1,48422,162,0.99 [0.64-1.52],0.9507291953328189
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXDC2,Plexin domain-containing protein 2,43118,128,1.22 [0.68-2.21],0.5016478164057712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNA4,Plexin-A4,49537,166,0.98 [0.82-1.16],0.7768165209839417
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB2,Plexin-B2,49978,168,1.77 [1.04-3.03],0.0366602176054513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLXNB3,Plexin-B3,49442,165,0.98 [0.73-1.31],0.8887686174868208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,49371,165,0.99 [0.92-1.06],0.7908142932906033
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMCH,Pro-MCH,41815,123,1.11 [0.93-1.33],0.2610285979574602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMM2,Phosphomannomutase 2,41815,123,1.06 [0.79-1.42],0.6783990457720368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMS1,PMS1 protein homolog 1,42038,121,1.08 [0.77-1.50],0.6571015502569681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMVK,Phosphomevalonate kinase,48362,166,1.04 [0.92-1.18],0.5431404462962959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIP,Pancreatic triacylglycerol lipase,43258,128,1.05 [0.81-1.36],0.7003317989049345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP1,Inactive pancreatic lipase-related protein 1,43118,128,1.08 [0.88-1.33],0.4509663220554732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNLIPRP2,Pancreatic lipase-related protein 2,49581,165,0.98 [0.94-1.02],0.3639687382775356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA1,Paraneoplastic antigen Ma1,42083,123,0.86 [0.63-1.19],0.3643335378860968
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNMA2,Paraneoplastic antigen Ma2,41816,123,1.19 [0.84-1.70],0.3207066870194122
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",48668,162,1.00 [0.89-1.13],0.961077046255612
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL,Podocalyxin,49371,166,0.59 [0.24-1.44],0.2429917485826309
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL2,Podocalyxin-like protein 2,49753,165,1.18 [0.73-1.92],0.4975797640435695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POF1B,Protein POF1B,41967,124,1.07 [0.73-1.55],0.7403852484446103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2A,DNA-directed RNA polymerase II subunit RPB1,41967,124,1.37 [0.80-2.33],0.2496482359669715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",49371,166,1.40 [1.03-1.90],0.0324039814013695
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POMC,Pro-opiomelanocortin,42083,123,1.15 [0.91-1.47],0.2428573734517186
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,43258,128,0.51 [0.31-0.85],0.0091281079947834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON2,Serum paraoxonase/arylesterase 2,48693,163,1.32 [0.90-1.94],0.1615763347239784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON3,Serum paraoxonase/lactonase 3,49821,165,0.97 [0.63-1.49],0.8860749795558946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,POSTN,Periostin,43224,130,1.11 [0.71-1.72],0.6487180362526803
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPBP,Platelet basic protein,42964,129,1.02 [0.83-1.24],0.8549443670064814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPCDC,Phosphopantothenoylcysteine decarboxylase,50052,168,1.06 [0.79-1.42],0.6813341127086578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIB,Peptidyl-prolyl cis-trans isomerase B,49648,168,1.01 [0.88-1.17],0.8554240482980655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIE,Peptidyl-prolyl cis-trans isomerase E,42437,128,1.07 [0.83-1.38],0.5967863120912253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",43224,130,1.06 [0.83-1.37],0.6273248055625652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPL,Periplakin,41967,124,1.48 [0.95-2.30],0.0828639959518598
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1A,Protein phosphatase 1A,48422,162,1.28 [0.88-1.85],0.1933837525581181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1B,Protein phosphatase 1B,41967,124,0.88 [0.63-1.22],0.4339384872135376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1F,Protein phosphatase 1F,43226,128,0.96 [0.70-1.33],0.8132087718920988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPME1,Protein phosphatase methylesterase 1,49371,166,1.13 [0.90-1.42],0.2769138160956909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,43021,127,0.95 [0.78-1.17],0.6544546107725688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,49753,165,0.98 [0.85-1.14],0.8266289022582526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,42437,128,0.90 [0.69-1.16],0.4077167281994698
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,43149,126,0.97 [0.78-1.21],0.8139910585571691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,43149,126,1.44 [1.00-2.06],0.0513291941408861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R2,Protein phosphatase inhibitor 2,49610,166,1.02 [0.86-1.22],0.7934981506056585
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP1R9B,Neurabin-2,50157,167,0.93 [0.80-1.07],0.3147184208957815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,43035,128,0.98 [0.85-1.14],0.8348343943792217
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPP3R1,Calcineurin subunit B type 1,49224,166,1.11 [0.79-1.56],0.5512596527937303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPT1,Palmitoyl-protein thioesterase 1,42038,121,1.08 [0.88-1.33],0.464076442618773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPY,Pancreatic prohormone,49522,164,1.07 [0.94-1.23],0.2898454777178914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PQBP1,Polyglutamine-binding protein 1,48422,162,1.06 [0.84-1.33],0.6355181460795397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAME,Melanoma antigen preferentially expressed in tumors,41687,124,1.46 [0.79-2.71],0.2309181486576164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRAP1,Proline-rich acidic protein 1,43224,130,1.56 [1.01-2.40],0.0449663946250739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRC1,Protein regulator of cytokinesis 1,43021,127,1.25 [0.95-1.64],0.1114114270064392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRCP,Lysosomal Pro-X carboxypeptidase,49914,167,0.95 [0.62-1.45],0.8007852521260381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX1,Peroxiredoxin-1,48199,163,1.03 [0.88-1.21],0.6935965047068422
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX2,Peroxiredoxin-2,42526,128,0.82 [0.62-1.08],0.1520973281279529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",48668,162,1.01 [0.83-1.22],0.9540948462225356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX5,"Peroxiredoxin-5, mitochondrial",50157,167,0.99 [0.81-1.21],0.9094629604247184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX6,Peroxiredoxin-6,50024,168,1.05 [0.84-1.31],0.6869619076045372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PREB,Prolactin regulatory element-binding protein,48668,162,1.61 [1.14-2.28],0.0074069355574765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,49581,165,2.37 [1.32-4.27],0.0039430267788806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,43224,130,1.53 [1.13-2.07],0.0061134336043712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG3,Proteoglycan 3,43224,130,1.24 [0.89-1.72],0.2066316629577438
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,48668,162,1.04 [0.80-1.35],0.7945360611578908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,42038,121,0.49 [0.26-0.93],0.0301709030765253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,49610,166,1.00 [0.85-1.18],0.9937275324033958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,43038,128,0.97 [0.78-1.20],0.7710968846490011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKCQ,Protein kinase C theta type,48668,162,1.19 [0.89-1.59],0.2425538427160078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKD2,Serine/threonine-protein kinase D2,41815,123,1.00 [0.67-1.50],0.9925009882644072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKG1,cGMP-dependent protein kinase 1,42273,122,0.92 [0.80-1.06],0.2515139667479127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,48422,162,1.02 [0.83-1.26],0.8386480391379474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRL,Prolactin,50052,168,1.03 [0.86-1.24],0.7451079204080805
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRND,Prion-like protein doppel,43118,128,0.86 [0.62-1.21],0.4008230832728996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROC,Vitamin K-dependent protein C,49726,167,0.73 [0.43-1.25],0.2563657950985893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROCR,Endothelial protein C receptor,41815,123,0.98 [0.59-1.64],0.9505340893191628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROK1,Prokineticin-1,49537,166,1.36 [1.08-1.71],0.0097984432772345
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PROS1,Vitamin K-dependent protein S,43287,129,1.56 [0.83-2.95],0.1684083379700685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR4,Proline-rich protein 4,41960,122,0.99 [0.77-1.27],0.936078121449982
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRR5,Proline-rich protein 5,41967,124,1.44 [1.07-1.93],0.0152185290055197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRRT3,Proline-rich transmembrane protein 3,42083,123,1.10 [0.70-1.71],0.6810365257868268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS2,Trypsin-2,49806,167,1.06 [0.83-1.35],0.6506660410662333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS22,Brain-specific serine protease 4,41967,124,1.57 [1.12-2.18],0.0082769060429077
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS27,Serine protease 27,49448,166,1.04 [0.74-1.46],0.8167416327305814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS53,Serine protease 53,43118,128,0.67 [0.43-1.03],0.0670553037247927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRSS8,Prostasin,49417,165,1.48 [1.07-2.03],0.0166600018926364
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,48439,166,1.04 [0.91-1.17],0.5790083060197406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTG,Protogenin,50024,168,1.53 [0.89-2.63],0.1235864988964935
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTN3,Myeloblastin,48376,162,1.28 [1.00-1.64],0.0538246725347822
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRUNE2,Protein prune homolog 2,42437,128,1.30 [0.78-2.18],0.319440213027807
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAP,Prosaposin,42822,130,1.75 [1.11-2.77],0.0158074544282665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSAPL1,Proactivator polypeptide-like 1,43035,128,0.92 [0.66-1.28],0.6191768078910199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSCA,Prostate stem cell antigen,43035,128,1.06 [0.99-1.14],0.0737068950844333
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSG1,Pregnancy-specific beta-1-glycoprotein 1,49224,166,1.01 [0.89-1.13],0.9140466259599632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSIP1,PC4 and SFRS1-interacting protein,49537,166,1.07 [0.88-1.30],0.5059328286567226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMA1,Proteasome subunit alpha type-1,48422,162,0.71 [0.51-1.01],0.0544123066418956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMC3,26S proteasome regulatory subunit 6A,41687,124,0.56 [0.31-1.01],0.0556969171214868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD1,26S proteasome non-ATPase regulatory subunit 1,43149,126,0.96 [0.68-1.36],0.8043892430085164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD5,26S proteasome non-ATPase regulatory subunit 5,42038,121,0.84 [0.58-1.22],0.3600490087843466
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMD9,26S proteasome non-ATPase regulatory subunit 9,49371,166,1.11 [0.88-1.41],0.3702199861815006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME1,Proteasome activator complex subunit 1,49145,165,1.20 [0.83-1.74],0.3241535121879307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSME2,Proteasome activator complex subunit 2,48994,165,1.34 [0.93-1.95],0.1188427615473599
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG3,Proteasome assembly chaperone 3,49537,166,1.25 [0.97-1.62],0.0873617984662053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMG4,Proteasome assembly chaperone 4,41967,124,0.99 [0.73-1.33],0.9291225013549136
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSPN,Persephin,49537,166,0.98 [0.84-1.13],0.7431682481010746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSRC1,Proline/serine-rich coiled-coil protein 1,48422,162,0.97 [0.76-1.23],0.8043336968718471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,40761,114,0.95 [0.81-1.13],0.5783806339363693
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",48439,166,1.02 [0.65-1.62],0.9187055103880342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGDS,Prostaglandin-H2 D-isomerase,49236,166,1.62 [1.09-2.40],0.0159305369402243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGES2,Prostaglandin E synthase 2,41640,123,1.27 [0.94-1.73],0.1249684051442967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTGR1,Prostaglandin reductase 1,43226,128,0.99 [0.81-1.21],0.9315202332049448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH,Parathyroid hormone,42038,121,1.14 [0.92-1.40],0.225480439805929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,49537,166,1.31 [0.99-1.73],0.0581958926350684
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTK7,Inactive tyrosine-protein kinase 7,48439,166,1.13 [0.78-1.63],0.5230844554371565
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTN,Pleiotrophin,48693,163,1.35 [1.03-1.77],0.0297853876175477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTP4A3,Protein tyrosine phosphatase type IVA 3,41967,124,1.04 [0.75-1.43],0.834724795134332
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,49224,166,1.05 [0.88-1.25],0.6062999707807418
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,49744,165,1.06 [0.91-1.24],0.4520823544308525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,41891,124,0.90 [0.56-1.45],0.679627769569399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRB,Receptor-type tyrosine-protein phosphatase beta,43226,128,1.46 [0.83-2.55],0.1886402062596228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRC,Receptor-type tyrosine-protein phosphatase C,43224,130,1.10 [0.53-2.26],0.801041555094453
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRF,Receptor-type tyrosine-protein phosphatase F,50221,168,0.91 [0.57-1.45],0.680909738993847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRH,Receptor-type tyrosine-protein phosphatase H,43035,128,1.03 [0.73-1.47],0.8557930950865216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,43035,128,1.02 [0.47-2.19],0.9628683387828132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRM,Receptor-type tyrosine-protein phosphatase mu,49456,165,0.81 [0.46-1.41],0.4514342615568851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,49060,166,0.95 [0.62-1.44],0.7964078764192091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRR,Receptor-type tyrosine-protein phosphatase R,43118,128,0.89 [0.56-1.40],0.6028554662669963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRS,Receptor-type tyrosine-protein phosphatase S,50221,168,1.39 [0.82-2.38],0.2237603236604076
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,43226,128,1.42 [0.84-2.41],0.1929868577034958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,42273,122,0.84 [0.63-1.13],0.2475002089149426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTS,6-pyruvoyl tetrahydrobiopterin synthase,48214,166,1.05 [0.82-1.34],0.7207253946112366
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTTG1,Securin,42437,128,0.74 [0.47-1.15],0.1816721227540723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTX3,Pentraxin-related protein PTX3,49537,166,1.35 [0.99-1.83],0.0553502132453916
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVALB,Parvalbumin alpha,49797,167,1.09 [0.96-1.24],0.1757636217895121
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,50052,168,2.00 [1.45-2.76],2.187634549912402e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXDNL,Peroxidasin-like protein,43021,127,1.07 [0.82-1.41],0.6028355653755427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PXN,Paxillin,48439,166,1.11 [0.86-1.43],0.4155932476657739
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYDC1,Pyrin domain-containing protein 1,42083,123,1.03 [0.68-1.55],0.9027537885571753
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYY,Peptide YY,41815,123,1.24 [1.05-1.45],0.0091170092226509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PZP,Pregnancy zone protein,43287,129,1.21 [0.85-1.73],0.2795379110768863
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QDPR,Dihydropteridine reductase,49366,165,1.05 [0.76-1.45],0.7899268352630868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,49667,166,2.52 [1.59-3.99],8.005434565972219e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,42425,127,1.52 [1.24-1.86],4.824240909906922e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB10,Ras-related protein Rab-10,43226,128,0.92 [0.67-1.27],0.6295470690983707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB11FIP3,Rab11 family-interacting protein 3,43226,128,0.89 [0.76-1.04],0.1451298491320837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB27B,Ras-related protein Rab-27B,43226,128,0.89 [0.73-1.08],0.2302667892313485
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB2B,Ras-related protein Rab-2B,43021,127,1.01 [0.77-1.34],0.9161320442980004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB33A,Ras-related protein Rab-33A,41815,123,0.99 [0.76-1.29],0.954166249403786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB37,Ras-related protein Rab-37,48668,162,0.92 [0.77-1.11],0.3844678938487178
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB39B,Ras-related protein Rab-39B,41815,123,0.89 [0.70-1.11],0.299969594136964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,41816,123,0.98 [0.72-1.33],0.882038502038906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB44,Ras-related protein Rab-44,43021,127,1.22 [0.91-1.63],0.1890774646097034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6A,Ras-related protein Rab-6A,49537,166,0.82 [0.60-1.11],0.1934595812843631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAB6B,Ras-related protein Rab-6B,48439,166,1.07 [0.81-1.41],0.6517356313244203
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEP1,Rab GTPase-binding effector protein 1,42273,122,0.84 [0.66-1.06],0.1357186202125915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEPK,Rab9 effector protein with kelch motifs,48422,162,1.13 [0.91-1.42],0.2718364515447168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABGAP1L,Rab GTPase-activating protein 1-like,48668,162,0.99 [0.79-1.25],0.9436495557867356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAC3,Ras-related C3 botulinum toxin substrate 3,42038,121,1.14 [0.92-1.42],0.2410936546513498
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD23B,UV excision repair protein RAD23 homolog B,48422,162,1.08 [0.80-1.45],0.621790368025557
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD51,DNA repair protein RAD51 homolog 1,42437,128,0.72 [0.48-1.08],0.1078283565902556
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALB,Ras-related protein Ral-B,41967,124,1.45 [0.83-2.54],0.18919782966871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RALY,RNA-binding protein Raly,43021,127,1.04 [0.74-1.45],0.8385303977684523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP1,Ran-specific GTPase-activating protein,42083,123,1.06 [0.76-1.47],0.7189408074889592
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANBP2,E3 SUMO-protein ligase RanBP2,41816,123,0.91 [0.53-1.57],0.7361480636977447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RANGAP1,Ran GTPase-activating protein 1,48422,162,0.82 [0.59-1.14],0.2358611585753023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAP1A,Ras-related protein Rap-1A,41967,124,1.21 [1.00-1.46],0.0500765715378099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAPGEF2,Rap guanine nucleotide exchange factor 2,42437,128,0.76 [0.54-1.08],0.1293070825980572
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES1,Retinoic acid receptor responder protein 1,48422,162,1.28 [0.90-1.82],0.1690176799049992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES2,Retinoic acid receptor responder protein 2,49891,167,1.33 [1.03-1.72],0.0313763218837329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASA1,Ras GTPase-activating protein 1,48439,166,1.17 [0.78-1.76],0.4569039809409483
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,41687,124,1.00 [0.67-1.49],0.996956992235312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RASSF2,Ras association domain-containing protein 2,48422,162,1.27 [1.06-1.52],0.0108408423339061
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,43149,126,1.94 [1.48-2.56],2.19614362511302e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBKS,Ribokinase,48451,166,1.25 [0.96-1.63],0.1009246106009898
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM17,Splicing factor 45,43149,126,1.02 [0.82-1.28],0.8333218891904567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM19,Probable RNA-binding protein 19,41815,123,1.09 [0.76-1.56],0.6319891606085477
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBM25,RNA-binding protein 25,41687,124,1.02 [0.70-1.49],0.9230308570610316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP1,Retinol-binding protein 1,42038,121,1.12 [0.90-1.40],0.3151715066136086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP2,Retinol-binding protein 2,49371,166,1.05 [0.88-1.25],0.6069054130112241
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP5,Retinol-binding protein 5,49371,166,1.33 [1.06-1.68],0.0138886602920405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBP7,Retinoid-binding protein 7,43035,128,1.29 [1.02-1.64],0.0327376057081463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS,RNA-binding protein with multiple splicing,41967,124,0.94 [0.70-1.25],0.6713493638612796
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBPMS2,RNA-binding protein with multiple splicing 2,42083,123,0.96 [0.81-1.15],0.6821497322210404
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCC1,Regulator of chromosome condensation,43021,127,1.11 [0.81-1.51],0.5227757306128156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RCOR1,REST corepressor 1,48693,163,1.00 [0.72-1.38],0.9941169329353704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,42083,123,1.22 [0.53-2.80],0.6438400765787851
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REEP4,Receptor expression-enhancing protein 4,43149,126,0.95 [0.71-1.27],0.7352514022758041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,49316,165,1.41 [1.11-1.80],0.0048046913055479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,50221,168,1.34 [1.09-1.66],0.0064172311702044
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,50221,168,1.36 [1.12-1.65],0.001741109188161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3G,Regenerating islet-derived protein 3-gamma,43021,127,1.10 [0.73-1.65],0.6517020414333785
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,49664,165,1.70 [1.34-2.16],1.4438542756976566e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELB,Transcription factor RelB,41967,124,0.96 [0.67-1.38],0.8271947566446816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,49619,166,1.89 [1.24-2.89],0.0030889016147548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REN,Renin,49610,166,1.23 [1.06-1.43],0.0062854290577496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REPS1,RalBP1-associated Eps domain-containing protein 1,41967,124,1.07 [0.69-1.66],0.7543809282641645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REST,RE1-silencing transcription factor,41687,124,0.82 [0.49-1.39],0.470605153121334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,49371,166,0.65 [0.46-0.93],0.0176779740460925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,49504,166,1.64 [1.24-2.16],0.0004601549103776
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REXO2,"Oligoribonuclease, mitochondrial",41815,123,0.79 [0.52-1.21],0.2778087642016583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RFC4,Replication factor C subunit 4,43021,127,1.06 [0.48-2.32],0.883860865854426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGCC,Regulator of cell cycle RGCC,43149,126,0.99 [0.79-1.23],0.8966995012727734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,42437,128,0.95 [0.72-1.26],0.7319356976962146
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMA,Repulsive guidance molecule A,50052,168,1.12 [0.73-1.71],0.6161537364672018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGMB,RGM domain family member B,50052,168,1.14 [0.70-1.86],0.5968816189172943
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS10,Regulator of G-protein signaling 10,43149,126,1.01 [0.76-1.35],0.93864189251718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RGS8,Regulator of G-protein signaling 8,48668,162,0.71 [0.53-0.94],0.0172572178824239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RHOC,Rho-related GTP-binding protein RhoC,48935,166,1.03 [0.91-1.16],0.6503239439756321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RICTOR,Rapamycin-insensitive companion of mTOR,41967,124,1.14 [0.83-1.56],0.4205955935938275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,42273,122,1.05 [0.75-1.48],0.7639908973885905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILP,Rab-interacting lysosomal protein,49878,168,1.15 [0.92-1.44],0.2139348861349464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RILPL2,RILP-like protein 2,43226,128,1.00 [0.84-1.18],0.96807361915261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,41815,123,0.97 [0.74-1.26],0.7956075004368457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN1,Prorelaxin H1,43149,126,0.96 [0.67-1.38],0.8190876004598447
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RLN2,Prorelaxin H2,42195,121,1.01 [0.77-1.32],0.9312102455764506
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE1,Ribonuclease pancreatic,43258,128,1.78 [1.00-3.18],0.0503574989743312
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE10,Inactive ribonuclease-like protein 10,42083,123,1.03 [0.72-1.47],0.8669349823489386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE3,Eosinophil cationic protein,49372,166,1.09 [0.97-1.22],0.1363678990369806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE4,Ribonuclease 4,41841,125,1.67 [0.97-2.89],0.0638930941759633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,42961,128,1.65 [1.18-2.31],0.0033227985906536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASEH2A,Ribonuclease H2 subunit A,43149,126,0.84 [0.57-1.24],0.383828283542546
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,49988,167,2.09 [1.36-3.22],0.0007646535946442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF149,E3 ubiquitin-protein ligase RNF149,42083,123,1.56 [0.95-2.56],0.078443120587816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF168,E3 ubiquitin-protein ligase RNF168,41967,124,1.05 [0.69-1.62],0.8113249469036372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF31,E3 ubiquitin-protein ligase RNF31,41967,124,1.03 [0.64-1.65],0.907228761244826
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF4,E3 ubiquitin-protein ligase RNF4,42437,128,0.91 [0.69-1.20],0.5013680663760307
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF41,E3 ubiquitin-protein ligase NRDP1,48422,162,1.02 [0.83-1.26],0.8322334331461817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF43,E3 ubiquitin-protein ligase RNF43,42437,128,1.00 [0.74-1.35],0.9960425817147244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNF5,E3 ubiquitin-protein ligase RNF5,42083,123,0.83 [0.66-1.05],0.1213193898227316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO1,Roundabout homolog 1,49664,165,1.69 [0.98-2.92],0.0571213049450784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO2,Roundabout homolog 2,50052,168,1.32 [0.73-2.37],0.3596100397656373
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROBO4,Roundabout homolog 4,42083,123,1.10 [0.41-2.92],0.8491118393742285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,49610,166,1.59 [1.04-2.41],0.0309871697551232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RP2,Protein XRP2,49371,166,1.27 [0.94-1.72],0.1152501000906449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPA2,Replication protein A 32 kDa subunit,41967,124,1.04 [0.60-1.81],0.8840659410794329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPE,Ribulose-phosphate 3-epimerase,42437,128,0.91 [0.71-1.17],0.4478353997190463
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPGR,X-linked retinitis pigmentosa GTPase regulator,42038,121,1.24 [0.87-1.77],0.2403388437959066
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPL14,60S ribosomal protein L14,42083,123,0.93 [0.59-1.46],0.7553475342844784
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RPS10,40S ribosomal protein S10,41815,123,1.19 [0.83-1.72],0.3419503809467911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRAS,Ras-related protein R-Ras,42038,121,0.93 [0.81-1.07],0.293218289764305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2,Ribonucleoside-diphosphate reductase subunit M2,48422,162,1.18 [0.93-1.49],0.1659984067769465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,48422,162,1.06 [0.87-1.31],0.5527058236507609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RRP15,RRP15-like protein,41816,123,0.99 [0.82-1.20],0.918444319498055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO1,R-spondin-1,49224,166,1.64 [1.14-2.37],0.0082067781434622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,50024,168,2.63 [1.78-3.89],1.2533462027043378e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTBDN,Retbindin,49371,166,0.97 [0.61-1.54],0.9063785528456656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTKN2,Rhotekin-2,41815,123,1.31 [1.02-1.68],0.0367960748798932
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",43149,126,0.99 [0.83-1.20],0.9423804379545712
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RTN4R,Reticulon-4 receptor,50024,168,1.40 [0.96-2.05],0.0778395268080763
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RUVBL1,RuvB-like 1,48422,162,1.06 [0.93-1.20],0.3700840135368799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RWDD1,RWD domain-containing protein 1,50052,168,1.01 [0.82-1.26],0.9051574735461396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RYR1,Ryanodine receptor 1,41815,123,0.68 [0.37-1.23],0.1998782291256022
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,49215,165,1.45 [1.17-1.80],0.0007288644790295
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A12,Protein S100-A12,48901,166,1.26 [1.05-1.50],0.011536490817223
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A13,Protein S100-A13,41967,124,1.69 [1.15-2.47],0.0074631131824161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A14,Protein S100-A14,43149,126,0.85 [0.61-1.19],0.3519471020164102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A16,Protein S100-A16,48361,166,0.84 [0.66-1.07],0.1657898645190127
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A3,Protein S100-A3,43021,127,1.08 [0.76-1.53],0.6749290746395039
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A4,Protein S100-A4,49753,165,1.00 [0.79-1.28],0.9732340549127992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100G,Protein S100-G,43149,126,1.00 [0.70-1.42],0.9954937080130536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100P,Protein S100-P,48693,163,1.20 [0.96-1.49],0.1062742908381551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,43287,129,1.55 [1.17-2.05],0.00233815195421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAFB2,Scaffold attachment factor B2,43149,126,0.84 [0.44-1.62],0.6119518102079722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAG,S-arrestin,41816,123,1.01 [0.72-1.42],0.9348715730649048
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAMD9L,Sterile alpha motif domain-containing protein 9-like,49537,166,1.05 [0.87-1.27],0.6066160400661289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAP18,Histone deacetylase complex subunit SAP18,42437,128,0.96 [0.76-1.22],0.7377294128657569
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SARG,Specifically androgen-regulated gene protein,43068,128,0.99 [0.85-1.15],0.8879603873280012
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SART1,U4/U6.U5 tri-snRNP-associated protein 1,41815,123,1.25 [0.87-1.81],0.2275673415850859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT1,Diamine acetyltransferase 1,41815,123,1.15 [0.84-1.58],0.3809424205822723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAT2,Thialysine N-epsilon-acetyltransferase,42437,128,1.05 [0.82-1.34],0.7149159491344148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SATB1,DNA-binding protein SATB1,43149,126,0.98 [0.55-1.77],0.9526508218576676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SBSN,Suprabasin,43144,130,0.80 [0.49-1.28],0.3487155181737924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCAMP3,Secretory carrier-associated membrane protein 3,49371,166,1.05 [0.90-1.24],0.5326469671054419
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARA5,Scavenger receptor class A member 5,50052,168,1.56 [1.00-2.42],0.048714787272199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB1,Scavenger receptor class B member 1,48439,166,0.99 [0.77-1.27],0.9093288939546867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,48282,164,2.12 [1.49-3.01],2.8836764606601527e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF1,Scavenger receptor class F member 1,50221,168,1.17 [0.85-1.61],0.3450100160890412
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,50052,168,2.38 [1.53-3.69],0.0001115843506647
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG2,Secretogranin-2,49796,168,1.62 [1.09-2.42],0.0177236689725936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG3,Secretogranin-3,49664,165,0.95 [0.63-1.42],0.7966383365153794
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB1A1,Uteroglobin,49664,164,0.83 [0.65-1.05],0.1182770021389414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB2A2,Mammaglobin-A,41815,123,1.19 [0.71-2.00],0.5118138390581357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A1,Secretoglobin family 3A member 1,42273,122,0.64 [0.33-1.26],0.1970422623994993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGB3A2,Secretoglobin family 3A member 2,49744,165,1.13 [0.98-1.31],0.0912248679585548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCGN,Secretagogin,48668,162,1.05 [0.77-1.43],0.7577384240180767
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCIN,Adseverin,41816,123,1.03 [0.82-1.30],0.791498900987901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCLY,Selenocysteine lyase,49878,168,1.18 [0.89-1.56],0.2586212042566274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2A,Sodium channel protein type 2 subunit alpha,41816,123,1.11 [0.80-1.55],0.5202319614720676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN2B,Sodium channel subunit beta-2,42038,121,0.95 [0.50-1.78],0.8642576634373629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3A,Sodium channel protein type 3 subunit alpha,42038,121,1.02 [0.63-1.66],0.925423053830283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN3B,Sodium channel subunit beta-3,41816,123,0.81 [0.54-1.22],0.3142372349194925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCN4B,Sodium channel subunit beta-4,42083,123,0.92 [0.62-1.38],0.6935507247323967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCP2,Non-specific lipid-transfer protein,48422,162,0.98 [0.80-1.19],0.8033350492400386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCPEP1,Retinoid-inducible serine carboxypeptidase,41926,123,1.06 [0.75-1.50],0.7548433661024992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRG1,Scrapie-responsive protein 1,43226,128,1.75 [1.06-2.88],0.0281174445011713
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRIB,Protein scribble homolog,42083,123,0.93 [0.75-1.14],0.4646481351986782
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRN1,Secernin-1,49537,166,1.08 [0.84-1.38],0.548681833438245
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCT,Secretin,42038,121,1.03 [0.72-1.47],0.8848836828957926
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC1,Syndecan-1,49610,166,1.18 [0.84-1.66],0.3269934189853827
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC4,Syndecan-4,49610,166,0.81 [0.61-1.08],0.1469978766742835
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDCCAG8,Serologically defined colon cancer antigen 8,43021,127,0.96 [0.83-1.12],0.5955240916398099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDHB,Succinate dehydrogenase,43035,128,1.09 [0.85-1.40],0.4777012053407204
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDK2,Protein sidekick-2,42273,122,0.79 [0.49-1.28],0.3442232258804653
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEC31A,Protein transport protein Sec31A,42083,123,0.96 [0.77-1.20],0.714043049601018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEL1L,Protein sel-1 homolog 1,42083,123,1.16 [0.71-1.92],0.5521335584604834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELE,E-selectin,50221,168,1.00 [0.77-1.31],0.9717937945334272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELENOP,Selenoprotein P,43287,129,0.77 [0.37-1.62],0.4911436297314298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELL,L-selectin,43287,129,1.32 [0.64-2.71],0.4484061150148006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELP,P-selectin,49806,167,0.90 [0.71-1.15],0.408246701615233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELPLG,P-selectin glycoprotein ligand 1,49537,166,0.77 [0.50-1.17],0.2196704638593184
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3F,Semaphorin-3F,49610,166,1.57 [0.95-2.62],0.0805264142894059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA3G,Semaphorin-3G,42273,122,1.24 [0.85-1.80],0.263259353011836
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4C,Semaphorin-4C,49371,166,1.58 [1.09-2.29],0.0164112500853451
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA4D,Semaphorin-4D,50052,168,0.90 [0.57-1.41],0.6415487491615246
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA6C,Semaphorin-6C,41967,124,1.59 [0.94-2.66],0.0809058703580735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEMA7A,Semaphorin-7A,50058,168,1.41 [0.91-2.20],0.1244065600475945
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN3,Neuronal-specific septin-3,43149,126,1.10 [0.89-1.37],0.3708194661586099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN7,Septin-7,42437,128,1.23 [0.96-1.58],0.1076834574402147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN8,Septin-8,43036,128,1.63 [1.03-2.58],0.0369360104099702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEPTIN9,Septin-9,49371,166,1.18 [0.75-1.86],0.4747505932008768
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA1,Alpha-1-antitrypsin,42479,129,5.04 [1.24-20.57],0.0241731640563523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,50221,168,2.01 [1.43-2.82],5.1872640346527614e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA12,Serpin A12,48169,160,1.03 [0.91-1.16],0.6691891637626601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA3,Alpha-1-antichymotrypsin,43137,129,2.05 [0.79-5.27],0.137953315364062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA4,Kallistatin,42501,126,2.26 [1.12-4.55],0.0230494450573119
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA5,Plasma serine protease inhibitor,42663,128,1.15 [0.69-1.91],0.6044770006771814
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA6,Corticosteroid-binding globulin,43287,129,2.04 [0.73-5.73],0.176822796646587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA7,Thyroxine-binding globulin,43287,129,0.92 [0.37-2.27],0.8602673477280421
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA9,Serpin A9,49137,166,1.09 [0.90-1.31],0.3825994284681157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB1,Leukocyte elastase inhibitor,49462,166,1.11 [0.95-1.28],0.1876556756801472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB5,Serpin B5,48693,163,0.95 [0.72-1.27],0.7420631719167602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB6,Serpin B6,49888,168,1.03 [0.81-1.30],0.8327211891589275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB8,Serpin B8,50157,167,1.22 [1.01-1.47],0.0408069548406248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINB9,Serpin B9,49224,166,1.26 [0.83-1.91],0.2805445650207816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINC1,Antithrombin-III,43204,129,2.62 [0.86-8.00],0.0913421127880602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPIND1,Heparin cofactor 2,43204,129,1.62 [0.90-2.94],0.1094130777809564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE1,Plasminogen activator inhibitor 1,50221,168,0.95 [0.78-1.17],0.6520858230807081
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINE2,Glia-derived nexin,43226,128,0.90 [0.70-1.18],0.455746459066199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF1,Pigment epithelium-derived factor,42627,129,1.19 [0.63-2.23],0.5930640812457249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINF2,Alpha-2-antiplasmin,42473,128,3.55 [1.10-11.47],0.0340144833519583
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPING1,Plasma protease C1 inhibitor,43204,129,2.37 [0.97-5.82],0.0597654991889256
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINH1,Serpin H1,42437,128,1.01 [0.88-1.15],0.9157503811616032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI1,Neuroserpin,42194,122,0.93 [0.51-1.68],0.8057959867850527
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINI2,Serpin I2,43035,128,1.05 [0.78-1.40],0.753725837494522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,48439,166,0.98 [0.79-1.22],0.8761726011668893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SETMAR,Histone-lysine N-methyltransferase SETMAR,49063,166,0.90 [0.56-1.43],0.6498411093998242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6,Seizure protein 6 homolog,42038,121,1.20 [0.69-2.09],0.5175109573138041
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L,Seizure 6-like protein,49753,165,1.02 [0.62-1.68],0.9281246548674013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SEZ6L2,Seizure 6-like protein 2,49371,166,1.40 [0.80-2.48],0.2420469143877274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SF3B4,Splicing factor 3B subunit 4,49371,166,1.05 [0.87-1.26],0.59790193865193
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,49061,166,1.71 [1.33-2.21],3.036812641771642e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP4,Secreted frizzled-related protein 4,42273,122,0.72 [0.47-1.12],0.1427298639555773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA1,Pulmonary surfactant-associated protein A1,48422,162,1.16 [0.93-1.44],0.189134893911939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,48422,162,1.51 [1.20-1.91],0.0005183258349403
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPD,Pulmonary surfactant-associated protein D,49610,166,0.95 [0.78-1.16],0.6172906089864716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SGSH,N-sulphoglucosamine sulphohydrolase,42511,128,1.09 [0.81-1.46],0.5585192415048662
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2B3,SH2B adapter protein 3,48422,162,1.00 [0.86-1.15],0.9668857047260004
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH2D1A,SH2 domain-containing protein 1A,49537,166,0.90 [0.70-1.16],0.4261456435580808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,41816,123,1.21 [0.96-1.52],0.1018058900673499
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3BP1,SH3 domain-binding protein 1,43035,128,0.98 [0.70-1.39],0.9258470369182118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GL3,Endophilin-A3,42205,128,0.97 [0.80-1.19],0.7864395996124998
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SH3GLB2,Endophilin-B2,43118,128,1.04 [0.81-1.34],0.7364196987233458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHBG,Sex hormone-binding globulin,43258,128,1.18 [0.83-1.67],0.3482040783508062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHC1,SHC-transforming protein 1,41687,124,1.08 [0.94-1.24],0.2799771861233457
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHD,SH2 domain-containing adapter protein D,41733,123,1.06 [0.89-1.28],0.5027151002067392
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHH,Sonic hedgehog protein,41967,124,0.76 [0.50-1.17],0.2183553315404013
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,43224,130,1.97 [1.34-2.89],0.000567848802474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHMT1,"Serine hydroxymethyltransferase, cytosolic",49744,165,0.99 [0.84-1.17],0.9195230182481564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHPK,Sedoheptulokinase,42437,128,0.93 [0.60-1.44],0.7546611022289889
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIAE,Sialate O-acetylesterase,49672,164,1.11 [0.82-1.49],0.4950789560427393
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC1,Sialoadhesin,49821,165,1.52 [1.12-2.08],0.0079936762943065
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC10,Sialic acid-binding Ig-like lectin 10,49537,166,1.15 [0.78-1.70],0.4899611483820905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC15,Sialic acid-binding Ig-like lectin 15,48439,166,0.88 [0.71-1.07],0.2025909097986619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC5,Sialic acid-binding Ig-like lectin 5,49619,166,1.16 [1.01-1.32],0.0339553581487584
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC6,Sialic acid-binding Ig-like lectin 6,50024,168,1.21 [0.81-1.81],0.3512944615730691
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC7,Sialic acid-binding Ig-like lectin 7,49610,166,1.15 [0.70-1.88],0.5786387227287777
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC8,Sialic acid-binding Ig-like lectin 8,42083,123,1.47 [1.02-2.13],0.0394975617731971
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC9,Sialic acid-binding Ig-like lectin 9,49953,168,1.41 [0.90-2.22],0.1360207309696676
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIL1,Nucleotide exchange factor SIL1,42083,123,1.02 [0.59-1.76],0.941412981622346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,49736,168,1.33 [1.03-1.72],0.0291076949306522
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRPB1,Signal-regulatory protein beta-1,49497,165,1.21 [0.91-1.61],0.1963191386940903
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT1,NAD-dependent protein deacetylase sirtuin-1,41967,124,0.98 [0.79-1.21],0.8296561063111377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT2,NAD-dependent protein deacetylase sirtuin-2,49371,166,1.11 [0.95-1.30],0.2006338782974168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",48439,166,1.00 [0.78-1.29],0.9808512931970867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIT1,Signaling threshold-regulating transmembrane adapter 1,48668,162,1.09 [0.85-1.39],0.4965733379815031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP1,Src kinase-associated phosphoprotein 1,49141,166,0.95 [0.79-1.14],0.5847992160901883
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKAP2,Src kinase-associated phosphoprotein 2,49821,165,0.96 [0.84-1.09],0.518449650267508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SKIV2L,Helicase SKI2W,41815,123,1.06 [0.69-1.62],0.7962050046940464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLA2,Src-like-adapter 2,43149,126,1.02 [0.87-1.20],0.7713157521178244
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF1,Signaling lymphocytic activation molecule,48668,162,1.33 [1.04-1.68],0.0204960032893757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF6,SLAM family member 6,48422,162,0.92 [0.63-1.33],0.6474124344810999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF7,SLAM family member 7,49537,166,1.23 [0.98-1.54],0.0695240551313233
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF8,SLAM family member 8,48422,162,1.50 [1.15-1.95],0.0025678428531101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC12A2,Solute carrier family 12 member 2,41815,123,1.27 [0.75-2.14],0.3712491729955746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC13A1,Solute carrier family 13 member 1,43021,127,0.85 [0.60-1.20],0.3536882657411491
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC16A1,Monocarboxylate transporter 1,48439,166,1.07 [0.85-1.35],0.5611634556393925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC1A4,Neutral amino acid transporter A,42038,121,1.24 [0.92-1.66],0.1514179564880635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC27A4,Long-chain fatty acid transport protein 4,48439,166,1.09 [0.89-1.34],0.4181056041960913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC28A1,Sodium/nucleoside cotransporter 1,41687,124,1.11 [0.85-1.45],0.4402153642806551
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC34A3,Sodium-dependent phosphate transport protein 2C,41687,124,1.12 [0.80-1.57],0.5043270456795156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A14,Zinc transporter ZIP14,48439,166,1.35 [0.94-1.95],0.1065438716605782
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC39A5,Zinc transporter ZIP5,49537,166,1.23 [0.98-1.56],0.0780778591104436
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC44A4,Choline transporter-like protein 4,42038,121,1.14 [0.92-1.43],0.2339966677953528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC4A1,Band 3 anion transport protein,43224,130,1.04 [0.73-1.47],0.8460977074324031
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC51B,Organic solute transporter subunit beta,41815,123,0.97 [0.76-1.23],0.7983307341505137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,42273,122,1.00 [0.82-1.23],0.9746599457354308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,43035,128,1.14 [0.85-1.53],0.3700726464566529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",41687,124,0.85 [0.60-1.19],0.3347824736313508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLIT2,Slit homolog 2 protein,48439,166,0.92 [0.70-1.21],0.5436114555060874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK1,SLIT and NTRK-like protein 1,41967,124,0.69 [0.40-1.18],0.1723648293243325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK2,SLIT and NTRK-like protein 2,50024,168,0.93 [0.66-1.31],0.698099141632619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLITRK6,SLIT and NTRK-like protein 6,48693,163,1.05 [0.70-1.56],0.8183969201525205
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLK,STE20-like serine/threonine-protein kinase,42437,128,0.98 [0.78-1.23],0.8688595703255859
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLMAP,Sarcolemmal membrane-associated protein,43035,128,1.02 [0.83-1.25],0.852037742340144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLURP1,Secreted Ly-6/uPAR-related protein 1,42906,128,1.09 [0.71-1.67],0.707092125270472
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD1,Mothers against decapentaplegic homolog 1,48422,162,1.02 [0.86-1.21],0.8234258361552651
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD2,Mothers against decapentaplegic homolog 2,43021,127,0.96 [0.75-1.23],0.7650717663174809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD3,Mothers against decapentaplegic homolog 3,43021,127,1.05 [0.76-1.46],0.7635732240887754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMAD5,Mothers against decapentaplegic homolog 5,49371,166,0.80 [0.40-1.60],0.537601802286165
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMARCA2,Probable global transcription activator SNF2L2,48439,166,0.87 [0.71-1.06],0.1674883361544928
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMC3,Structural maintenance of chromosomes protein 3,41687,124,0.86 [0.60-1.22],0.4012052787343459
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMNDC1,Survival of motor neuron-related-splicing factor 30,43035,128,1.17 [0.93-1.47],0.1746107386989147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,50024,168,1.98 [1.36-2.90],0.0004051928303078
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC2,SPARC-related modular calcium-binding protein 2,49821,165,1.52 [1.08-2.14],0.0165257730933222
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD1,Sphingomyelin phosphodiesterase,49810,168,1.17 [0.89-1.52],0.2531731292961192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPD3,Sphingomyelin phosphodiesterase 3,41967,124,1.11 [0.84-1.47],0.4745648893956882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,49737,165,1.18 [0.95-1.46],0.1315519934170534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,43021,127,0.99 [0.79-1.24],0.924670482879354
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMS,Spermine synthase,41816,123,0.97 [0.73-1.29],0.8584060778140257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMTN,Smoothelin,43036,128,1.01 [0.84-1.22],0.8960777184497523
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP23,Synaptosomal-associated protein 23,49610,166,0.93 [0.80-1.08],0.3453671756326674
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP25,Synaptosomal-associated protein 25,41816,123,1.31 [0.92-1.86],0.1374482658692162
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAP29,Synaptosomal-associated protein 29,49753,165,0.98 [0.85-1.14],0.8250840187710649
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAPIN,SNARE-associated protein Snapin,43149,126,0.78 [0.57-1.06],0.107053026589216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCA,Alpha-synuclein,42273,122,0.97 [0.84-1.13],0.7314193376291622
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,49224,166,1.51 [1.22-1.86],0.0001244609567194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",42083,123,1.13 [0.67-1.91],0.6537579330701093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNRPB2,U2 small nuclear ribonucleoprotein B'',43118,128,1.18 [0.88-1.58],0.2581545017959821
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNU13,NHP2-like protein 1,41815,123,0.78 [0.56-1.10],0.1544220605088882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX15,Sorting nexin-15,42273,122,0.96 [0.70-1.33],0.8218658514490531
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX18,Sorting nexin-18,43035,128,1.21 [0.86-1.71],0.2809431944353543
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX2,Sorting nexin-2,43021,127,0.90 [0.72-1.11],0.316154678560944
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX5,Sorting nexin-5,42083,123,0.89 [0.48-1.63],0.6984571211831442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNX9,Sorting nexin-9,49610,166,1.04 [0.85-1.27],0.7146631794604957
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD1,Superoxide dismutase [Cu-Zn],48619,164,1.11 [0.83-1.48],0.472092951846809
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD2,"Superoxide dismutase [Mn], mitochondrial",49619,166,1.28 [0.92-1.79],0.1481134317983766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOD3,Extracellular superoxide dismutase,43258,128,1.00 [0.75-1.32],0.9849113556883904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORBS1,Sorbin and SH3 domain-containing protein 1,43149,126,1.38 [1.01-1.89],0.0424901230158624
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORCS2,VPS10 domain-containing receptor SorCS2,48422,162,1.38 [0.95-2.01],0.0901863055952143
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORD,Sorbitol dehydrogenase,49796,167,1.02 [0.83-1.25],0.8628742097980664
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SORT1,Sortilin,49536,166,0.97 [0.67-1.40],0.8681149863831665
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOST,Sclerostin,49536,166,0.89 [0.63-1.26],0.504808446955334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,42038,121,0.99 [0.70-1.41],0.9637031257677708
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX2,Transcription factor SOX-2,43066,126,0.59 [0.28-1.27],0.1784451982509895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SOX9,Transcription factor SOX-9,42038,121,1.55 [0.81-2.98],0.1848564286351112
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,43149,126,1.17 [0.69-1.99],0.5700269089304195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPAG1,Sperm-associated antigen 1,43149,126,0.91 [0.66-1.24],0.5426737148919811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARC,SPARC,49753,165,0.94 [0.78-1.14],0.5585182153640315
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPARCL1,SPARC-like protein 1,49645,167,1.12 [0.69-1.81],0.6385652709022469
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPART,Spartin,42273,122,0.88 [0.69-1.11],0.2659521432667688
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPESP1,Sperm equatorial segment protein 1,43226,128,0.96 [0.57-1.62],0.8908979220610067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,49619,166,1.74 [1.33-2.29],6.085102615209409e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK2,Serine protease inhibitor Kazal-type 2,42273,122,1.37 [0.89-2.12],0.156199801708495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,49537,166,1.32 [1.10-1.60],0.0036529376564427
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK5,Serine protease inhibitor Kazal-type 5,49619,166,1.27 [0.86-1.88],0.225945931561475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK6,Serine protease inhibitor Kazal-type 6,50024,168,1.37 [1.05-1.78],0.0188564842166617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK8,Serine protease inhibitor Kazal-type 8,41815,123,1.02 [0.64-1.65],0.9208475427264912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,49454,165,2.03 [1.26-3.25],0.0034183945202057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT2,Kunitz-type protease inhibitor 2,49821,165,1.28 [0.90-1.80],0.1645277854947751
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT3,Kunitz-type protease inhibitor 3,43035,128,0.99 [0.89-1.10],0.8463832526849328
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPOCK1,Testican-1,49224,166,0.81 [0.48-1.38],0.4470817525404886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,49664,165,2.16 [1.60-2.91],3.83049386433931e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON2,Spondin-2,49371,165,2.01 [1.38-2.93],0.0002628344432769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPP1,Osteopontin,50142,168,1.49 [1.12-1.98],0.0067084147350182
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",41967,124,0.93 [0.61-1.42],0.7216010998906909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRING1,SREBP regulating gene protein,41687,124,0.91 [0.66-1.25],0.5610730642781375
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR1B,Cornifin-B,42437,128,0.92 [0.74-1.16],0.4923266906217443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRR3,Small proline-rich protein 3,43118,128,1.07 [0.83-1.38],0.5843110356539001
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPRY2,Protein sprouty homolog 2,48668,162,0.98 [0.84-1.15],0.8247458982969719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",41816,123,0.80 [0.45-1.44],0.4545130137064663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPTLC1,Serine palmitoyltransferase 1,43118,128,1.05 [0.68-1.63],0.8311024880803015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRC,Proto-oncogene tyrosine-protein kinase Src,49672,165,1.00 [0.89-1.12],0.9657095733955384
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRP14,Signal recognition particle 14 kDa protein,49371,166,1.27 [1.03-1.56],0.0265045947610107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPK2,SRSF protein kinase 2,49537,166,0.97 [0.82-1.15],0.7526722766591682
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPX,Sushi repeat-containing protein SRPX,43226,128,1.96 [1.23-3.13],0.0048432741893741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSB,Lupus La protein,48439,166,1.03 [0.81-1.29],0.8256781322367097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",41967,124,1.06 [0.66-1.72],0.7985395082660142
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,49536,166,0.95 [0.85-1.07],0.3807273290614431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,49806,167,1.21 [0.88-1.66],0.2443166072495786
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSH3,Protein phosphatase Slingshot homolog 3,41687,124,1.14 [0.64-2.02],0.6478839127858742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSNA1,Sjoegren syndrome nuclear autoantigen 1,43035,128,1.10 [0.80-1.52],0.5574305056706901
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST13,Hsc70-interacting protein,42273,122,0.83 [0.60-1.13],0.2313381900987108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",49371,166,0.87 [0.62-1.22],0.4189655537727635
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",50221,168,1.31 [0.85-2.03],0.2244323642116876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",41967,124,1.17 [0.87-1.57],0.289854957304769
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAB2,Stabilin-2,43224,130,1.76 [0.97-3.18],0.0612328854646629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAM,Signal transducing adapter molecule 1,43021,127,0.91 [0.56-1.48],0.7170419330464874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAMBP,STAM-binding protein,49141,166,1.02 [0.82-1.27],0.8623318501458797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT2,Signal transducer and activator of transcription 2,41967,124,1.04 [0.83-1.30],0.7649038989039347
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAT5B,Signal transducer and activator of transcription 5B,49371,166,1.01 [0.91-1.12],0.8217408269270989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,41687,124,0.84 [0.62-1.13],0.2478322253749433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC1,Stanniocalcin-1,50052,168,1.30 [0.98-1.74],0.0727801197803927
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC2,Stanniocalcin-2,49550,166,1.60 [0.91-2.84],0.1056356197457837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STEAP4,Metalloreductase STEAP4,41816,123,0.77 [0.57-1.04],0.0885471375290783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STIP1,Stress-induced-phosphoprotein 1,49536,166,1.10 [0.89-1.36],0.3669979206193959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK11,Serine/threonine-protein kinase STK11,48693,163,1.07 [0.88-1.29],0.5158673619819987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK24,Serine/threonine-protein kinase 24,48439,166,1.03 [0.82-1.29],0.8142945861202153
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STK4,Serine/threonine-protein kinase 4,49610,166,0.97 [0.83-1.14],0.691982735455019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STOML2,"Stomatin-like protein 2, mitochondrial",41687,124,1.08 [0.91-1.29],0.3949435925706405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX16,Syntaxin-16,48422,162,1.05 [0.82-1.34],0.7166790859630954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX1B,Syntaxin-1B,42038,121,1.06 [0.71-1.58],0.7664581118160619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX3,Syntaxin-3,43118,128,0.79 [0.47-1.31],0.3572215051490847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX4,Syntaxin-4,49371,166,1.10 [0.88-1.38],0.4067980781016848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX5,Syntaxin-5,41967,124,1.18 [0.81-1.72],0.3889082037356329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX6,Syntaxin-6,48422,162,0.86 [0.68-1.10],0.225282599585264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX7,Syntaxin-7,41967,124,0.93 [0.65-1.33],0.6883866544532811
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX8,Syntaxin-8,49537,166,1.15 [0.87-1.52],0.3260681063477844
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP1,Syntaxin-binding protein 1,43149,126,0.97 [0.78-1.21],0.8045349096363719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STXBP3,Syntaxin-binding protein 3,48422,162,1.26 [0.93-1.69],0.1345970700019834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGP1,SURP and G-patch domain-containing protein 1,43035,128,0.79 [0.51-1.24],0.3061506461357059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGT1,Protein SGT1 homolog,48422,162,1.10 [0.92-1.31],0.2778972209298631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT1A1,Sulfotransferase 1A1,50052,168,1.03 [0.93-1.15],0.5552784592828386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SULT2A1,Bile salt sulfotransferase,49537,166,1.32 [1.08-1.61],0.0068988011497915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF1,Formylglycine-generating enzyme,41967,124,1.09 [0.86-1.38],0.4859679988831139
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,50052,168,1.02 [0.78-1.32],0.9023100592710468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUOX,"Sulfite oxidase, mitochondrial",43149,126,0.99 [0.75-1.31],0.9559367883523228
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD1,Sushi domain-containing protein 1,48693,163,1.09 [0.82-1.45],0.5726258493136958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD2,Sushi domain-containing protein 2,49619,166,1.70 [1.10-2.61],0.0167359520403732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD4,Sushi domain-containing protein 4,43021,127,1.13 [0.76-1.68],0.5447074420819633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUSD5,Sushi domain-containing protein 5,42047,121,1.10 [0.66-1.83],0.7111662562889407
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SV2A,Synaptic vesicle glycoprotein 2A,42038,121,0.89 [0.66-1.20],0.4301760874759954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SWAP70,Switch-associated protein 70,43035,128,1.08 [0.68-1.70],0.756189623783594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYAP1,Synapse-associated protein 1,42273,122,0.83 [0.60-1.13],0.2366788039814034
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,41816,123,0.98 [0.72-1.33],0.8900430809175658
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYT1,Synaptotagmin-1,43118,128,0.95 [0.61-1.49],0.836803854590074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SYTL4,Synaptotagmin-like protein 4,43226,128,0.94 [0.75-1.20],0.6389770658819558
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,42437,128,0.88 [0.75-1.04],0.1403839664465284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACC3,Transforming acidic coiled-coil-containing protein 3,49371,166,1.02 [0.91-1.15],0.6939894160718431
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,43944,144,1.76 [1.19-2.60],0.0045272283831804
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TADA3,Transcriptional adapter 3,43021,127,1.10 [0.72-1.69],0.6499413432507861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAFA5,Chemokine-like protein TAFA-5,49371,166,1.72 [1.22-2.42],0.0019840405523429
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAGLN3,Transgelin-3,41687,124,1.20 [0.93-1.55],0.1593922584286329
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TALDO1,Transaldolase,43070,130,0.95 [0.64-1.39],0.7814796012723176
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TANK,TRAF family member-associated NF-kappa-B activator,48668,162,0.96 [0.78-1.17],0.6681874462652515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAP1,Antigen peptide transporter 1,42437,128,0.91 [0.66-1.25],0.5526098829132128
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARBP2,RISC-loading complex subunit TARBP2,48439,166,0.99 [0.83-1.18],0.9182425600634668
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",42038,121,0.88 [0.68-1.14],0.3207168926937226
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",43021,127,0.98 [0.62-1.56],0.9321688413969276
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAX1BP1,Tax1-binding protein 1,43118,128,0.96 [0.73-1.27],0.7725562558211242
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D17,TBC1 domain family member 17,48439,166,1.08 [0.81-1.46],0.5928500243950003
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D23,TBC1 domain family member 23,49371,166,0.95 [0.81-1.10],0.4789295726920172
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBC1D5,TBC1 domain family member 5,49537,166,0.98 [0.82-1.17],0.8387316690915005
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCA,Tubulin-specific chaperone A,42273,122,0.94 [0.76-1.15],0.539708923043925
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCB,Tubulin-folding cofactor B,49224,166,1.05 [0.92-1.21],0.4580119075162298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBCC,Tubulin-specific chaperone C,49224,166,1.06 [0.89-1.26],0.5085259666283619
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBL1X,F-box-like/WD repeat-containing protein TBL1X,48422,162,1.03 [0.88-1.22],0.6842071522365578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TBR1,T-box brain protein 1,42038,121,0.86 [0.58-1.30],0.4811342940993801
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,49151,166,0.83 [0.73-0.95],0.0067428054992254
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1B,T-cell leukemia/lymphoma protein 1B,48693,163,0.97 [0.81-1.17],0.7479440558565986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN1,Transcobalamin-1,42401,127,1.22 [0.80-1.86],0.3455695448188508
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCN2,Transcobalamin-2,50142,168,1.71 [1.17-2.50],0.0059328462175208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCOF1,Treacle protein,43226,128,1.09 [0.65-1.84],0.7434946245503018
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCP11,T-complex protein 11 homolog,42437,128,1.04 [0.79-1.38],0.7729218695902355
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCTN3,Tectonic-3,43226,128,1.14 [0.65-1.99],0.6467130907341267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDGF1,Teratocarcinoma-derived growth factor 1,48439,166,0.96 [0.87-1.06],0.4206133077767389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDO2,"Tryptophan 2,3-dioxygenase",42038,121,0.93 [0.58-1.50],0.7761967957943391
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDP1,Tyrosyl-DNA phosphodiesterase 1,43021,127,0.98 [0.77-1.25],0.883052191370036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TDRKH,Tudor and KH domain-containing protein,48439,166,1.06 [0.90-1.25],0.5143462901163423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEF,Thyrotroph embryonic factor,41815,123,1.09 [0.74-1.61],0.6607587127366547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEK,Angiopoietin-1 receptor,49753,165,1.60 [0.86-2.97],0.1365992112390383
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TERF1,Telomeric repeat-binding factor 1,41967,124,1.08 [0.60-1.94],0.8034271831081492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TET2,Methylcytosine dioxygenase TET2,42360,128,1.07 [0.92-1.25],0.3667589820260458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX101,Testis-expressed protein 101,42038,121,0.69 [0.50-0.95],0.02432727831829
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX33,Testis-expressed protein 33,42437,128,0.85 [0.52-1.39],0.521073191982236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TF,Serotransferrin,43287,129,1.02 [0.47-2.21],0.9593126353762896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFAP2A,Transcription factor AP-2-alpha,41816,123,1.02 [0.77-1.36],0.8843905510915087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,49381,165,1.24 [1.06-1.44],0.0055162581784631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,49744,165,1.51 [1.22-1.87],0.0001553273721137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,49566,167,1.56 [1.25-1.94],7.877570400102439e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI,Tissue factor pathway inhibitor,49482,167,0.94 [0.61-1.47],0.7982302202307681
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFPI2,Tissue factor pathway inhibitor 2,49603,164,1.28 [0.99-1.67],0.0629788211385123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFRC,Transferrin receptor protein 1,49812,166,1.18 [0.83-1.68],0.34966886441617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TG,Thyroglobulin,43021,127,1.07 [0.93-1.24],0.3511406567831797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,49537,166,1.53 [1.18-2.00],0.0014574980840861
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB1,Transforming growth factor beta-1 proprotein,50075,166,1.28 [0.91-1.81],0.159938292064089
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFB2,Transforming growth factor beta-2 proprotein,43021,127,0.99 [0.72-1.37],0.9739145264163552
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBI,Transforming growth factor-beta-induced protein ig-h3,49317,166,0.82 [0.50-1.36],0.4492471084742293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR1,TGF-beta receptor type-1,41967,124,1.48 [0.75-2.91],0.2619718978935909
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,49753,165,1.72 [1.22-2.43],0.0020893897749087
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR3,Transforming growth factor beta receptor type 3,50221,168,1.48 [0.95-2.29],0.0829177773168995
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGM2,Protein-glutamine gamma-glutamyltransferase 2,49526,166,1.12 [0.93-1.34],0.2331144873357091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGOLN2,Trans-Golgi network integral membrane protein 2,43258,128,1.23 [0.65-2.31],0.5217062592819948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THAP12,52 kDa repressor of the inhibitor of the protein kinase,41614,124,1.00 [0.82-1.23],0.9987704172581
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBD,Thrombomodulin,49610,166,1.14 [0.71-1.82],0.5798452403581026
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,49619,166,1.66 [1.21-2.27],0.0014880636917052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,49644,167,1.60 [1.19-2.15],0.0016602041675473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THOP1,Thimet oligopeptidase,49375,165,1.09 [0.71-1.69],0.6865176367959396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THPO,Thrombopoietin,48693,163,1.04 [0.73-1.47],0.8477391618827402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THRAP3,Thyroid hormone receptor-associated protein 3,41815,123,1.09 [0.95-1.26],0.2217138747917706
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THSD1,Thrombospondin type-1 domain-containing protein 1,41640,123,0.90 [0.53-1.52],0.7003391371110448
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THTPA,Thiamine-triphosphatase,42942,127,0.92 [0.76-1.12],0.4151832050364834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THY1,Thy-1 membrane glycoprotein,50052,168,1.57 [1.00-2.49],0.0516079475595575
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIA1,Nucleolysin TIA-1 isoform p40,48150,160,1.05 [0.93-1.17],0.444878908648443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIE1,Tyrosine-protein kinase receptor Tie-1,50221,168,0.97 [0.70-1.33],0.8320168050783368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",48356,166,1.27 [0.96-1.67],0.0902167720043313
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,42437,128,0.77 [0.47-1.27],0.3123216985990232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,49806,167,1.49 [1.10-2.01],0.0099425364238528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,43226,128,0.91 [0.59-1.40],0.6634222013359719
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,43118,128,0.92 [0.76-1.13],0.4365254082949694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP1,Metalloproteinase inhibitor 1,49078,166,1.83 [1.19-2.82],0.005952717491371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP2,Metalloproteinase inhibitor 2,43226,128,1.32 [0.85-2.07],0.219314151260456
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP3,Metalloproteinase inhibitor 3,49821,165,1.02 [0.92-1.13],0.7677557765010893
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP4,Metalloproteinase inhibitor 4,49619,166,1.46 [1.06-1.99],0.0186756040103846
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TINAGL1,Tubulointerstitial nephritis antigen-like,49452,166,1.54 [0.83-2.86],0.1729695852616867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJAP1,Tight junction-associated protein 1,49753,165,0.93 [0.78-1.10],0.3750600866043468
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TJP3,Tight junction protein ZO-3,41816,123,0.84 [0.54-1.31],0.4427784836854098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TK1,"Thymidine kinase, cytosolic",42437,128,0.99 [0.68-1.45],0.9756773965810294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR1,Toll-like receptor 1,41967,124,1.52 [0.83-2.79],0.1790143077715487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR2,Toll-like receptor 2,42437,128,0.98 [0.47-2.03],0.949650231811912
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR3,Toll-like receptor 3,50157,167,0.89 [0.72-1.11],0.2940652968181781
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TLR4,Toll-like receptor 4,41967,124,0.97 [0.52-1.79],0.9117781627471948
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,42038,121,1.21 [0.90-1.62],0.211050642967164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED1,Transmembrane emp24 domain-containing protein 1,42437,128,0.79 [0.56-1.12],0.1800205643645378
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED10,Transmembrane emp24 domain-containing protein 10,41815,123,1.06 [0.76-1.48],0.7379039567583963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED4,Transmembrane emp24 domain-containing protein 4,41815,123,1.04 [0.78-1.40],0.7679656506642261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMED8,Protein TMED8,43035,128,0.97 [0.83-1.15],0.757431841388377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM106A,Transmembrane protein 106A,43021,127,0.87 [0.68-1.11],0.2693338749262495
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM132A,Transmembrane protein 132A,42083,123,1.08 [0.82-1.42],0.6055504250042356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMEM25,Transmembrane protein 25,43149,126,0.99 [0.68-1.43],0.9461801008327376
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMOD4,Tropomodulin-4,41687,124,0.93 [0.60-1.45],0.7528022681990278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11B,Transmembrane protease serine 11B,41816,123,1.13 [0.92-1.38],0.2470695046946687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS11D,Transmembrane protease serine 11D,43036,128,1.31 [0.88-1.93],0.1788991724522644
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS15,Enteropeptidase,49371,166,0.96 [0.82-1.11],0.5595805232302657
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMPRSS5,Transmembrane protease serine 5,48989,166,1.03 [0.72-1.47],0.8812415314622749
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TMSB10,Thymosin beta-10,49619,166,1.27 [1.06-1.52],0.0099627959502924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNC,Tenascin,49806,167,1.48 [1.12-1.94],0.0052303922577214
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNF,Tumor necrosis factor,48620,163,1.20 [0.87-1.66],0.2706198001534842
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,43035,128,1.12 [0.80-1.56],0.5197238989998756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,48668,162,0.92 [0.63-1.35],0.6673659199354174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,42273,122,0.88 [0.67-1.18],0.3999649287267515
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,49224,166,1.84 [1.37-2.45],4.0111612095975647e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,49224,166,1.35 [1.14-1.60],0.0005293657077591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,49737,167,1.10 [0.83-1.46],0.5082464053466701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,50157,167,1.56 [1.14-2.15],0.0061819842996815
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,49581,165,2.44 [1.61-3.70],2.7258131451660387e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,49753,165,1.67 [1.17-2.39],0.0049762813555372
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,49664,165,1.75 [1.33-2.30],5.870044380854451e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,48668,162,0.88 [0.63-1.22],0.4368205760996986
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,49664,165,1.69 [1.11-2.55],0.0136582806759611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,42273,122,1.08 [0.71-1.65],0.7067889872211732
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,50024,168,1.73 [1.20-2.50],0.0032342152251103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,49619,166,2.25 [1.54-3.29],2.6984966266471056e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,49619,166,1.53 [1.18-1.98],0.001319077668996
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,50052,168,1.58 [0.99-2.53],0.0544492334919402
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,50075,166,1.47 [1.05-2.05],0.0237652496923757
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,49224,166,1.41 [1.14-1.73],0.0013105628454939
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,50052,168,1.26 [0.94-1.68],0.1167316538991155
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,49224,166,1.36 [1.03-1.81],0.0324204315736308
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,50157,167,0.49 [0.29-0.82],0.0073302708104215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF11,Tumor necrosis factor ligand superfamily member 11,49537,166,0.79 [0.63-0.99],0.0420510703133015
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF12,Tumor necrosis factor ligand superfamily member 12,50157,167,1.02 [0.63-1.65],0.9358848696862362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13,Tumor necrosis factor ligand superfamily member 13,49821,165,1.77 [1.08-2.89],0.0231849155255631
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,50140,168,1.94 [1.29-2.93],0.0014811761205019
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF14,Tumor necrosis factor ligand superfamily member 14,49224,166,1.22 [0.97-1.53],0.0913457396326215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF8,Tumor necrosis factor ligand superfamily member 8,43224,130,1.13 [0.72-1.78],0.5877699795334479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNIP1,TNFAIP3-interacting protein 1,43118,128,0.96 [0.79-1.16],0.6497902990539268
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNN,Tenascin-N,43224,130,1.09 [0.74-1.61],0.6487270549791093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNNI3,"Troponin I, cardiac muscle",48693,163,1.18 [0.99-1.41],0.0614094044514895
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNPO1,Transportin-1,42437,128,0.87 [0.53-1.43],0.5876771955624344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNR,Tenascin-R,49224,166,0.72 [0.52-0.99],0.0441412448925232
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNXB,Tenascin-X,49619,166,0.98 [0.58-1.67],0.9431299267549011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,43226,128,0.94 [0.75-1.18],0.606495858615967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1,DNA topoisomerase 1,43035,128,0.94 [0.82-1.09],0.4223890577005876
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP1MT,"DNA topoisomerase I, mitochondrial",41687,124,1.29 [0.96-1.75],0.0924162987257779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOP2B,DNA topoisomerase 2-beta,41967,124,1.04 [0.83-1.29],0.7528613815095259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TOR1AIP1,Torsin-1A-interacting protein 1,42083,123,0.97 [0.69-1.35],0.8545928924331723
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53,Cellular tumor antigen p53,48422,162,0.94 [0.67-1.30],0.690577661387486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53BP1,TP53-binding protein 1,41967,124,1.04 [0.85-1.28],0.670510650857933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53I3,Quinone oxidoreductase PIG3,41361,119,0.99 [0.71-1.38],0.9410452615174648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP53INP1,Tumor protein p53-inducible nuclear protein 1,48693,163,0.93 [0.58-1.49],0.753274862497954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TP73,Tumor protein p73,42038,121,1.04 [0.62-1.74],0.8752070545814277
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPBGL,Trophoblast glycoprotein-like,42038,121,0.81 [0.51-1.29],0.3728294116572331
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPD52L2,Tumor protein D54,42273,122,0.98 [0.83-1.15],0.8066440054772838
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPK1,Thiamin pyrophosphokinase 1,43226,128,0.67 [0.36-1.23],0.1977436644710185
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPM3,Tropomyosin alpha-3 chain,41815,123,1.01 [0.68-1.48],0.9782939426436924
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPMT,Thiopurine S-methyltransferase,48422,162,1.09 [0.90-1.31],0.3943719308939377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPP1,Tripeptidyl-peptidase 1,49263,164,1.22 [0.92-1.61],0.1610899482449399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP2,Tubulin polymerization-promoting protein family member 2,42437,128,0.91 [0.72-1.15],0.4213618364496554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPPP3,Tubulin polymerization-promoting protein family member 3,48439,166,0.99 [0.69-1.41],0.9518199618262618
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPR,Nucleoprotein TPR,41815,123,1.05 [0.75-1.47],0.7724461511685259
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPRKB,EKC/KEOPS complex subunit TPRKB,41687,124,1.05 [0.82-1.36],0.6844677516190338
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSAB1,Tryptase alpha/beta-1,50072,167,1.36 [1.04-1.77],0.0249405327359414
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSD1,Tryptase delta,43149,126,1.19 [0.80-1.77],0.3825945634584677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPSG1,Tryptase gamma,41967,124,1.17 [0.63-2.17],0.6133499039230415
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TPT1,Translationally-controlled tumor protein,48668,162,1.06 [0.87-1.30],0.545593562180381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF2,TNF receptor-associated factor 2,49537,166,0.87 [0.71-1.06],0.1681342941978056
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3,"TNF receptor-associated factor 3, Isoform 2",41967,124,0.94 [0.59-1.50],0.7846527511977696
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,41815,123,0.95 [0.65-1.38],0.7813377879931235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,42437,128,1.00 [0.82-1.22],0.990458614008072
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREH,Trehalase,43224,130,1.11 [0.88-1.39],0.3863393719619148
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREM2,Triggering receptor expressed on myeloid cells 2,49581,165,1.05 [0.82-1.36],0.6950281406204744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML1,Trem-like transcript 1 protein,43258,128,0.85 [0.61-1.18],0.3279139494794399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TREML2,Trem-like transcript 2 protein,49619,166,1.18 [0.80-1.75],0.4016764771394344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIAP1,TP53-regulated inhibitor of apoptosis 1,50024,168,1.24 [1.00-1.53],0.0547979791051284
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM21,E3 ubiquitin-protein ligase TRIM21,49537,166,0.91 [0.76-1.09],0.3024090521703401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM24,Transcription intermediary factor 1-alpha,42358,128,0.96 [0.74-1.26],0.7856802881189124
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,43035,128,0.91 [0.78-1.06],0.2378588860599267
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM26,Tripartite motif-containing protein 26,41687,124,0.93 [0.67-1.28],0.6393397942764398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM40,E3 ubiquitin ligase TRIM40,42038,121,1.01 [0.79-1.28],0.9662413647429156
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM5,Tripartite motif-containing protein 5,49537,166,0.95 [0.81-1.11],0.5114295437363976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRIM58,E3 ubiquitin-protein ligase TRIM58,43021,127,0.92 [0.76-1.12],0.418571062786963
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TRPV3,Transient receptor potential cation channel subfamily V member 3,41815,123,1.29 [0.98-1.69],0.0713693869824166
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC1,Hamartin,41967,124,0.92 [0.71-1.20],0.5264605639501168
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC22D1,TSC22 domain family protein 1,43149,126,0.97 [0.74-1.26],0.7938836980458248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSHB,Thyrotropin subunit beta,49610,166,0.89 [0.74-1.06],0.1853911972726258
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSLP,Thymic stromal lymphopoietin,48693,163,0.95 [0.75-1.21],0.6713493659022701
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSNAX,Translin-associated protein X,41815,123,0.90 [0.57-1.41],0.6491398806046011
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN1,Tetraspanin-1,48693,163,0.92 [0.76-1.13],0.4330908416272381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN15,Tetraspanin-15,41815,123,1.06 [0.78-1.45],0.6918366398771594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN7,Tetraspanin-7,41816,123,1.03 [0.86-1.23],0.7647740013355091
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPAN8,Tetraspanin-8,43035,128,1.10 [0.93-1.30],0.2671549878002964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSPYL1,Testis-specific Y-encoded-like protein 1,41967,124,1.25 [0.83-1.89],0.2924406661379529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TST,Thiosulfate sulfurtransferase,48358,166,1.03 [0.86-1.24],0.7217430971629377
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTF2,Transcription termination factor 2,42038,121,0.69 [0.47-1.01],0.0577003900246746
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTN,Titin,41815,123,1.05 [0.81-1.35],0.7240772906787799
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTR,Transthyretin,42825,127,0.70 [0.36-1.35],0.2808411928848434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TUBB3,Tubulin beta-3 chain,41816,123,1.17 [0.64-2.15],0.6025044039289791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TWF2,Twinfilin-2,43224,130,0.98 [0.80-1.19],0.8176457741819443
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXK,Tyrosine-protein kinase TXK,42437,128,0.84 [0.64-1.10],0.1973993827741265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXLNA,Alpha-taxilin,49224,166,0.98 [0.84-1.15],0.7908963017793548
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXN,Thioredoxin,42562,126,1.25 [0.89-1.75],0.207066059777524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC15,Thioredoxin domain-containing protein 15,49753,165,1.40 [0.85-2.29],0.1844470238296718
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC5,Thioredoxin domain-containing protein 5,50052,168,1.13 [0.93-1.38],0.2304174397207875
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNDC9,Thioredoxin domain-containing protein 9,43118,128,1.00 [0.73-1.38],0.98916587446187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNL1,Thioredoxin-like protein 1,41735,123,0.86 [0.70-1.07],0.1748073030343847
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",49619,166,1.11 [0.83-1.50],0.4813922638694221
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYMP,Thymidine phosphorylase,49292,164,1.08 [0.87-1.33],0.50065618368266
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRO3,Tyrosine-protein kinase receptor TYRO3,49610,166,1.25 [0.77-2.03],0.3711120467110382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",41967,124,1.09 [0.83-1.44],0.527327661555274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBAC1,Ubiquitin-associated domain-containing protein 1,49371,166,1.19 [0.80-1.77],0.3818140171069816
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2B,Ubiquitin-conjugating enzyme E2 B,43021,127,1.04 [0.58-1.88],0.8864892214285356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,43226,128,1.13 [0.86-1.49],0.379739869384389
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,41967,124,1.12 [0.85-1.48],0.4101476802348305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,41815,123,1.46 [1.18-1.81],0.0004922683161257
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBXN1,UBX domain-containing protein 1,42273,122,0.95 [0.73-1.23],0.6825657191253423
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,43035,128,0.98 [0.87-1.11],0.7459180361129988
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UGDH,UDP-glucose 6-dehydrogenase,41815,123,0.94 [0.77-1.14],0.504109882902792
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UHRF2,E3 ubiquitin-protein ligase UHRF2,41815,123,1.05 [0.63-1.72],0.8619943411837027
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ULBP2,UL16-binding protein 2,49224,166,1.34 [0.95-1.88],0.0903356266443808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UMOD,Uromodulin,50064,168,0.88 [0.69-1.13],0.3228556743154382
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC5D,Netrin receptor UNC5D,41967,124,1.11 [0.59-2.12],0.7422067163700934
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNC79,Protein unc-79 homolog,41687,124,0.91 [0.65-1.26],0.5513401945694275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UNG,Uracil-DNA glycosylase,43021,127,0.93 [0.56-1.53],0.7636976980262441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPB1,Beta-ureidopropionase,43226,128,1.17 [0.98-1.40],0.0846505073548841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3A,Uroplakin-3a,41816,123,1.13 [0.80-1.58],0.4930398288262743
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UPK3BL1,Uroplakin-3b-like protein 1,42353,128,0.80 [0.54-1.19],0.2812194687526096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROD,Uroporphyrinogen decarboxylase,42273,122,0.85 [0.66-1.10],0.2120667234086656
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UROS,Uroporphyrinogen-III synthase,42038,121,0.75 [0.56-1.01],0.0589985539128279
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USO1,General vesicular transport factor p115,49371,166,1.05 [0.90-1.23],0.4957941418440645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP25,Ubiquitin carboxyl-terminal hydrolase 25,43021,127,0.98 [0.78-1.25],0.89403202952371
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP28,Ubiquitin carboxyl-terminal hydrolase 28,43118,128,1.49 [1.05-2.09],0.0237241456868611
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP47,Ubiquitin carboxyl-terminal hydrolase 47,41815,123,0.97 [0.79-1.20],0.8024738241830311
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,USP8,Ubiquitin carboxyl-terminal hydrolase 8,48693,163,1.03 [0.89-1.19],0.7273242141237093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UXS1,UDP-glucuronic acid decarboxylase 1,48422,162,0.93 [0.70-1.22],0.5852673945128686
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP5,Vesicle-associated membrane protein 5,48693,163,1.21 [0.97-1.51],0.0837013652747192
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAMP8,Vesicle-associated membrane protein 8,41967,124,1.04 [0.85-1.27],0.696845144383931
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASH1,Tubulinyl-Tyr carboxypeptidase 1,49537,166,1.07 [0.91-1.27],0.3979509238177074
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASN,Vasorin,48828,163,1.12 [0.68-1.85],0.655331911247911
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VASP,Vasodilator-stimulated phosphoprotein,43258,128,0.94 [0.74-1.19],0.5973887173546812
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,49371,166,0.61 [0.30-1.24],0.1742606239209104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VAV3,Guanine nucleotide exchange factor VAV3,41816,123,1.00 [0.84-1.19],0.9969064552595872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAM1,Vascular cell adhesion protein 1,49726,167,1.86 [1.16-2.96],0.0093736041672987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAN,Versican core protein,50052,168,1.54 [0.99-2.38],0.0554636063465535
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCPKMT,Protein-lysine methyltransferase METTL21D,41687,124,0.89 [0.71-1.13],0.3465922057679897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFA,Vascular endothelial growth factor A,49993,166,1.05 [0.83-1.33],0.6676783740619707
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFB,Vascular endothelial growth factor B,41967,124,1.52 [0.84-2.73],0.1636196320991249
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFC,Vascular endothelial growth factor C,49753,165,1.00 [0.79-1.28],0.979266336167494
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VEGFD,Vascular endothelial growth factor D,50074,166,1.49 [1.02-2.16],0.0380076154756832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VGF,Neurosecretory protein VGF,43149,126,0.65 [0.37-1.15],0.1400597930067171
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIM,Vimentin,48693,163,1.00 [0.89-1.13],0.9393771606752608
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIPR1,Vasoactive intestinal polypeptide receptor 1,42083,123,0.89 [0.42-1.89],0.7696723077891274
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VIT,Vitrin,43226,128,1.35 [0.87-2.10],0.1776780640418536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VMO1,Vitelline membrane outer layer protein 1 homolog,49371,166,1.00 [0.82-1.22],0.975395996935766
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN1,Pantetheinase,43258,128,0.97 [0.77-1.22],0.7872879380012475
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VNN2,Vascular non-inflammatory molecule 2,49371,166,1.55 [1.13-2.13],0.0061922705663306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS28,Vacuolar protein sorting-associated protein 28 homolog,42437,128,0.93 [0.71-1.21],0.5934478853168216
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS37A,Vacuolar protein sorting-associated protein 37A,49371,166,0.96 [0.80-1.14],0.6210622975401262
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS4B,Vacuolar protein sorting-associated protein 4B,43021,127,1.01 [0.85-1.21],0.8775478234279536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VPS53,Vacuolar protein sorting-associated protein 53 homolog,49371,166,0.99 [0.83-1.19],0.9184100142255628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10,V-set and immunoglobulin domain-containing protein 10,43021,127,1.04 [0.65-1.68],0.8694615213360947
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,41815,123,0.99 [0.58-1.68],0.9635542598477398
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG2,V-set and immunoglobulin domain-containing protein 2,43021,127,1.46 [1.16-1.83],0.0010591800528793
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,49550,166,1.69 [1.25-2.29],0.0007115471079754
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,49534,166,1.03 [0.82-1.28],0.8238739905606449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSNL1,Visinin-like protein 1,43118,128,1.02 [0.66-1.58],0.9122605065671144
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM1,V-set and transmembrane domain-containing protein 1,48439,166,1.18 [0.90-1.54],0.2377853410279104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2B,V-set and transmembrane domain-containing protein 2B,42437,128,0.89 [0.57-1.39],0.6079622974284787
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,48693,163,0.78 [0.60-1.01],0.0606367694709059
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,50052,168,1.04 [0.86-1.25],0.71586625488028
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTCN1,V-set domain-containing T-cell activation inhibitor 1,48422,162,1.09 [0.70-1.70],0.7110551397435321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,42273,122,0.92 [0.67-1.26],0.6069913965044441
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA1,von Willebrand factor A domain-containing protein 1,49949,168,1.13 [0.81-1.57],0.4697605248879629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWA5A,von Willebrand factor A domain-containing protein 5A,41687,124,0.93 [0.73-1.19],0.5671082600658715
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2,Brorin,49059,166,1.34 [0.96-1.88],0.0832231883197455
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWC2L,von Willebrand factor C domain-containing protein 2-like,43149,126,0.87 [0.57-1.33],0.5203690259666097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VWF,von Willebrand factor,50221,168,1.06 [0.88-1.27],0.5551791103910626
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WARS,"Tryptophan--tRNA ligase, cytoplasmic",49619,166,1.35 [0.94-1.93],0.10460971533534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WAS,Wiskott-Aldrich syndrome protein,48668,162,0.94 [0.76-1.17],0.6043983979526625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF1,Wiskott-Aldrich syndrome protein family member 1,48693,163,0.98 [0.84-1.14],0.8226256535082358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASF3,Wiskott-Aldrich syndrome protein family member 3,48439,166,1.08 [0.92-1.28],0.3447417799547896
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASHC3,WASH complex subunit 3,43118,128,0.93 [0.74-1.17],0.5395049204990529
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WASL,Neural Wiskott-Aldrich syndrome protein,41967,124,0.87 [0.63-1.20],0.393153707775617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WDR46,WD repeat-containing protein 46,43021,127,1.16 [0.76-1.77],0.4978186450557862
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC1,WAP four-disulfide core domain protein 1,42163,124,1.02 [0.74-1.39],0.910898548230559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC12,WAP four-disulfide core domain protein 12,49941,168,1.06 [0.86-1.30],0.610949984645196
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,47080,155,2.04 [1.54-2.70],6.366863003876852e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",49063,166,0.70 [0.50-0.98],0.0374925811953852
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",49664,165,1.09 [0.72-1.63],0.6909942321983482
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,50024,168,1.89 [1.28-2.79],0.0012671560070591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,48668,162,1.80 [1.20-2.71],0.0047209563816765
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,49224,166,0.89 [0.68-1.15],0.36755541816433
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XCL1,Lymphotactin,50024,168,1.30 [1.05-1.62],0.0155902099262493
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,49982,168,1.77 [1.22-2.56],0.0026508695619667
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XIAP,E3 ubiquitin-protein ligase XIAP,41967,124,0.91 [0.66-1.24],0.530114911740756
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XPNPEP2,Xaa-Pro aminopeptidase 2,49753,165,0.84 [0.74-0.95],0.0070829763112687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XRCC4,DNA repair protein XRCC4,48439,166,0.89 [0.61-1.32],0.5721155905091837
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,43118,128,3.02 [1.84-4.95],1.2087852931299509e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",43035,128,1.00 [0.89-1.12],0.9351725334670462
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YES1,Tyrosine-protein kinase Yes,49371,166,0.98 [0.86-1.10],0.6865298296526
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YJU2,Splicing factor YJU2,43021,127,1.15 [0.69-1.90],0.589706495568625
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YOD1,Ubiquitin thioesterase OTU1,41815,123,0.96 [0.73-1.27],0.7659206708247321
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YTHDF3,YTH domain-containing family protein 3,48668,162,0.96 [0.82-1.13],0.6409223071639962
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YWHAQ,14-3-3 protein theta,42273,122,0.91 [0.71-1.15],0.4248668763024199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YY1,Transcriptional repressor protein YY1,41967,124,0.77 [0.41-1.45],0.412662454665587
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBP1,Z-DNA-binding protein 1,41967,124,1.07 [0.70-1.63],0.7627492689070032
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB16,Zinc finger and BTB domain-containing protein 16,48422,162,1.03 [0.84-1.25],0.7978340059690959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZBTB17,Zinc finger and BTB domain-containing protein 17,48693,163,1.16 [0.85-1.56],0.3479780262343663
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZCCHC8,Zinc finger CCHC domain-containing protein 8,41815,123,0.91 [0.67-1.23],0.5352426110723325
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZFYVE19,Abscission/NoCut checkpoint regulator,43035,128,0.99 [0.82-1.20],0.9209281768317092
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZHX2,Zinc fingers and homeoboxes protein 2,43118,128,1.07 [0.67-1.70],0.7815634458700227
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF174,Zinc finger protein 174,41967,124,1.01 [0.64-1.61],0.9557918021137316
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF75D,Zinc finger protein 75D,42437,128,0.94 [0.70-1.26],0.665226567740704
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF830,Zinc finger protein 830,43021,127,1.26 [1.05-1.50],0.0124305061966841
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRD2,Protein ZNRD2,43035,128,1.05 [0.82-1.34],0.7016019168596288
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,43021,127,1.22 [0.91-1.63],0.1880786121639683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP3,Zona pellucida sperm-binding protein 3,42083,123,1.01 [0.95-1.08],0.6862021502840434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZP4,Zona pellucida sperm-binding protein 4,41687,124,0.64 [0.33-1.24],0.1838175828254563
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZPR1,Zinc finger protein ZPR1,41816,123,0.98 [0.81-1.18],0.8290254922423579
